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INAPPROPRIATE ANTIBIOTIC USE: A SURVEY OF PROVIDER PRESCRIBING
BEHAVIORS

An Abstract of the Scholarly Project by
Brice I. Saunders

Antibiotics save lives and are one of the most widely used medications of modern
medicine. However, the widespread use of antibiotics has led to the development of
antimicrobial resistance (AMR). AMR is a major public health crisis with disastrous
consequences on national and global healthcare systems. AMR is associated with
increased healthcare costs, increased morbidity and mortality, longer hospital stays,
increased readmission rates, and overall poorer patient outcomes. The use of antibiotics is
the single most important leading factor involved in the development of resistance.
Current estimates suggest that at least 30% and up to 50% of all antibiotics prescribed are
unnecessary. The majority of antibiotic consumption takes place in the outpatient setting.
Acute upper respiratory infections (URIs) are the most common reason for which
antibiotics are prescribed in the outpatient setting. However, the majority of common
acute URIs are self-limiting, viral infections that rarely require antibiotic treatment. To
determine underlying factors involved in prescribing behaviors, a pre-validated survey
adapted from Rodrigues et al. (2016) was used to identify and explore provider’s
knowledge, attitudes, perceptions (KAPs) and prescribing behaviors regarding antibiotic
use and resistance in the primary and secondary care setting. The survey was distributed
to 116 providers from three separate practice settings in Southeast Kansas and Southwest
Missouri. A total of 54 (N=54; 46.6% response rate) provider responses were analyzed
using descriptive statistics and univariate analysis of variance (ANOVA). The findings
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suggest that inappropriate antibiotic use is not the result of provider ignorance or
unfamiliarity with clinical practice guidelines. Rather, inappropriate prescribing may
better be explained as the result of complex interactions involving both patient-related
and provider-related factors. Patient-related related factors include lack of education,
satisfaction, and pressure applied on providers to prescribe antibiotics. Provider-related
factors include time constraints, patient workload, gender differences, questionable
follow-up, and clinical uncertainty. Based on these findings, targeted educational
resources and strategies developed by the Centers for Disease Control and Prevention
(CDC) were identified and included in the scholarly project.
Keywords: antibiotic overuse, antibiotic resistance, acute upper respiratory tract
infections, antimicrobial stewardship, knowledge, attitudes, perceptions, and prescribing
practice surveys
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Chapter I.

Introduction/Purpose

Description of Clinical Problem/Issue
Antibiotics are one of the most widely used pharmacotherapeutic interventions of
modern medicine (Centers for Disease Control and Prevention [CDC], 2013). In the early
20th century, before the discovery of antibiotics, infectious diseases were rampant with
pneumonia, tuberculosis, and enteritis representing the three leading causes of death and
accounting for more than one third of all deaths in the United States (CDC, 1999). The
early 1940’s marked the dawn of the golden age of antibiotic discovery (Davies, 2006).
Today, acute and chronic non-infectious conditions, such as coronary heart disease,
cancer, and chronic obstructive pulmonary disease, account for the leading causes of
death in the United States (CDC, 2017). The epidemiological transition from infectious
disease to non-infectious disease as the major cause of morbidity and mortality can be
traced back to the advent of antimicrobials, widespread vaccination efforts, and advances
in healthcare (Mercer, 2014).
However, the widespread use of antibiotics has not come without consequence.
The increasing use of antibiotics has led to the development of antimicrobial resistance
(Davies, 2006). Antimicrobial resistance (AMR) is described as the phenomenon by
which microbes develop the ability to evade the bactericidal effects of antibiotics thereby
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rendering them ineffective (World Health Organization [WHO], 2017). AMR has been
identified as an urgent global issue that threatens the effectiveness of many medical
treatments and potentially disrupting the overall integrity of the US health care system.
As stated by the WHOs Director-General Chan (2015), “antimicrobial resistance
threatens the very core of modern medicine and the sustainability of an effective, global
public health response to the enduring threat from infectious disease” (p. 7).
Antibiotic use has been identified as a leading factor involved in the development
of resistance (CDC, 2013). The prescription of antibiotics in situations that do not
warrant their use must be contained in an overall effort to reduce antibiotic consumption
rates. Controlling the rates of antibiotic consumption is the first step in the direction of
reducing the incidence and prevalence of antimicrobial resistance (Ritterman, 2006). The
identified problem of this DNP scholarly project is the inappropriate use of antibiotics in
the primary and secondary care setting leading to the development of resistance.
Significance
Inappropriate antibiotic use is a leading cause of preventable antimicrobial
resistance development (CDC, 2013). AMR has disastrous effects on all healthcare
systems at the national and international level. AMR has been associated with increased
costs, longer hospital stays, post-surgical complications, decreased effectiveness of
standard treatments, and increased morbidity and mortality resulting in poorer patient
outcomes. In 2013, the CDC estimated the overall cost burden of AMR equated to more
than 20 billion a year. In addition, the CDC found that AMR significantly increased
morbidity and mortality, estimating that over two million illnesses and 23,000 deaths
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result from AMR-associated infections every year in the United States alone (CDC,
2013).
It is estimated that 50% or more of all antibiotics prescribed in the United States
are unnecessary. Oral antibiotics are most commonly prescribed in the primary care
setting, followed by ambulatory prescriptions given in urgent and emergent care settings
(Yates et al., 2018). Acute respiratory tract indications (RTIs), a term used to describe a
constellation of common presenting symptoms and diagnoses that include the common
cold, acute cough, rhinitis, rhinosinusitis, sore throat, and acute bronchitis (Dekker,
Verheij, and Van Der Velden, 2015). RTIs are the most common reasons for which
antibiotics are prescribed in the primary and secondary care setting (Dekker et al., 2015).
Historically, when exploring the cause and solution to antibiotic misuse, most
studies have primarily focused on factors involving the patient (Teiexeira-Rodrigues,
Roque, Falcao, Fingueiras, Herdeiro, 2013; Yates et al., 2018). However, the source of
antibiotic use is not singular, it involves both the prescribing provider and the receiving
patient. It is the ethical responsibility of the provider to prescribe or not prescribe an
antibiotic based on the patient’s presenting symptoms and diagnosis. Despite numerous
clinical guidelines promoting the appropriate use of antibiotics for common respiratory
conditions, providers continue to inappropriately and excessively prescribe antibiotics for
RTIs (Dekker et al., 2015). More studies are needed to provide greater insight into the
complex relationship of provider-to-patient interactions and how these interactions
influence antibiotic use in the primary and secondary care setting.
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Specific Aim/Purpose
The purpose of this DNP scholarly project is three-fold: 1) to analyze the
knowledge, perceptions, and beliefs of provider prescribing behaviors involving the use
of oral antibiotics in primary and secondary care settings, 2) to identify facilitators and
barriers to appropriate antibiotic use, and 3) to identify target educational resources and
strategies focused on enhancing both the appropriate use of antibiotics and awareness of
antimicrobial resistance. The major aim of this project is to support the judicious use of
antibiotics and enhance provider’s awareness and knowledge regarding the impact of
inappropriate antibiotic use and the development of resistance.
To identify the factors involved in antibiotic prescribing practices, a crosssectional observational research design involving the application of a pre-validated
survey was employed. The pre-validated survey, previously tested for its validity and
reliability, adapted from Rodrigues et al. (2016) was used to enhance the generalizability
of the results. The survey addressed various aspects of provider prescribing behaviors and
collected information on the following: 1) demographical information, 2) a visual analog
agreement scale addressing attitudes and knowledge of antibiotic use and resistance, 3)
sources of knowledge to guide the management of patients and prescription of antibiotics,
and 4) a blank open-discussion section, allowing providers to express ideas and views of
antibiotic use and resistance (Teixeira-Rodrigues et al., 2016).
Various aspects of the survey also addressed provider’s perception of facilitators
and barriers to appropriate antibiotic use. Questions that addressed factors involving
patient pressures/satisfaction, diagnostic tests, unclear follow-up, time constraints, and
the availability of educational resources were analyzed to determine provider’s
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perception of the major causes of antibiotic misuse. In addition, inclusion of an openended section at the end of the survey allowed providers to address any aspects the
survey may have missed and/or provide an opportunity to add any additional
recommendations or input.
Analysis of provider responses were used to identify recommendations for
reducing inappropriate antibiotic use. Based on the analysis, areas in need of educational
intervention were identified. Identified target educational resources and strategies
approved by the CDC are provide in the appendices of this project. The educational
material presented in this project are intended to provide useful resources of knowledge
that both healthcare providers and patients can utilize. The purpose of the target
educational resources and strategies are to enhance the awareness of appropriate
antibiotic use, antimicrobial resistance, and inform the clinical management of patients in
primary and secondary care settings presenting with common RTIs.
Theoretical Framework
In 1991, the author Icek Ajzen, a Professor of Psychology at the University of
Massachusetts Amherst, created “The Theory of Planned Behavior” or TPB. The TPB
attempts to provide greater insight into explaining human behavior. The theory is guided
by three major considerations or concepts, including: 1) behavioral beliefs, 2) normative
beliefs, and 3) control beliefs (Ajzen, 1991). As described by Ajzen, behavioral beliefs
are an individuals’ attitude toward behavior, and such behavior is affected by the
perceived or likely outcomes of performing a behavior. Normative beliefs are influenced
by the subjective “norms” or expectations of others and therefore motivate individuals to
comply by performing expectant behaviors. The third major concept, control beliefs, is an
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individual’s perceived behavioral control that either inhibits or facilitates behavioral
functioning, thereby influencing the enactment of a certain behavior (Ajzen, 1991).
At the pinnacle of these three major concepts is intention and behavior. Intention and
behavior are theorized to be the product of attitudes towards behavior, perceived social
pressures to perform certain behaviors, and the individual’s perception of control over
these factors. As stated by Ajzen (2006), the major theoretical assumption is “the more
favorable the attitude and subjective norm, and the greater the perceived control, the
stronger should be the person’s intention to perform the behavior in question” (p.1). For
this reason, intention is thought to exist prior to the performance of any behavior and that
the perceived control of such factors influencing behaviors can be used to predict the
behavior in question.
The predictive theory of planned behavior can be appropriately applied to the subject
of antibiotic prescribing by facilitating the process of investigating “why” behaviors are
influenced by personal beliefs, societal norms, and perceived control over one’s own
behavior. To incorporate a change in behavior will require changing the provider’s
intention by examining the factors that influence prescribing behaviors. The major
consideration of societal norms strongly applies to the concept of patient-satisfaction
pressures placed on the provider to prescribe antibiotics in unwarranted clinical
situations. The perceived control a provider has in regard to antibiotic prescription, in
turn, affects their intentions to treat. Thus, personal beliefs and attitudes held by the
provider, societal beliefs, patient satisfaction/pressure, and control over one’s own
behavior all influence the prescription of antibiotics either appropriately or
inappropriately. Lastly, the TPB can be used as a theoretical framework for the purpose
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of predicting behavior, identifying areas in need of behavioral change, and to incorporate
strategies to elicit change for the purpose of positively influencing the outcomes of
appropriate antibiotic prescribing in the clinical setting. As evidenced by a literature
review, the TPB has been utilized as the theoretical framework in multiple studies
attempting to explain the behaviors behind inappropriate antibiotic prescribing for the
purpose of identifying strategies to improve the appropriateness of antibiotic
prescriptions (Cortoos et al., 2012; McIntosh & Dean, 2015; Milos et al., 2013).
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Figure 1. Application of Theory
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Figure 1: DNP Scholarly project conceptual framework. Demonstrates factors that influence providers prescribing behavior involving
the use of antibiotics for common respiratory tract indications (RTIs). Target teaching interventions represent the means by which
behavior is changed. Adapted from Icek Ajzen’s theory of planned behavior.
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Practice Question(s)
•

What are the knowledge, attitudes, and perceptions (KAPs) underlying providers
prescription of antibiotics for common respiratory indications in the primary and
secondary care setting?

•

What differences exist between provider characteristics and antibiotic-prescribing
behavior and knowledge of antimicrobial resistance in the primary and secondary
setting?

Defining Key Terms/Variables
Antibiotic resistance is the phenomenon by which microbes develop the ability to evade
the bactericidal effects of antibiotics, thereby rendering them ineffective (World Health
Organization [WHO], 2017).
Antimicrobial stewardship is the adoption of principles to ensure responsible antibiotic
use through the development of interventional programs committed to using antibiotics
only when necessary to preserve the effectiveness and life-saving capabilities of
antibiotics for current and future generations (Centers for Disease Control and Prevention
[CDC], 2013).
Barriers are perceived obstacles to appropriate antibiotic use.
Educational intervention is the use of pre-approved teaching/educational information
from prominent sources, such as the CDC, that is incorporated into the clinical setting to
improve the awareness of appropriate antibiotic use and resistance.
Facilitators are perceived catalysts to appropriate antibiotic use.
Inappropriate antibiotic use is the misuse and overuse of antibiotics in the context of
prescribing antibiotics against clinical guideline recommendations.
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Knowledge, Attitude and Perception (KAP) surveys are focused evaluations using
open and closed-ended questions to analyze the beliefs, pre-conceived ideas, and unique
experiences of participants to describe a clinical behavior. KAP surveys are useful in
providing insight into knowledge gaps, misconceptions, and potential barriers belonging
to a particular clinical problem for the purpose of developing focused interventions
(WHO, 2008).
Patient Pressure and satisfaction is the provider’s feeling of being pressured into
prescribing an antibiotic to align with the belief’s or expectation of the patient and/or
complying with such expectations for the purpose of providing satisfactory care.
Providers include nurse practitioners, physician assistants, and physicians.
Primary and secondary care settings denote the settings in which providers work
including primary care offices, community clinics, and secondary acute care settings such
as urgent and emergent care departments.
Respiratory Tract Indications (RTIs) are common acute respiratory conditions for
which guidelines and recommendations are available to facilitate providers in their
treatment and management. RTIs include both common presenting symptoms and actual
diagnoses commonly encountered in primary and secondary care settings. RTIs include,
acute otitis media, acute sore throat, common cold, acute rhinosinusitis, acute
cough/bronchitis (National Institute for Health and Clinical Excellence [NICE] Clinical
Guideline, 2008). For the purpose of this project, the term RTI(s) are synonymous and
may be used interchangeably with acute upper respiratory tract infections (URTIs) or
acute upper respiratory conditions throughout this paper.
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Figure 2. Logic Model of Proposed Project
PURPOSE: Explore factors that influence the antibiotic prescribing practices of providers working in primary and secondary care settings caring
for patients with common respiratory tract indications (RTIs).

INPUTS
Evidence
Develop a greater
understanding of antibiotic
prescribing behavior.
Explore knowledge, attitudes
and practices (KAP) among
providers regarding
antibiotic use and resistance.
Interventions to enhance
provider awareness of
appropriate antibiotic use
and resistance.
• Provider Education
• Clinical Practice
Guidelines
Major Barriers
Hospital regulations
Provider time-constraints

INTERVENTIONS

OUTPUTS

EFFECTS

KAP Survey
Previously used valid and
reliable tool to qualitatively
assess provider’s antibiotic
prescribing behaviors,
knowledge of resistance, and
preferred clinical
management tools to guide
practice.

Participants
Health care providers (NP,
PA, DO, MD)

Outcomes to be measured
with valid and reliable tool

Identify barriers and
facilitators to appropriate
antibiotic prescribing
Identify target education in
need of addressing
Teaching/Education
Dissemination of education
based on a needs assessment
identified via the KAP
survey

Site
Primary care offices and
urgent and emergent care
settings located in rural areas
of South-East Kansas and a
small metropolitan area of
South-West Missouri.

Knowledge, attitudes and
practices involved in
antibiotic prescribing
behaviors of providers
assessed through the use of a
KAP survey developed by
Teixeira-Rodrigues et al.
(2016).

Population-Focus
Patients of all ages seeking
care for common & acute
RTIs.

Statistical Analysis
Frequency distributions of
all variables, including
provider demographics

Estimated Time-Frame
1-2 months

P values based on 2-sided
test

Collection Method
Qualitative surveys

Chi-squared analysis to test
differences in proportions of
provider responses

Major Facilitators
Academic advisors (project
committee members)

Persons Collecting Data
Student investigator & project
committee members

Emergent & urgent care
providers

Informed Consent
Obtained from all providers
who volunteer to participate
in survey
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Application of Survey
Results
Dissemination of educational
material provided by the
CDC targeting key variables
identified in the analysis of
survey responses.

Summary of Chapter I.
Antibiotics play an essential role in the treatment of infectious disease and are one
of the most commonly prescribed medications in modern medicine (CDC, 2013). Oral
antibiotic consumption is highest in the primary care setting with excessively high rates
also being noted in secondary care settings, including urgent and emergent care. In these
settings, respiratory tract indications (RTIs), an umbrella of common and acute
presenting symptoms and diagnoses, account for the most common reason for which
antibiotics are prescribed. Even though the majority of these conditions belong to a viral
etiology, it is estimated that over 50% of all antibiotics prescribed for RTIs is
unnecessary (Yates et al., 2018).
The use of antibiotics is the single most important factor leading to the
development of resistance (CDC, 2013). Antimicrobial resistance (AMR) is a global
crisis that has devastating effects on healthcare. AMR is associated with excessive
healthcare costs and increased morbidity and mortality, all of which threaten the
provision of quality care and adversely affect patient outcomes (CDC, 2013). Decreasing
the inappropriate use of antibiotics is essential to controlling the global threat of AMR.
To develop effective antimicrobial stewardship interventions, the factors involved in
influencing antibiotic use must be identified. Historically, patient factors leading to the
misuse of antibiotics have been the focus of many studies (Teiexeira-Rodrigues et al.,
2013; Yates et al., 2018). However, inappropriate antibiotic use is not the result of a
single factor. It is the provider’s responsibility to provide appropriate patient education
and prescribe antibiotics judiciously and only when indicated. Furthermore, even though
numerous clinical practice guidelines exist, providers continue to inappropriately
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prescribe antibiotics for common respiratory tract indications at excessively high rates
(Sanchez, Roberts, Albert, Johnson, & Hicks, 2014).
Exploring the knowledge, attitudes, and prescribing practices of providers
involving the use of antibiotics for patients presenting to primary and secondary care
settings with common respiratory tract indications is the purpose of this DNP scholarly
project. Through the use of a valid and reliable KAP survey as a measurement tool
(Teixeira-Rodrigues et al., 2016), the researcher attempted to identify major factors
involved in influencing provider prescribing behaviors, distinguish barriers and
facilitators to appropriate antibiotic use, and apply this information to identify target
educational resources and strategies. Through the identification of target educational
needs, the researcher sought to provide informative information that can be utilized in the
clinical setting for the purpose of enhancing provider and consumer awareness of
appropriate antibiotic use and antimicrobial resistance.

13

Chapter II.

Evidence/Integrated Review of Literature

Descriptive literature, relevant studies, and clinical practice guidelines were
identified by searching various databases including National Guideline Clearinghouse,
PubMed, Cochrane Database of Systematic Reviews, ProQuest Nursing and Allied
Health Database, and Cumulative Index to Nursing and Allied Health Literature
(CINAHL). The majority of literature reviewed was obtained from PubMed. Search
criteria included publications between the dates of 2007 to 2018, peer-reviewed articles,
quantitative and qualitative data, and practice guidelines. Additional studies were
obtained by reviewing citations provided in the text of the various literature sources
reviewed. Although the majority of the studies obtained were conducted in the United
States, the search was expanded to include studies from other countries as well. In
addition, a variety of educational material was obtained from the CDC’s website. Various
keywords were used to search for relevant literature within the databases, including:
antibiotic resistance, antimicrobial resistance, inappropriate or overuse use, acute upper
respiratory tract indications/infections or illnesses, ambulatory or outpatient or primary
care settings, acute or urgent or emergency or secondary care settings, knowledge and
attitude and perception/practice (KAP) survey, patient satisfaction or pressure, primary
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care provider, general practitioner, physician, nurse practitioner, prescribing behaviors,
evidenced based guideline, and clinical practice guideline.
A total of 36 references (24 articles, eight studies, four guidelines) were included
in the integrative review of literature (see Appendix A). The following review of
literature is divided into 4 major sections, including: 1) descriptive, 2) critical appraisal of
previous studies, 3) clinical practice guidelines, and 4) antimicrobial stewardship and
recommendations for providers. The descriptive section includes 23 articles that provides
an overview of the discovery and benefits of antibiotics, antibiotic resistance, and the
overuse of antibiotics specific to common respiratory tract indications including acute
bronchitis, acute rhinosinusitis, acute pharyngitis, and acute otitis media. The second
section, critical appraisal of previous studies, includes a total of eight research studies of
varying methodology including quantitative, qualitative, and mixed methods research.
The third section, clinical practice guidelines, includes four evidence-based guidelines
that provide the most current widely accepted recommendations involving the use of
antibiotics for acute upper respiratory tract indications. Lastly, the fourth and final
section, antimicrobial stewardship and recommendations for providers, includes the
CDC’s most recent publication on outpatient antimicrobial stewardship program
recommendations in the United States.
Antibiotics: Discovery and Benefits
The 1940’s was a period of great advancement, expansion of research, and
improved therapeutics essential to the progression of modern medicine today. This
essential time in medical history, often referred to as the “Golden Era of Antibiotics”,
marked the introduction of penicillin as the first antibiotic used to treat serious infections.
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Since this time, antibiotics have saved millions of lives around the world and have
transformed modern medicine (CDC, 2013).
The impact of antibiotics on modern medicine can be demonstrated by
retrospectively analyzing epidemiological trends in major morbidity and mortality before
and after the introduction of antibiotics. During the 1920’s, before the introduction of
antibiotics, the average life expectancy was 56.4 years of age and the major cause of
morbidity and mortality belonged to infectious diseases (Ventola, 2015). Today, the
average life expectancy in the United States is 80 years of age with major morbidity and
mortality attributed to chronic diseases including coronary artery disease, malignancies,
and chronic lower respiratory disease (Ventola, 2015). Antibiotics save lives and
represent a vital component of healthcare in their attribution to the major decreases in
morbidity and mortality and increased life expectancy that has occurred over the last
century.
The major epidemiological shift in all-cause mortality from the 1920s to today
provide a testament to the pivotal role that antibiotics play in the prevention and
treatment of infectious disease. The continued effectiveness of antibiotics is essential to
many aspects of healthcare. Today, antibiotics play an important role in preventing and
treating infections of cancer patients receiving chemotherapy, treating acute infections
(especially pneumonia and sexually transmitted infections), as well as the treatment of
infections in patients with chronic diseases causing alterations in immunity to fight
infections that would commonly resolve in otherwise healthy persons. In addition, the
prophylactic use of antibiotics remains essential to improving outcomes of complex
surgeries that carry a high risk for infection (organ transplants, joint replacements, and
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cardiac surgeries). Lastly, antibiotics continue to play an important role in treating and
preventing food-borne and poverty-related infections which are often endemic to many
developing countries with poor sanitation (Ventola, 2015).
Antibiotic Resistance
The discovery of antibiotics was one of the greatest medical breakthroughs in
history and remains a cornerstone of modern medicine (George Washington University,
2017). However, the widespread use of antibiotics has not come without consequence.
Antibiotic resistance occurs through a process by which certain strains of bacteria
develop the ability to mutate and survive the killing effects of antibiotics thereby
becoming resistant to the effects of antibiotics (George Washington University, 2018).
Today, antibiotic resistance is one of the greatest public health threats of our time
(George Washington University, 2018).
Soon after the discovery of antibiotics and before the introduction of their use in
medicine, resistant strains of bacteria to penicillin were noted as early as the 1920’s
(Ventola, 2015). In the 1950’s, substantial development of penicillin-resistance was noted
that subsequently led to the development of beta-lactam antibiotics. In 1962, the first case
of methicillin-resistant staphylococcus aureus (MRSA) was identified. The MRSA threat
continued to wreak havoc on the healthcare system, becoming widespread, and
eventually leading to the introduction of the antibiotic vancomycin in 1972 for the
purpose of treating MRSA infections. In 1979, the first case of bacterial resistance to
vancomycin was identified (Ventola, 2015).
Antimicrobial resistance (AMR) is regarded as a natural and expected
consequence that occurs in every antibiotic after a period of extended use (George
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Washington University, 2018). Just as the resistance developed against penicillin, over
the past 70 years, bacteria have shown the ability to develop resistance to nearly every
antibiotic that have been introduced into medicine (CDC, 2013). In 2013, in response to
the growing threat of AMR the CDC developed a document that categorized various
bacterial resistant threats according to their urgency. At the global level, gram-positive
resistant bacteria, including MRSA and vancomycin-resistant enterococci (VRE), pose
the greatest threat (Ventola, 2015). In the U.S., MRSA kills more persons than
HIV/AIDS, Parkinson’s disease, emphysema, and homicide each year combined
(Ventola, 2015).
The burden of AMR on the healthcare system and the population as a whole is
terrifically disturbing in itself. AMR significantly contributes to increased morbidity and
mortality, with more than two million deaths and 23,000 illnesses being attributed to
AMR infections each year (CDC,2013). The Antibiotic Resistance Action Center
(ARAC) at the Milken Institute of Public Health of George Washington University
(2018) stated: “in the next 30 years, antibiotic resistance infections are expected to
overtake cancer as a leading cause of death worldwide, and experts predict that based on
current estimates, could kill one person every 3 seconds” (p.1). The ARAC predicts that
by 2050, an estimated 10 million people will die each year from AMR infections (George
Washington University, 2017).
In addition to the major burden on morbidity and mortality, AMR contributes
significantly to increased healthcare costs. In the U.S. alone, the economic burden of
AMR contributes to $20 billion in excess healthcare costs and $35 billion in lost
productivity each year (CDC, 2013). Based on current estimates the ARAC predicts that
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by 2050, over a $100 trillion in global economic productivity will have been lost due to
AMR infections (George Washington University, 2017). AMR also contributes
significantly to longer hospital stays and results in higher incidence of long-term
disability and reduced patient outcomes (CDC, 2013). Lastly, AMR limits the usefulness
of first and second-line therapies resulting in the use of alternative agents that are more
expensive and more toxic to the patient (Ventola, 2015).
Multiple factors contribute to the emergence of antibiotic resistance including the
following: 1) overuse, 2) inappropriate prescribing, 3) extensive agricultural use, 4) lack
of availability of new antibiotics, and 5) regulatory barriers (Ventola, 2015). The overuse
of antibiotics is the single most important factor leading to the development of resistance
(CDC, 2013) and will be further discussed in the following section. The inappropriate
prescription of antibiotics significantly contributes to the overuse of antibiotics and is the
focus of this scholarly project. The extensive use of antibiotics for agricultural purposes
to promote growth is a central issue that is often the focus of agenda produced by the
U.S. Department of Agriculture (USDA) and the Food and Drug Administration (FDA)
that is beyond the scope of this scholarly project. The lack of antibiotic research and
development and regulatory barriers placing strains on pharmaceutical companies that
impede the introduction of new antibiotics being placed on the market are additional
contributory factors that will briefly be discussed in the next paragraph.
In response to the growing concerns for AMR, the 1960’s to 1980’s saw a surge
of antibiotic research and development by pharmaceutical companies to address the
resistance problem. The periodic introduction of new antibiotics enhances the access of
antimicrobials practitioners have at their disposal and allows providers, clinics, and
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hospitals to alter their use of antimicrobials resulting in lower resistance rates and better
clinical outcomes (Livermore, 2004). However, as Ventola (2015) states: “the number of
new antibiotics developed and approved has decreased steadily over the past three
decades, leaving fewer options to treat resistant bacteria” (p. 279). Major pharmaceutical
companies are abandoning the antibiotic field largely due to economic and regulatory
obstacles. Antibiotics, which are often curative for acute conditions, are seen as a poor
investment for pharmaceutical companies due to their lack in need for extended use and
low profitability when compared to drugs used to treat chronic conditions. In addition, for
the few pharmaceutical companies interested in developing new antibiotics, regulatory
barriers enforced by current practices of regulatory bodies such as the FDA represent a
major barrier for newly developed antibiotics to receive approval. To summarize, lack of
economic relevance, obstacles posed by regulatory bodies, and a lack of consistency in
policies and incentives to promote the introduction of new antibiotics all contribute to a
decline in antibiotic research and development (Ventola, 2015).
Overuse of Antibiotics
As previously stated, the overuse of antibiotics is the leading factor involved in
the development of resistance (CDC, 2013). AMR is a natural and expected consequence
that occurs in every antibiotic after a period of continued use (Merk, 2015). Antibiotics
are a highly effective but limited resource. Epidemiological studies show a direct
relationship between antibiotic consumption and the development of resistant strains of
bacteria (Ventola, 2015). Historically, epidemiological studies reveal that the more
antibiotics are used, the more quickly bacteria develop resistance, and the less likely
antibiotics will remain effective in the future (CDC, 2013).
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Antibiotics are the most common medications prescribed in modern medicine
today. However, an estimated 50% of all antibiotics prescribed are unnecessary and the
use of antibiotics has been found to be the single most important factor leading to AMR
(CDC, 2013). The exposure of antibiotics to bacteria can induce resistance spontaneously
through mutations in genes and alterations in surface proteins (Ventola, 2015). These
mutated genes can be transferred to other bacteria causing them to become resistance.
Strains of antibiotic resistant bacteria can be passed from person-to-person, can cross
international boundaries, and spread between continents with remarkable speed and ease
(CDC, 2013).
Antibiotic resistance has been described as “nightmare bacteria” that “pose a
catastrophic threat” to persons in every country around the world (CDC, 2013, p.11). As
antibiotics continue to be overused and AMR is allowed to continue, antibiotics used to
treat once common and non-threatening infections are beginning to lose their
effectiveness and may soon not work at all. The CDC (2013) describes that when the
ability of antibiotics to effectively fight infections is lost, the ability to offer “many lifesaving and life-improving modern medical advantages will be lost with it” (p. 24).
In 2010, the U.S. population consumed an estimated 22.0 units (one unit equaling
one pill or ampule) of antibiotics per person. Astonishingly in some states, the number of
antibiotics prescribed per year exceeded the entire population of that state (Ventola,
2015). Despite recent efforts to curtail the overuse of antibiotics, trends of continued
inappropriate antibiotic use continue to occur at high rates. It is estimated that 80-90% of
antibiotic consumption by volume occurs in the outpatient setting (CDC, 2018). In 2016,
270.2 million courses of antibiotics were dispensed to outpatient pharmacies, equally 836
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prescriptions per every 1,000 persons in the U.S. (CDC, 2018). Of these antibiotics
prescribed in the various outpatient settings, one in three were unnecessary, equally 47
million inappropriate prescriptions per year (PEW Charitable Trust, 2017).
Local outpatient prescribing practices contribute significantly to local resistance
patterns (CDC, 2018). Evidence collected via local outpatient isolates and anti-biogram
data reveal that areas with greater rates of antibiotic consumption have higher rates of
bacterial resistance (Sorensen, 2018). Antibiotic consumption is highest in the SouthCentral region of the U.S. and decreases as you move towards the Western region (CDC,
2018). The CDC found that prescribing is greatest in the winter months and acute
respiratory tract indications (RTIs) are the most common reason for which antibiotics are
prescribed, including: acute rhinosinusitis, acute bronchitis, common cold or non-specific
upper respiratory tract infections (URI), pharyngitis, and acute otitis media (AOM)
(CDC, 2018). The two most common antibiotics prescribed in the outpatient setting are
Azithromycin and Amoxicillin (CDC, 2018).
In the U.S. acute respiratory indications or infections (RTIs) are the most
common reason for which antibiotics are prescribed in the outpatient setting. (CDC,
2018). Most ARIs are due to a self-limited viral etiology and an estimated two-thirds of
primary care visits for ARIs are not necessary for appropriate antibiotic management
(Renati & Linder, 2016). Despite most RTIs being attributed to a viral origin, antibiotics
are prescribed in 40% to 50% of patient encounters presenting with upper respiratory
complaints (Hart, 2007). The following paragraphs will briefly address the etiology and
epidemiology of common acute respiratory indications seen in primary and secondary
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care settings. Recommendations and current clinical practice guidelines addressing the
various RTIs will also be included in a later section.
The “common cold” is a benign non-specific viral infection predominantly
affecting the upper respiratory tract (Hart, 2007). It is the most frequently encountered
acute illness in the U.S. (Sexton & McClain, 2019). This viral syndrome produces
variable degrees of nasal congestion, rhinorrhea, sneezing, sore throat, cough, headache,
malaise and low-grade fever (Sexton & McClain, 2019). Less than two percent of cases
are complicated by bacteria and the use of antibiotics have not been shown to shorten the
course of the illness (Hart, 2007). Despite evidence strongly discouraging their use,
antibiotics continue to be prescribed in practices throughout the U.S. for this self-limited
condition (Sexton & McClain, 2019). A retrospective study of over 180,000 patients
presenting with non-specific respiratory complaints found that the majority of these
complaints were due to the common cold, yet 46 percent of these patients received a
prescription for an antibiotic (Silverman et al., 2017).
Acute Rhinosinusitis; commonly known as “sinusitis” or simply a sinus infection;
is defined as an inflammation of the nasal mucosa and paranasal sinuses lasting less than
four weeks in duration (Hart, 2007). It is one of the most common conditions treated in
the ambulatory care settings and the fifth most common diagnosis for which antibiotics
are prescribed in the U.S. (Aring & Chan, 2016). Most cases of acute rhinosinusitis are
attributed to a viral etiology with less than two percent from a bacterial origin (Aring &
Chan, 2016). In a study of 33,273 patients presenting with RTI complaints, 1,150 were
found to have acute rhinosinusitis. Of these 1,150 patients, results revealed that over 50
percent received an inappropriate prescription for an antibiotic (defined as mild
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symptoms for less than 5 days with or without fever) (Jorgensen, Christensen, Currea,
Llor, & Bjerrum, 2013).
Acute Bronchitis is defined as a clinical diagnosis with predominant symptom of
cough lasting two to three weeks caused by inflammation of the trachea and large airways
in the absence of pneumonia (Kinkade & Long, 2016). Acute bronchitis is a very
common condition encountered in the clinical setting. In the U.S., it is among the top ten
most common acute illnesses accounting for 10 percent of ambulatory care visits (Singh
& Zahn, 2018). Peak incidence occurs in late fall and winter when transmission of
respiratory viruses is highest (File, 2018). An estimated 95 percent of acute bronchitis
cases are due to a viral etiology (Singh & Zahn, 2018). Studies show that only one to 10
percent of cases are due to bacterial infection (Kinkade & Long, 2016). For this reason,
current guidelines recommend against the prescription of antibiotics for uncomplicated
acute bronchitis. Despite these recommendations, antibiotics continue to be prescribed at
excessively high rates. In a study conducted on 3,616 visits for uncomplicated acute
bronchitis from the years 2011 to 2016, results found that 2,244 (62.1%) of these visits
resulted in a prescription of an antibiotic (Grigoryan et al., 2017).
Acute pharyngitis is a common acute upper respiratory illness with the
predominate symptom of sore throat and accounts for 12 million (1-2%) of ambulatory
care visits each year in the United States (Chow & Doron, 2018). Acute pharyngitis is
most common in the pediatric population with 50% of all cases occurring before the age
of 18 years (Chow & Doron, 2018). Respiratory viruses are the most common cause,
with approximately 25 to 45 percent of cases being due to a viral etiology (Chow &
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Doron, 2018). Group A Streptococcus (GAS) is the most common bacterial etiology
accounting for five to 15 percent of cases (Chow & Doron, 2018).
Distinguishing between the two most common causes is essential to the
management of acute pharyngitis because GAS is treated with antibiotics and viral
pharyngitis is treated with supportive measures. In a large study of 1,644 patients of two
major health centers in Indonesia, 226 patients (13.77%) were diagnosed with strep
pharyngitis, 1,179 patients (71.85%) were infected by viruses, and in 236 (14.38%)
patients the etiology could not be determined (Yuniar, Anggadiredja, & Islamiyah, 2017).
Results of the study revealed that 50 percent of all antibiotics prescribed for these 1,644
patients were given to patients with viral pharyngitis (Yuniar, Anggadiredja, &
Islamiyah, 2017). Suspected cases of GAS should be evaluated with the use of a rapid
antigen test (RADT) to confirm a bacterial etiology and avoid the inappropriate use of
antibiotics (Chow & Doron, 2018). RADT negative results should be treated with
supportive measures only (Chow & Doron, 2018).
Acute Otitis Media (AOM) is an infection or inflammation of the middle ear and
structures (Harmes et al., 2013). AOM is a leading cause of episodic visits in the
ambulatory care setting and is the most common reason for which antibiotics are
prescribed in children (Pelton, 2019). A study examining the incidence of AOM from the
years 2008 to 2014 in the U.S. found the overall annual rate of AOM-related visits to be
60.5 per 1000 persons-years with the majority of visits taking place in the
office/outpatient setting (55.7 per 1000 persons-years) (Tong, Amand, Kieffer, & Kyaw,
2018). Peak incidence of AOM occurs between six to 18 months of age, and declines
thereafter becoming increasingly infrequent after age seven (Pelton, 2019). The most
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common pathogens involved in AOM infections are Streptococcus pneumoniae,
Haemophilus influenzae, Moraxella catarrhalis, and Group A Streptococcus (Leibovitz,
Broides, Greenberg, & Newman, 2010). Due to the high incidence of antibiotic
consumption for AOM, antibiotic resistance has become a major concern with an
estimated 30 to 70% of S. pneumoniae strains being resistant to penicillins and
macrolides, and an estimated 20 to 40% of H. influenzae strains being beta-lactamaseproducing (Leibovitz et al., 2010).
Due to the concerns for development of high rates of resistance in common
pathogens responsible for AOM, stringent guidelines have been developed that call for
clinicians to carefully consider specific criteria before prescribing an antibiotic (Pelton,
2019). Most notably, is the concept of “watchful waiting” or delayed prescribing. Using
this strategy, the parent is given a prescription for an antibiotic and is told to fill and
initiate the prescription only if their child’s symptoms persist or worsen over a 48 to 72hour period (Pelton, 2019).
Inappropriate Prescribing & Clinician’s Knowledge, Attitudes, and Perceptions
(KAP)
The following section represents an analysis of previous studies and their
findings. Three quantitative studies that analyze rates of inappropriate antibiotic
prescribing, four qualitative studies analyzing clinician’s knowledge, attitudes, and
perceptions (KAP) regarding antibiotic prescribing, and one mixed-method study of both
antibiotic prescribing rates and clinician’s KAPs will be included in this analysis. The
order of the following sections is as follows: quantitative, mixed-methods, then
qualitative studies.

26

A study published in 2016 titled “Prevalence of Inappropriate Antibiotic
Prescription Among U.S. Ambulatory Care Visits, 2010-2011” used a quantitative
observational design to examine population-adjusted antibiotic (ABX) prescribing rates
in the United States from the years 2010 to 2011 (Fleming-Dutra et al., 2016). The
objective of the study was to estimate total rates of oral antibiotic prescriptions and
determine the proportion of annual inappropriate antibiotic prescriptions per 1000
persons in the U.S. ambulatory care setting. The method of measuring antibiotic
prescription rates was done via the analysis of U.S. ambulatory care visits (n = 184,032)
using two national surveys, including: 1) the 2010-2011 National Ambulatory Care
Survey (NAMCS), and 2) the 2010-2011 National Hospital Ambulatory Medical Care
Surveys (NHAMCS) (Fleming-Dutra et al., 2016). Annual numbers and populationadjusted rates of ambulatory visits with oral antibiotic prescriptions by age, geographical
region, and diagnoses were estimated. The data was then analyzed against national
guidelines and regional variations in prescribing to determine proportions of antibiotic
prescriptions and their appropriateness.
Of the 184,032 visits, 12.6% resulted in an antibiotic prescription. Acute
respiratory conditions had the highest absolute ABX prescriptions, with the diagnosis of
sinusitis having the most ABX prescriptions per 1000 population followed by otitis
media, then acute pharyngitis. A total of 221 ABX prescriptions were given annually for
acute respiratory disorders, but only 111 were estimated to be appropriate (50%)
(Fleming-Dutra et al., 2016). Combining all ages and conditions in 2010-2011, an
estimated 506 ABX prescriptions were given annually and only 353 were considered
appropriate (69%) (Fleming-Dutra et al., 2016). Thus, the authors concluded that 50% of
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all antibiotics prescribed for acute respiratory conditions were unnecessary, and 31% of
all ABX prescribed annually for all ages and diagnoses were inappropriate (FlemingDutra et al., 2016). The estimate results of the study provide evidence supporting the
urgency of ABX misuse, supports the notion that most inappropriate antibiotic use occurs
in acute respiratory conditions, and reinforces the need for establishing out-patient
antibiotic stewardship programs (Fleming-Dutra et al., 2016).
A study titled “Outpatient Antibiotic Prescribing Among United States Nurse
Practitioners and Physician Assistants” also employed the use of the NAMCS and
NHAMCS national surveys to collect data on outpatient antibiotic prescribing (Sanchez,
Hersh, Shapiro, Cawley, & Hicks, 2016). However, this quantitative study analyzed
antibiotic prescribing rates in the U.S. ambulatory care setting according to specific
provider type (Nurse Practitioners [NP], Physician Assistant [PA], and Physician). Using
the NAMCS/NHAMCS, data collected from 1998 to 2011 was used to assess trends in
ambulatory visits by provider type. Data collected from 2006-2011 was used to assess
both overall proportions of antibiotic prescribing rates for all ambulatory care visits as
well as antibiotic prescribing rates for acute respiratory tract infection (ARTI) visits
(Sanchez et al., 2016).
A total of 1,301,474 visits were sampled, of this sample 6.3% involved NPs or
PAs. Over the study period, the proportion of NP/PA visits more than doubled in the
ambulatory care setting and more than tripled in the emergency care setting (ED or ER)
(Sanchez et al., 2016). The observed increase in non-physician visits provides a testament
to the rapid expansion of the NP and PA role in ambulatory and emergency care settings.
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The study also found that higher proportions of visits resulted in antibiotic prescription
when a non-physician provider was involved.
When compared to physicians, NPs/PAs are more likely to prescribe antibiotics in
all ambulatory care visits (17% for NP/PA vs 12% for physicians). In visits involving
ARTI diagnoses, NPs/PAs are more likely to prescribe antibiotics when compared to
physicians (61% for NP/PA vs 54% for physicians). Even after using a multi-variable
logistic regression analysis controlling for patient and practice-level variables, the authors
still found that NPs or PAs had independently higher odds of prescribing antibiotics
(odds ratio = 1.13) (Sanchez et al., 2016). The importance of prescribing behaviors as a
leading difference in the proportions of antibiotics prescribed by non-physician providers
was emphasized by the authors Sanchez et al. (2016) in the following remark:
Elements of antibiotic stewardship are often included in NP, PA, and physician
curricula, suggesting that potential differences in antibiotic prescribing are more
likely due to practice environment, learned clinical behaviors, or differences in
patient communication rather than medical education. (p.2).
A study published in 2019 titled “Variability of Antibiotic Prescribing in a Large
Healthcare Network Despite Adjusting for Patient-Mix: Reconsidering Targets for
Improved Prescribing” used a quantitative cross-sectional design to study patient
encounters presenting with diagnoses of acute respiratory infections (ARIs) in 15 primary
care clinics belonging to a large healthcare network located in Atlanta, Georgia between
the years 2015 to 2017 (Jung, Sexton, Owens, Spell, & Fridkin). The objective of the
study was to identify predictors of inappropriate antibiotic prescribing for ARIs in the
outpatient setting (Jung et al., 2019). Variables included ARIs diagnoses distinguished by
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ICD-10 codes, patient-level variables categorized by age, race, and comorbid conditions,
as well as provider-level variables categorized by professional training (physicians, NPs
and PAs, and resident physicians) (Jung et al., 2019). To evaluate the appropriateness of
antibiotics, antibiotic-appropriate ICD-10 codes were excluded, including sinusitis,
pharyngitis, and tonsillitis (Jung et al., 2019).
Over the course of the two-year study period, a total of 9,600 patient visits (
N=9,600) were seen by a total of 109 providers. A multi-variable logistic regression
analysis was used to identify predictive characteristics of antibiotic prescribing. Of the
9,600 patient encounters, more than half (53.4%) resulted in an antibiotic prescription.
Median provider prescribing rates remained high (43%) even after modifying variables to
include only ARI ICD-10 codes that were deemed antibiotic-inappropriate (Jung et al.,
2019). Using an adjusted odds ratio (aOR), antibiotic prescribing rates were found to be
higher whites (aOR=1.59), patients 51 years or older (aOR=1.32), and those with
comorbid conditions (aOR=1.19). According to provider-type, antibiotic prescribing rates
were lowest in resident physicians, while no difference was found to exist between
NPs/PAs and physicians (Jung et al., 2019).
The study found that significant predictors of antibiotic prescribing included: 1)
Caucasian race, 2) older age, and 3) presence of comorbid conditions (Jung et al., 2019).
More than 50% of patients with a diagnosis of ARI received an antibiotic during the twoyear study period. Based on an ARI target prescribing rates of 20% or less, the data
suggests that 30% or more of these 9,600 patients unnecessarily received an antibiotic.
The authors commented on the finding of prescribing rates being lowest in resident
physicians, stating that this was likely the result of required rotations with infectious
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disease specialists’ that residents must fulfill during their training through this particular
healthcare network. The authors indicate further investigations should be sought on
provider knowledge, beliefs, and attitudes (KAPs) as the evidence suggests these factors
may play a significant role in the appropriateness of antibiotic prescribing (Jung et al.,
2019).
A mixed-methods observational/research study titled “Inappropriate Antibiotic
Prescription for Respiratory Tract Indications: Most Prominent in Adult Patients” aimed
to both quantify and qualify inappropriate antibiotic prescriptions for respiratory tract
indications (RTIs) among general practitioners (GPs) caring for adults in the primary care
setting (Dekker, Verheij, & Van Der Velden, 2015). During a two-year study period in
the years 2008 to 2010, data was obtained from a total of 2,724 RTI visits (n=2,724) with
GPs from 48 Dutch primary care clinics. GPs were asked to provide various aspects of
clinical data via an online registry for patients presenting with RTIs. All patients
presenting with acute RTIs in which specific evidence-based guidelines (AOM, ARS,
sore throat, and acute cough) were included. Recommendations from national guidelines
were used as a benchmark to classify GPs prescribing decisions as correct or incorrect.
In addition to clinical practice guidelines used to benchmark data, presenting signs and
symptoms, patient characteristics (age, medical history, expectations of antibiotics, etc.),
and disease severity were also considered in an analysis of the results (Dekker, Verheij,
& Van Der Velden, 2015).
The results revealed that of the 2,724 RTI visits, 46% received an antibiotic that
was not indicated by clinical practice guidelines. Over-prescribing was highest in ICD
diagnoses bronchitis and tonsillitis. Adults aged 18 to 65 years received the highest
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proportion of antibiotic over-prescriptions and this trend was found to increase with age.
Amoxicillin was the most commonly prescribed antibiotic in children and doxycycline
was most commonly prescribed in the elderly. In terms of qualitative data, GPs cited the
most common reasons for which an antibiotic was prescribed was due to patient
expectations of an antibiotic, presence of fever, and symptom duration greater than one
week. Of these three qualitative measures, patient pressures from expectations of
receiving an antibiotic was the strongest determining factor in the inappropriate
prescription of an antibiotic (Dekker, Verheij, & Van Der Velden, 2015).
In a qualitative study sponsored by the CDC titled “Effects of Knowledge,
Attitudes, and Practices of Primary Care Providers on Antibiotic Selection, United
States” conducted open-ended interviews with 36 primary care providers to explore their
knowledge, attitudes, and self-report practices and the influence these factors have on the
appropriateness and selection of antibiotic drugs (Sanchez, Roberts, Albert, Johnson, &
Hicks, 2014). Participants included 27 physicians, five NPs, and four PAs. Interview
questions addressed the following factors: self-reported antibiotic prescribing practices,
attitudes towards clinical practice guidelines (CPGs), knowledge of narrow versus broadspectrum antibiotics, preferred educational resources utilized in practice, and attitudes
towards antimicrobial resistance (Sanchez et al., 2014). Participants were asked to rank
12 factors that influence their prescription of antibiotics from greatest to least influence.
Lastly, clinical scenario questions were asked to assess compliance with CPGs and
clinicians were asked to provide input on strategies to improve antibiotic prescribing
(Sanchez et al., 2014).
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An analysis of responses revealed that providers were aware of the antimicrobial
resistance (AMR) threat and had a good understanding of CPGs, yet many admitted to
intermittent non-compliance with these recommendations when prescribing antibiotics.
Provider concerns for patient satisfaction and pressures was the most commonly
perceived reason for inappropriate antibiotic prescribing (Sanchez et al., 2014). Fear of
complications and low-confidence in prescribing abilities were factors commonly cited
that lead to the prescription of broad-spectrum antibiotics. There was a consensus
agreement among the providers that AMR is a major health care issue, however,
resistance is not commonly considered when selecting antimicrobial therapy. Lastly, the
majority of providers agreed that the best way to change prescribing behaviors is to alter
the expectations of patients to reduce the pressures applied on providers to prescribe
antibiotics (Sanchez et al., 2014).
In a research study titled “Physicians’ Attitudes and Knowledge Concerning
Antibiotic Prescription and Resistance: Questionnaire Development and Reliability” the
authors aimed to develop a reliable and valid questionnaire instrument to assess the
attitudes and knowledge underlying physician antibiotic prescribing behaviors in both
primary and hospital-based care settings (Teixeira Rodrigues et al., 2016). The study was
conducted in September 2013, using a convenience sample of 61 primary care physicians
and 50 hospital physicians (N=111) located in Portuguese. The survey’s development and
validation process was divided into two major steps, including: 1) content and face
validation, and 2) reliability analysis. Content validity was achieved through a literature
review and an analysis of previous qualitative studies conducted by a panel of experts
(n=10). To achieve face validity, a panel of clinical psychologists and linguist experts
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reviewed the selected literature. To analyze the reliability of the survey, a pilot study was
conducted, and a re-test study was performed two to four weeks later (Teixeira Rodrigues
et al., 2016).
The response rate of primary care physicians included, 1) pre-test 64% (n=39),
and 2) re-test 49% (n=30). The response rate of hospital care physicians included, 1) pretest 66% (n=33), and 2) re-test 60% (n=30). Using strategies to ensure content validity
resulted in nine changes to the professional concepts section of the questionnaire. Face
validity resulted in a total of 19 changes to the linguistic and interpretive terms of the
questionnaire. Results of the reliability analysis included: 1) internal validity via
Cronbach alpha value ( >0.70) was considered satisfactory, and 2) intraclass correlation
coefficient (ICC) values indicated fair to good reproducibility (ICC >0.4). The final
questionnaire included the five following sections: Section 1—instructions for
completion of questionnaire, Section 2—17 statements on agreement via visual analog
scale (VAS) regarding attitudes and knowledge of antibiotic prescribing, use, and
resistance, Section 3—nine statements regarding the importance of various sources of
knowledge used for antibiotic prescribing, Section 4—demographic and professional
information of the physician completing the survey, and Section 5—a blank section
allowing participants to express ideas and views of antibiotic use and resistance (Teixeira
Rodrigues et al., 2016).
Historically, many questionnaires have been used to assess physician attitudes and
knowledge regarding antibiotic use and resistance, however most lack full validation. The
authors aimed to develop a reliable and valid measurement tool to identify underlying
factors regarding antibiotic prescriptions and resistance. Using the strategies outlined
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above, analysis of the questionnaire revealed content and face validity was reliable in
terms of internal consistency and reproducibility (Teixeira Rodrigues et al., 2016). For
these reasons, the questionnaire developed by Teixeira Rodrigues et al. (2016) (see
Appendix B) was adapted and used for the purpose of this DNP scholarly project for
collecting data on the knowledge, attitudes, and perceptions (KAP) of provider
prescribing behaviors (see Appendix C).
In a study titled “Not a Magic Pill: A Qualitative Exploration of Provider
Perspectives on Antibiotic Prescribing in the Outpatient Setting” the authors used a
qualitative phenomenological perspective design through semi-structured interviews with
key informants to examine provider antibiotic prescribing behaviors (Yates et al., 2018).
The key informants interviewed included a total of 17 outpatient providers, including 10
physicians and seven advanced care practitioners covering a large healthcare system in
North Carolina. The three objectives identified in the study included the following: 1)
investigate the factors involved in influencing provider prescribing decisions, 2) identify
potential strategies recommended by providers to address the issue of inappropriate
antibiotic use, and 3) inform clinical management of patients with infections that do not
require an antibiotic prescription in the outpatient setting (Yates et al., 2018).
The results were divided into themes based on a consensus of recurring provider
responses. Key factors in antibiotic decision making included: clinical presentation with
acute signs and symptoms, best practices based on current evidence, the age of the patient
and presence of comorbidities, and workflow of the clinical setting. Factors considered
essential in communicating with patients included: viral versus bacterial infections, the
disease course, role of symptomatic relief, signs and symptoms to watch for and report,
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and follow-up. Recommended factors to assist patients in the relief of symptoms
included: the use of over-the-counter (OTC) medications, personal care, and increased
fluids and rest. All of the providers perceived that patient expectations of receiving an
antibiotic is high and believe most patients deem antibiotics are necessary for a quick fix
regardless of the etiology causing their illness. Identified barriers to appropriate antibiotic
prescribing included: patient education and expectations, concerns of system-level
demands to see more patients, and time-constraints. The source of knowledge providers
used to make prescribing decisions included clinical practice guidelines and decision
support tools. Lastly, the majority of the providers believed antibiotic resistance was a
major issue and believed requirements of antibiotic use reporting and system-wide
strategies to improve prescribing behaviors would be well received by most practicing
clinicians (Yates et al., 2018).
Based on the study’s findings, the authors concluded a myriad of factors are
involved in influencing provider’s antibiotic prescribing decisions. In regard to
inappropriate antibiotic prescribing, among the most influential factors involved patient
satisfaction, pressures, and expectations. The authors recommend education targeting
both patients and providers is essential to the success of any antimicrobial stewardship
program (Yates et al., 2018).
In the last study examined, titled “Clinicians’ Beliefs, Knowledge, Attitudes, and
Planned Behaviors on Antibiotic Prescribing in Acute Respiratory Infections”, a
qualitative study design was used to examine provider perceptions regarding appropriate
antibiotic use as well as to identify provider acceptability of proposed ASP interventions
aimed to improve the use of antibiotics for the treatment of ARIs in the outpatient setting
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(Hruza et al., 2018). The authors collected data using one-on-one interviews with
providers (n=20) working in emergency departments, primary care, and communitybased clinical settings of five VA Medical Centers in the U.S. conducted in May-July
2017. The semi-structured interview questions were developed using the Theory of
Planned Behavior (TPB) to assess providers’ beliefs and attitudes, behavioral control,
perceptions of societal norms, and planned future behaviors for managing ARIs (Hruza et
al., 2018).
Results on beliefs and attitudes revealed that providers positively perceived ASP
efforts and believed strategies such as audit-feedback and tools to improve antibiotic
prescribing practices would be well received. Perceived barriers to appropriate antibiotic
prescribing included patient demands, time constraints, and resource limitation. In terms
of behavioral control, providers felt they had full control over either prescribing or
withholding antibiotics. Regarding societal norms, providers perceived that poor peer
practices and lack of patient education are factors that potentiate patient demands for
antibiotics. Provider’s perceived that patient demands have the greatest role in
inappropriate prescribing and believed viable solutions to address this issue need to
include audit-feedback and communication strategies (Hruza et al., 2018).
The study found that providers often intend on prescribing antibiotics
appropriately. However, gaps in patient knowledge and perceived patient demands were
identified as significant barriers influencing appropriate antibiotic prescribing practices,
particularly in the treatment of ARIs. The authors concluded that ASP efforts should
utilize audit-feedback and Shared Decision-Making/Communication strategies
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specifically tailored to consider time constraints, available resources, and perceived
patient demands (Hruza et al., 2018).
ARI Clinical Practice Guidelines & Recommendations
The following section will examine four clinical practice guidelines and their
recommendations. All of the clinical practice guidelines included here are intended to
guide clinicians in the appropriateness of antibiotics for acute respiratory tract indication.
One guideline specifically focuses on acute otitis media, the leading cause for antibiotic
consumption in the pediatric population (Pelton, 2019). The following sections are not
comprehensive, rather the information presented here will cover the key
recommendations that are relevant and applicable to the DNP scholarly project. It is also
important to note that the first guideline covered is dated as it was published in 2008.
However, the guideline remains applicable and is frequently utilized in current clinical
practice settings and research and for these reasons it will be included in the following
overview.
In 2008 the National Institute for Health and Clinical Excellence (NICE)
developed a clinical practice guideline titled “Respiratory Tract Infections—Antibiotic
Prescribing: Prescribing of Antibiotics for Self-limiting Respiratory Tract Infections in
Adults and Children in Primary Care”. The guideline was developed for the purpose of
providing the best clinical advice regarding the care of adults and children three months
or older with respiratory tract infections (RTIs) for whom immediate antibiotic
prescribing is not indicated (NICE, 2008). The guideline recommends that parents’
and/or patients’ concerns and expectations should be determined and addressed when
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agreeing on the use of one of the three antibiotic prescribing strategies, including: no
prescribing, delayed prescribing, and immediate prescribing (NICE, 2008).
The guideline recommends that a no antibiotic prescribing or a delayed antibiotic
prescribing strategy should be utilized for the following conditions: 1) acute otitis media
(AOM), 2) acute sore throat/pharyngitis/tonsillitis, 3) common cold, 4) acute
rhinosinusitis (ARS), and 5) acute cough/acute bronchitis (NICE, 2008). Depending on
severity and duration, an immediate antibiotic prescribing or a delayed prescribing
strategy should be considered for the following conditions: 1) bilateral AOM in children
younger than two years of age, 2) AOM in a child with otorrhea, and 3) acute sore
throat/pharyngitis/tonsillitis if three or more Centor criteria are present (NICE, 2008).
Immediate antibiotic prescription and possibly further evaluation should be considered in
the following scenarios: 1) patient with systemic signs and symptoms (e.g. high-grade
fever, toxic-appearing, shortness of breath), 2) signs and symptoms suggestive of serious
illness/condition (e.g. pneumonia, peritonsillar abscess, mastoiditis), 3) patients at highrisk for serious complications due to pre-existing comorbidities, including significant
heart, lung, kidney, liver or neuromuscular disease, immunosuppression, long-term
corticosteroid use, diabetes, cystic fibrosis, or premature infants, and 4) patients 65 years
with acute cough with two or more of the following, including: recent hospitalization,
diabetes, history of congestive heart failure, or current use of systemic corticosteroids
(NICE, 2008).
For all antibiotic prescribing strategies, the patient and/or parents should be
educated on the following: 1) the natural course of the illness and the expected average
length of symptoms (e.g. AOM 4 days, sore throat 1 week, common cold 1 ½ weeks,
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ARS 2 ½ weeks, and acute bronchitis 3 weeks), and 2) symptom management including
antipyretics and analgesics (NICE, 2008). If a no antibiotic prescribing strategy is
utilized, the patient and/or parents should be offered the following: 1) reassurance and
why antibiotics are not needed, and 2) return visit if condition worsens or continues past
expected resolution time-frame (NICE, 2008). And lastly, when a delayed antibiotic
prescribing strategy is adopted, the patient and/or parents should be advised on initiating
the antibiotic if symptoms worsen or do not improve within 24 to 48hrs after initial visit
and following up with a return visit if symptoms worsen despite initiating the delayed
antibiotic (NICE, 2008).
In 2013, the American Academy of Pediatrics published a guideline that
specifically examined the appropriateness of antibiotics for acute otitis media (AOM)
titled “Clinical Practice Guideline: The Diagnosis and Management of Acute Otitis
Media” (Lieberthal et al., 2013). The guideline is intended to provide recommendations
to assist primary care providers in the diagnosis and management of uncomplicated AOM
in children six months to 12 years of age (Lieberthal et al., 2013).
The diagnosis of AOM requires the presence of moderate to severe bulging of the
tympanic membrane (TM) or new onset of otorrhea not caused otitis externa (Lieberthal
et al., 2013). The provider may diagnose AOM in the presence of mild TM bulging
accompanied by recent onset of otalgia (ear pain less than 48 hours in duration) or intense
erythema of the TM (Lieberthal et al., 2013). Additionally, the diagnosis of AOM should
not be made in the absence of middle ear effusion (MEE) (Lieberthal et al., 2013).
Regardless of age, antibiotic therapy is always recommended in the presence of
severe AOM (i.e. unilateral or bilateral moderate to severe otalgia for at least 48 hours
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with high-grade fever of 102.2 F or higher). Antibiotic therapy is recommended for
children six months to 23 months of age in the presence of non-severe bilateral AOM.
Non-severe unilateral AOM in children six to 23 months of age should be offered either
antibiotic therapy or observation with close follow-up. Lastly, children six months or
older with bilateral non-severe AOM should prescribed an antibiotic or offered
observation with close follow-up (Lieberthal et al., 2013).
The decision to either prescribe an antibiotic or closely observe should be based
on the joint decision-making between the provider and parent (Lieberthal et al., 2013). If
observation is chosen, the provider should provide a delayed antibiotic prescription or
ensure close follow-up and begin antibiotic therapy if the child fails to improve or
worsens within 48 to 72 hours (Lieberthal et al., 2013). If an antibiotic is prescribed and
the child has not received amoxicillin in the last 30 days, oral amoxicillin is the treatment
of choice. If the child has received amoxicillin in the last 30 days, amoxicillinclavulanate (Augmentin) should be given to reduce resistance rates. Regardless of
whether antibiotic therapy was initiated, all parents should be instructed to provide
symptomatic relief for pain control with either acetaminophen or an NSAID (Lieberthal
et al., 2013).
Due to high resistance rates, prophylactic antibiotics to reduce the frequency of
recurrent AOM is not recommended. Prevention of AOM should focus on following
recommended immunization schedules, with particular attention to ensure children
receive the pneumococcal conjugate and annual influenza vaccine. Other preventative
measures include exclusive breastfeeding for the first six months of life and avoiding
exposure of the child to cigarette smoke (Lieberthal et al., 2013).
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A clinical practice guideline published by the American College of Physicians
titled “Appropriate Antibiotic use for Acute Respiratory Tract Infection in Adults:
Advice for High-Value Care From the American College of Physicians and the Centers
for Disease Control And Prevention” intended to provide the best practices for antibiotic
use in healthy adults presenting with acute respiratory tract infection (ARTIs) (Harris,
Hicks, & Qaseem, 2016). The authors define “healthy adults” as those 18 years of age or
older without chronic lung disease or immunocompromising conditions (Harris, Hicks, &
Qaseem, 2016).
After a meta-analysis of recent and most relevant evidence-based clinical practice
guidelines, the authors developed four high-value clinical recommendations (see
Appendix D). Recommendation 1: providers should not perform diagnostic tests or
initiate antibiotic therapy for patients with acute bronchitis unless pneumonia is suspected
(Harris, Hicks, & Qaseem, 2016). Recommendation 2: patient’s with suspected group A
streptococcal pharyngitis should be tested using a rapid antigen detection swab and/or
culture and antibiotic therapy should only be initiated if group A strep is confirmed
positive by such testing (Harris, Hicks, & Qaseem, 2016). Recommendation 3: in the
treatment of acute rhinosinusitis, antibiotic therapy should be reserved for persistent
symptoms present greater than 10 days, severe symptoms (i.e. high fever 102.2 or greater
coupled with purulent discharge or facial/jaw pain) for three or more consecutive days, or
for double-sickening defined as the “onset of worsening symptoms following a typical
viral illness that lasted 5 days that was initially improving” (Harris, Hicks, & Qaseem,
2016, p. 1). And lastly, recommendation 4: providers should not prescribe antibiotics for
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the common cold regardless of perceived or actual patient expectations (Harris, Hicks, &
Qaseem, 2016).
The fourth and final clinical practice guideline examined is titled “Diagnosis and
Treatment of Respiratory Illness in Children and Adults” (Short et al., 2017) and was
published by the Institute for Clinical Systems Improvement (ICSI) in 2017. The
guideline provides algorithms for non-specific upper respiratory infections, acute
pharyngitis, non-infectious rhinitis, and acute sinusitis (see Appendix E). The purpose of
the guideline was to provide the best evidence-based clinical recommendations for
common acute upper respiratory infections with a specific focus on the appropriateness of
antibiotic therapy. The algorithms included in the guideline were intended to provide
clinicians with step-wise clinical support recommendations to aid in the diagnosis,
management, and determine the appropriateness of antibiotic therapy (Short et al., 2017).
Antimicrobial Stewardship
The term “Antibiotic Stewardship” refers to efforts aimed at improving and
measuring antibiotic prescribing. “Antimicrobial Stewardship Programs” or ASPs are the
interventions designed to ensure antibiotics are prescribed only when needed, and to
ensure the right drug, dose, and duration are selected when antibiotics are prescribed
(Sanchez, Fleming-Dutra, Roberts, & Hicks 2016) In response to the growing problem of
antibiotic overuse and the emergence of resistant infections, the CDC developed the Core
Elements of Outpatient Antibiotic Stewardship (Sanchez et al., 2016). These core
elements are intended provide a framework on the guidance of establishing, developing,
and monitoring ASPs in the outpatient setting.
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The four core elements of outpatient antibiotic stewardship (see Appendix F)
include the following: 1) commitment, 2) action for policy and practice, 3) tracking and
reporting, and 4) education and expertise (Sanchez et al., 2016). The use of these four
core elements is intended for any entity that uses antibiotics in the outpatient setting,
including primary care physicians, NPs/PAs, emergency departments, urgent cares,
community care clinics, dental clinics, and outpatient specialty and subspecialty clinics
(Sanchez et al., 2016).
The first core element of commitment defined by Sanchez et al. (2016) means to
“demonstrate dedication to and accountability for optimizing antibiotic prescribing and
patient safety” (p. 15). A commitment by all health care team members to prescribe
antibiotics appropriately and actively participate in ASP efforts collectively represents an
essential first-step in reducing the overuse and inappropriate prescription of antibiotics
(Sanchez et al., 2016). Clinicians’ and health care settings can demonstrate the core
element of commitment through the following: 1) displaying public posters and
commitment pledges to appropriate antibiotic prescribing in support of antibiotic
stewardship, 2) identify facility ASP team leaders to direct stewardship activities, 3)
include ASP duties in position descriptions and in criteria for evaluating job
requirements, and 4) consistent antibiotic prescribing behaviors through clear
communication with all staff members and patients about the indications for antibiotics
(Sanchez et al., 2016).
The second core element of action for policy and practice, the authors Sanchez et
al. (2016) recommend that outpatient settings “implement at least one policy or practice
to improve antibiotic prescribing, assess whether it is working, and modify as needed” (p.
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15). Clinicians can achieve this core element by employing evidence-based diagnostic
criteria and treatment recommendations or using watchful waiting or delayed prescribing
practices when prescribing antibiotics (Sanchez et al., 2016). Outpatient healthcare
settings can assist clinicians in prescribing efforts through the following: 1) providing
communication skills training for providers to help manage patient expectations, 2)
require written justification in the patient’s medical record when antibiotics are given for
a non-recommended condition or diagnosis, 3) provide clinicians with clinical decision
support systems to assist in appropriate management of common acute conditions, and 4)
utilizing nurse triage visits, call centers, and pharmacist consultations to minimize
unnecessary provider visits (Sanchez et al., 2016).
The third core element of tracking and reporting, the authors Sanchez et al. (2016)
recommend “monitoring antibiotic prescribing practices and offer regular feedback to
clinicians, or have clinicians assess their own antibiotic prescribing practices themselves”
(p. 15). Providers can achieve this core element by either self-evaluating their own
antibiotic prescribing practices or participating in continual education and quality
improvement activities aimed at tracking and improving antibiotic prescribing (Sanchez
et al., 2016). Outpatient clinical settings can employ programs such as the National
Healthcare and Safety Network (NHSM) survey’s that require clinicians to report
antibiotic usage and allow for the tracking of resistance data. Such data can be used for
the purposes of providing audit and feedback allowing for the assessment and sharing of
prescribing performance, setting of realistic goals, and promote quality measures that
address the appropriateness of antibiotic prescriptions within the setting (Sanchez et al.,
2016).
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The fourth and final core element of education and expertise is defined by
Sanchez et al. (2016) as the ability to “provide educational resources to clinicians and
patients on antibiotic prescribing and ensure access to needed expertise on optimizing
antibiotic prescribing” (p. 15). This core element can be accomplished by performing and
implementing the following: 1) utilize effective communication strategies aimed at
educating patients on when antibiotics are and are not indicated, 2) ensuring patients are
educated about the potential harms of antibiotic treatment including adverse events and
C. difficile associated diarrhea, 3) provide patients with recommended educational
materials, 4) provide opportunities for multi-disciplinary face-to-face educational
training, 5) provide continuing education activities for providers, and 6) ensure timely
access to persons with expertise to improve antibiotic prescribing for patients who require
specialty care (Sanchez et al., 2016).
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Chapter III.

Methodology & Plan

The following chapter will discuss the plan and methodology of the DNP
scholarly project. The research design of the project used a cross-sectional observational
approach which will be discussed in this section. The target population, recruitment
process, and inclusion and exclusion criteria will be addressed. The Institutional Review
Board (IRB) process and the protection of participants will be discussed. The student
used a pre-validated survey to collect data on participants. The instrument used to
conduct the survey, as well as the procedure and administration of the survey, will be
examined. Lastly, the intended outcomes of conducting this project and the plan for
sustainability will be included at the end of this chapter.
Project Design
For the scholarly project, the student desired to follow a quantitative design
strategy. A cross-sectional observational research design was used to identify and explore
healthcare provider’s knowledge, attitudes, and prescribing practices concerning
antibiotic use and resistance. Using this design, the researcher gathered objective data and
examined it statistically in order to attempt to answer the identified research questions:
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•

What are the knowledge, attitudes, and perceptions (KAPs) underlying providers
prescription of antibiotics for common respiratory indications in the primary and
secondary care setting?

•

What differences exist between provider characteristics and antibiotic-prescribing
behavior and knowledge of antimicrobial resistance in the primary and secondary
setting?
A pre-validated semi-structured survey developed by Rodrigues et al. (2016) was

used to obtain provider demographic information, assess factors that influence
prescribing behaviors, and identify common sources of knowledge used to guide
antibiotic prescribing in clinical practice. The focus of the survey questions mainly
concerned the use of oral antibiotics for common acute respiratory infections in the
primary and secondary care setting. Analysis of healthcare provider’s responses was
translated into statistical data using Qualtrics XM (Qualtrics, Provo, UT, 2020) statistical
analysis software to identify educational needs of the practice setting. Identified target
educational resources and strategies aimed at enhancing the awareness of appropriate
antibiotic use and resistance of both healthcare providers and consumers can be found in
the appendices of the project.
A descriptive cross-sectional study is an observational study design used to research
different groups of a sample population who differ in the variable of interest (knowledge,
attitudes, and prescribing behaviors) but share a common characteristic (educational
background/practice setting) for the purpose of determining the prevalence of the
outcome of interest . In a cross-sectional design, data on the variable of interest is
collected at one specified period of time and can be used to characterize the prevalence of
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an outcome in a given sample population (Alexander, Lopes, Ricchetti-Masterson, &
Yeatts, 2013). The goal of this research project was to identify factors involving provider
antibiotic prescribing practices. The variables of interest consisted of antibiotic
prescribing behaviors and knowledge of resistance. In addition, significant differences
between provider responses regarding the variables of interest were investigated. A prevalidated survey (Rodrigues et al., 2016) that included both closed and open-ended
questions allowed for the collection of quantitative and qualitative data. The data was
analyzed for the purpose of identifying the prevalence of antibiotic prescribing practices
of the sample population in an effort to identify educational needs and generalize findings
to the target population.
The pre-validated survey (Rodrigues et al., 2016) selected for this project
included primarily closed-ended questions with the exception of one open-ended question
at the end of the survey. A total of 23 statements measured on an unnumbered continuous
visual analog scale and nine questions on sociodemographic characteristics of the
provider allowed for the collection of quantitative data. Lastly, one open-ended
discussion question at the end of the survey allowed for the collection of qualitative data.
Target Population
The target population for this project was healthcare providers; including
physicians (DO or MD), physician-assistants (PAs), and nurse practitioners (NPs);
working in primary and secondary care settings of Southwest Missouri and Southeast
Kansas. A power analysis was performed and determined that 85 participants was
necessary for statistical significance. Using Cohen’s Statistical Power Analysis, the
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student investigator used .05 alpha, medium effect size (r =0.30), and 0.80 statistical
power ( =0.20) to make a determination of estimated sample size (Chuan, 2006).
Target Population Recruitment
The project utilized a convenience sampling methodology to gather data on the
target population. Using the inclusion and exclusion criteria identified below (Table 1),
the researcher obtained data from physicians, NPs, and PAs working in both primary and
secondary care settings. The student collected data on healthcare providers providing
primary care services in a rural access community health center in Southeast Kansas. For
the collection of data from secondary care settings, the student administered the survey to
healthcare providers working in emergency care services at 339-bed teaching hospital in
Southwest Missouri. The student also administered the survey to a group of healthcare
providers employed by an agency that provides emergent healthcare services in various
locations throughout the Southeast Kansas and Southwest Missouri area. All surveys
were completed on a voluntary basis via electronic submission through an anonymous
link that was disseminated to the provider’s work email. No monetary rewards or
incentives were used in the collection of data.
Inclusion and Exclusion Criteria
Inclusion and exclusion criteria were pre-determined before the administration of
the survey. The following (Table 1) represents the inclusion and exclusion criteria of the
research study:
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Table 1. Inclusion and exclusion criteria for a cross-sectional survey of healthcare
provider’s antibiotic prescribing practices.
Inclusion criteria

Exclusion criteria

•

Healthcare providers working in
•
primary and secondary care settings
(i.e. community clinic, emergency
care, and urgent care)
• Emergency medicine physicians,
•
primary care physicians (including
both DO and MD), physician
assistants, and nurse practitioners who •
prescribe medications
• Voluntary participation and informed
consent
Institutional Review Board and Site Approval

Out-patient surgical centers, in-patient
hospital admissions, and out-patient
specialty care services (e.g.
cardiology, nephrology, neurology)
Registered nurses and other healthcare
workers who do not directly prescribe
medications
Refusal to give informed consent

The DNP scholarly project proposal was submitted to Pittsburg State University
(PSU) Irene Ransom Bradley School of Nursing (IRBSON) Institutional Review Board
(IRB) on October 22nd, 2019. On October 30th, 2019 the formal DNP scholarly project
proposal took place at Pittsburg State University. During the proposal, a review of the
project’s methodology with the project advisor and committee chairs determined that the
project required data collection from a pre-validated survey and posed minimal risk to
participants. On December 3rd, 2019 the Institutional Review Board (IRB) at Pittsburg
State University granted and approved the project as being exempt for research involving
human subjects (see Appendix G).
Before obtaining IRB approval through IRBSON, the student made contact with
the clinical directors overseeing the various practice settings. A site approval letter was
manifested. After obtaining IRB approval through PSU, the student again made contact
with the various clinical directors. Signatures were obtained from these individuals
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granting site approval to conduct the survey on providers employed in these settings (see
Appendix H).
Protection of Human Subjects
Informed consent was provided in an introductory explanation delivered in the
email containing the anonymous link to the survey and was also stated in an explanatory
paragraph provided at the beginning of the survey. The introductory paragraph included
information about the research project, purpose of the survey, potential risks and benefits,
the meaning of voluntary participation, and how the data will be used to analyze the
prevalence of antibiotic prescribing behaviors, knowledge, and attitudes.
All participation was voluntary and involved adults over 18 years of age. Data
from the provider surveys was obtained via a secure online anonymous link provided
through an email distributed by the three clinical site directors. To ensure no identifying
information was obtained by the researcher, the student sent an email containing the
anonymous link to the survey to the clinical directors overseeing the research sites. The
clinical directors sent out the anonymous link to the survey to the providers of the clinical
settings via a secure work email database. De-identification was used to distribute the
online survey so that no association of responses could be linked back to the respondent.
No identifying personal information was obtained, and all surveys were completed
anonymously on a voluntary basis. To limit breach in confidentiality, all data obtained
from the surveys was stored on an encrypted USB drive. After completion of the project,
the USB drive was secured in a locked file cabinet at Pittsburg State University School of
Nursing. The USB drive will remain secured at this site for a period of two years, after
which data on the drive will be permanently deleted.
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Instrument
The two major variables of interest included the following: 1) antibiotic
prescribing practices, and 2) providers knowledge of antibiotic resistance. To collect data
on these variables, a pre-validated survey developed by Rodrigues et al. (2016) (see
Appendix B) was adapted and used (see Appendix C). The questionnaire was specifically
designed to assess providers’ attitudes and knowledge of antibiotic prescribing, antibiotic
use and antimicrobial resistance, as well as the usefulness of various sources of
knowledge/resources utilized in guiding antimicrobial use in the clinical setting
(Rodrigues et al., 2016).
The questionnaire took the form of a two-page document made up of the following five
sections:
•

Section 1 (“Filling Instructions”): instructions on completing the survey;

•

Section 2 (“About Antibiotics and Resistances”): 17 statements assessing provider
knowledge and attitudes concerning antibiotic use, antibiotic resistance, and
antibiotic prescribing practices;

•

Section 3 (“In The Treatment of Respiratory Infections, How Would You Rate
The Usefulness of Each of These Sources of Knowledge?”): 9 statements
concerning the providers’ perception involving the importance and usefulness of
various sources of knowledge for guiding the prescription of antibiotics in clinical
practice;

•

Section 4 (“Some questions about sociodemographic data and about your clinical
practice”): collection of provider sociodemographic information including age,
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gender, practice type, work settings, average number of patients seen per day, and
average time spent per patient;
•

Section 5 (“Do You Have Some Suggestions About Antibiotic Use and
Resistance?”): a final free-space open-discussion section allowing for providers to
express ideas and views on antibiotic use and resistance (Rodrigues et al., 2016).

Section 2 and 3, measured the providers’ agreement with the 26 statements using an
unnumbered continuous visual analogue scale (VAS), scoring their response from full
disagreement to full agreement (Rodrigues et al., 2016). Section 4 collected pertinent
sociodemographic information used to define professional attributes of the respondent.
Lastly, section 5 provided an opportunity to collect qualitative data from respondent’s in
a free-text, open-discussion format intended to expand on any variable not addressed in
the questionnaire’s statements, as well as provide an opportunity for respondents to
include any recommendations or suggestions on the topic of antibiotic use and resistance.
Rodrigues et al. (2016) developed a validated survey -in terms of face validity,
content validity and reliability- to be used as an instrument to assess the attitudes and
knowledge underlying provider antibiotic prescribing behaviors in both the hospital and
primary-care setting. Development of the instrument consisted of a literature review that
the authors used to construct the concepts of interest. After determining the concepts of
interest, the questionnaire was pre-tested by a panel of physicians to provide content
validity. Face validity was provided through an assessment of grammar, syntax,
organization, and logical sequence of the questionnaire’s statements by an expert panel
consisting of university professors, a clinical psychologist, and a linguistic expert.
Reliability of the survey was assessed through a test-retest methodology during a pilot
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study using Cronbach’s alpha ( >0.70) for internal consistency and interclass correlation
coefficient (ICC >0.4).
Under the Creative Commons Attribution 4.0 International License terms, the
questionnaire was considered open access allowing for unrestricted use. Therefore,
providing the user appropriately referenced the original authors Rodrigues et al. (2016),
permission to use the survey was not required. Regardless of the unrestricted nature of
the survey, the student did attempt to contact the author of the survey on February 4th,
2019 via email, but no response to this effort resulted.
It is important to note that the original survey developed by Rodrigues et al.
(2016) was adapted for the purpose of this study. The original survey can be found in
Appendix B and the adapted survey found in Appendix C. The adapted survey represents
the instrument that was sent out to the target population. Three adaptations to the original
survey were made. The first adaptation included the omission of wording to statement
number 13 of the original survey. The words “at the pharmacy” were omitted from this
statement to reduce respondent confusion as oral antibiotics cannot be obtained from a
pharmacy without a prescription in the United States. The second adaption was the
exclusion of the sociodemographic question asking the respondent to specify their area of
specialization. This was omitted for the purpose of reducing the occurrence of repetitive
questioning. The third and final adaptation includes the omission of an additional
sociodemographic question stated as the following: “Approximately, what is the number
of patients seen per day at the emergency service?” (Rodrigues et al., 2016). As the target
population of this study included both primary and secondary care providers, the decision
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to omit this item was made to avoid issues with provider non-response to a question that
applies only to those working in emergency care services.
Procedure
After the project’s proposal on October 30th, 2019, the researcher and board
committee members considered the proposed project to be feasible and sustainable. Due
to the relative ease of administering a pre-validated survey, limited resources needed to
disseminate and receive survey information, and the lack of financial resources necessary
for completion of the project, the researcher and board committee members deemed that
the means of performing the project justified the need.
No funding was necessary for the administration of the survey. No physical paper
copies of the survey were administered, and all data was sent and received electronically
via a secured online database. All data of provider responses were anonymous to ensure
no identifying information would be included, obtained, or could be traced back to a
specific respondent. To limit breach in confidentiality, all data obtained from the surveys
was stored on an encrypted USB drive.
The original survey developed by Rodrigues et al. (2016) was adapted into an
online survey using Qualtrics XM (Qualtrics, Provo, UT, 2020). Access to the online
survey software was provided free-of-charge to the researcher through Pittsburg State
University. Using this software, the pre-validated survey developed by Rodrigues et al.
(2016) was adapted into an online format and was distributed via an anonymous link that
was emailed to the three clinical site directors. Following a convenience sampling
methodology, the clinical site directors distributed the anonymous link to the survey via a
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secured work email database to the healthcare providers of the three target clinical
settings on December 12th, 2019.
The anonymous link was distributed to the three clinical settings and was first
open to responses on December 12th, 2019 and was closed to responses on January 6th,
2020. However, due to a low response rate, the student and committee members agreed to
reopen the survey. The survey was reopened on January 14th, 2020 and was closed to
responses for a final time on February 1st, 2020. During the time when the survey was
reopened, two reminders were sent out to the providers in the form of an email that was
distributed by the clinical site directors. In its entirety, the survey was open to responses
for exactly 45 days. The occurrence of major holidays during the month of December and
the beginning of January was thought to have contributed to the low response rate that
was experienced during the initial opening of the survey.
After collecting the data, the anonymous provider responses were analyzed using
Qualtrics XM crosstabulations statistical analysis (Qualtrics, Provo, UT, 2020). Through
the use of this software, the provider responses were transformed into statistical data that
allowed for the information to be analyzed for averages and differences pertaining to the
variables of interest. Data analysis of provider responses took place during the month of
February 2020. After an analysis and interpretation of the data, results were evaluated
during the months of February and March 2020. The evaluation and discussion of the
results can be found in chapter four and chapter five, respectively.
Outcomes
The primary outcome measure(s) of the DNP project included provider
attitude/knowledge, prescribing practices, and sources of knowledge concerning
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antibiotic use and antimicrobial resistance. The secondary outcome of this project was to
determine whether any differences between provider prescribing practices and provider
characteristics exist (i.e. age, gender, type of activity, workplace, and provider workload).
A pre-validated survey developed by Rodrigues et al. (2016) was used to assess the
variables of interest and collect outcome data. The survey was selected for this project for
its ability to show content validity, face validity, and reliability as a tool for assessing
provider’s attitudes, knowledge, and prescribing behaviors regarding antibiotic use and
resistance. The main objective of the DNP project was to identify the factors underlying
antibiotic prescription and antimicrobial resistance in the context of the primary and
secondary care setting.
The survey included 17 statements assessing provider fear (consequence if
antibiotics are not prescribed), perception of patient expectations and pressure, deficits in
knowledge, indifference, and perceived responsibility of others; and nine statements
evaluating provider’s perceived usefulness of sources of knowledge utilized for guiding
antibiotic use in clinical practice (Brown, 2017). Using an unnumbered ten-centimeter
horizontal continuous visual analogue scale (VAS), each provider response was measured
from full disagreement (0%) to full agreement (100%). The score of each response was
recorded as a number, ranging from zero to 100. Lower scores (< 49) delineate a greater
disagreement with the statement while higher scores (>50) indicate a greater agreement.
Using the Qualtrics XM program as the tool for statistical analysis, cross
tabulations were used to quantitatively analyze provider responses. Univariate analysis
allowed for the grouping of variables to understand the correlation between provider
responses to determine descriptive statistics (mean, standard deviation) measuring the
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level of agreement with statements regarding attitudes, knowledge, antibiotic prescribing
behaviors, resistance, and the usefulness of sources of knowledge to guide antibiotic use
in the primary and secondary case setting. The average (mean) level of agreement with
survey statements were measured using a continuous unnumbered VAS from zero (totally
disagree) to 100 (totally agree), where measures < 49 delineate a greater disagreement
with the statement, measures of 50 indicating an indifference level of agreement, and
measures > 50 delineating a greater agreement. Using analysis of variance (ANOVA) as
the statistical test, relationships between categorical (demographic data) and numerical
variables (statement agreement) was tested for differences between means. All statistical
tests used exact p values (p < 0.05) with 95% confidence intervals (CI) (Qualtrics, Provo,
UT, 2020).
Plan for Sustainability
The main objective of the DNP project was to identify the factors underlying
antibiotic prescription and knowledge of resistance. Thus, the sustainability of the DNP
project relies heavily on identifying the factors that underly inappropriate antibiotic use
and provide education based on evidenced-based research highlighting interventions and
knowledge emphasizing appropriate antibiotic use. Listed as one of the CDC’s four core
elements of antimicrobial stewardship, education is a key aspect to any antimicrobial
stewardship effort (Prinzi, 2019).
Provider reluctance to change antibiotic prescribing behaviors presents as a major
challenge to sustainability. One of the purposes of this project was to identify reasons
‘Why’ antibiotics are prescribed inappropriately in an effort to provide a basis for the
development of antimicrobial stewardship education and interventions. Appropriate
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antibiotic prescribing education must be tailored to the practice setting and involve the
support from site management and administration. Financial resources would be
necessary to continue the dissemination of evidenced-based, up-to-date recommendations
and education pertaining to antimicrobial use and resistance.
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Chapter IV.

Evaluation of Results
The overall purpose of this project was to identify and explore provider’s
knowledge, attitudes, and prescribing practices regarding antibiotic use and resistance. A
questionnaire adapted from a pre-validated survey developed by Rodrigues et al. (2016)
was anonymously distributed to a total of 116 providers from three separate practice
settings located in Southeast Kansas and Southwest Missouri. Using a cross-sectional
observational research design and pre-validated survey, the researcher sought to answer
the two identified research questions:
•

What are the knowledge, attitudes, and perceptions (KAPs) underlying providers
prescription of antibiotics for common respiratory indications in the primary and
secondary care setting?

•

What differences exist between provider characteristics and antibiotic-prescribing
behavior and knowledge of antimicrobial resistance in the primary and secondary
setting?
The following chapter will provide a description of the sample and population

surveyed, including the timeline, number of subjects, and demographic information of the
respondents. A description of major key variables will be discussed. Statistical analyses
included descriptive statistics (frequency, means, standard deviation), univariate analysis,
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and analysis of variance (ANOVA) to determine statistically significant differences of the
sample population. Results of the survey will be provided in the form of tables and an
evaluation and interpretation of these findings will be discussed.
Description of Sample/Population
The timeframe of the survey spanned from December 12th, 2019 to February 1st,
2020. The survey was originally set to open on December 12th and close January 6th.
However, due to a low response rate the survey was reopened on January 14th and closed
to responses for a final time on February 1st, 2020.
Table 2 provides a description of the population of focus. Distributed via an
anonymous link, a total of 116 providers were invited to take the adapted pre-validated
survey. To maintain full anonymity, an anonymous link was sent to the providers’ work
email by the clinical site coordinators of the target settings. The three target settings and
the number of providers invited to take the survey at each of these settings were as
follows: 1) 39 (33.6%) emergency care providers in Southwest Missouri, 2) 18 (15.5%)
emergency care providers in Southeast Kansas, and 3) 59 (50.9%) primary care providers
in Southeast Kansas.
Table 2. Study Population
116 Total Providers
Invited
Emergency Care Providers
in Southwest Missouri

#

%

39

33.6%

Emergency Care Providers
in Southeast Kansas

18

15.5%

Primary Care Providers in
Southeast Kansas

59

50.9%
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Table 3 provides a visual depiction of participant responses and response rates of the
sample population. Out of the 116 providers invited to take the survey, 70 responded. A
total of 16 responses were excluded for non-response and partial completion. Partial
completion was determined and defined as participants who responded to less than 75%
of the survey questions. After exclusion of non-responses and partial responses, a total of
54 responses (N=54) were included, resulting in an overall response rate of 46.6%.
Table 3. Participant Responses
Response
Total Excluded
Type
Anonymous
Link

70

16

Included
(N)
54

Response Rate (%)

46.6%

Table 4 provides a visual depiction summarizing the sociodemographic
characteristics of the provider participants (N=54) through the use of frequencies
(percentages [%]). The majority of the providers were between the ages of 31 to 50 years
of age (n=35; 68.6%). There was an equal distribution of males (n=27; 50%) versus
female (n=27; 50%) providers. The majority of providers reported they practiced in a
public practice (n=45; 83.3%), with only six from private practice (11.1%) and three from
both public and private practice (5.6%). The majority of providers reported they worked
in the hospital setting (n=28; 51.9%), followed by 21 providers working in the primary
care setting (38.9%), and five working in both settings (9.3%). Out of the 54 providers, a
total of 33 providers reported they worked in emergency medicine services (61.1%). The
majority of providers reported a workload of 11 to 20 patients per day (n=35; 76%), with
only two (4.3%) seeing less than 11 to 20 patients per day and nine (19.5%) seeing more
than 11 to 20 patients per day. The majority of providers reported that an average of 10 to
25 minutes (n=38; 71.7%) of time was needed to attend to one patient.
63

Table 4. Sociodemographic Characteristics of Participating Providers
Sociodemographics
n
How old are you? (years) (N=51)
26-30
8
31-40
25
41-50
10
51-68
8
Gender (N=54)
Male
27
Female
27
What type of activity? (N=54)
Public Practice
Private Practice
Both
In which workplace? (N=54)
Hospital Care
Primary Care
Both
Do you work at the emergency service? (N=54)
Yes
No
Approximately, what is the number of patients seen
per day? (patients per day) (N=46)
5-10 patients/day
11-15 patients/day
16-20 patients/day
21-25 patients/day
26-30 patients/day
> 31 patients/day
Approximately, how much time do you need to
attend to one patient? (minutes per patient)
(N=52)
10-15 min
20-25 min
30 min
45 min
> 60min

%
15.7
49
19.6
15.7
50
50

45
6
3

83.3
11.1
5.6

28
21
5

51.9
38.9
9.3

33
21

61.1
38.9

2
10
25
4
3
2

4.3
21.7
54.3
8.7
6.5
4.3

16
22
6
2
6

30.2
41.5
11.3
3.8
11.3

Table 5 provides a visual depiction of the frequencies of reported patient workload of
both providers working in primary care and hospital care. In terms of number of patients
seen per day, the results were similar for both providers working in the hospital setting
and the primary care setting. Out of the 25 providers reporting they worked in the
hospital setting, 76% reported an average workload of 11 to 20 patients per day.
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Similarly, 77.8% of providers working in the primary care setting reported an average
workload of 11 to 20 patients per day. In terms of the amount of time needed to attend to
one patient, only slight differences were noted between the hospital and primary care
setting. Of the providers who reported they worked in the hospital setting (n=27), 26%
reported an average of 10 to 15 minutes was needed to attend to one patient and 44.4%
reported an average of 20 to 30 minutes was needed. Conversely, of the providers who
reported they worked in the primary care setting (n=21), all either reported an average of
10 to 15 minutes (33.3%) or 20 to 25 minutes (66.7%) was needed to attend to one
patient.
Table 5. Patient Workload in Primary Care V.S. Hospital Care
# Of Patients Seen Hospital Care
Primary Care
Both (n=3)
Per Day (N=46)
(n=25)
(n=18)
5-10 patients/day
0 (0%)
1 (5.6%)
1 (33.3%)
11-15 patients/day
7 (28%)
3 (16.7%)
0 (0%)
16-20 patients/day
12 (48%)
11 (61.1%)
2 (66.7%)
21-25 patients/day
3 (12%)
1 (5.6%)
0 (0%)
26-30 patients/day
2 (8%)
1 (5.6%)
0 (0%)
>31 patients/day
1 (4%)
1 (5.6%)
0 (0%)
Minutes Needed
Per Patient (N=52)
10-15 min
20-25 min
30 min
45 min
>60 min

Hospital Care
(n= 27)
7 (26%)
6 (22.2%)
6 (22.2%)
2 (7.4%)
6 (22.2%)

Primary Care
(n=21)
7 (33.3%)
14 (66.7%)
0 (0%)
0 (0%)
0 (0%)

Both (n=4)
2 (50%)
2 (50%)
0 (0%)
0 (0%)
0 (0%)

Description of Key Variables
The pre-validated survey adapted from Rodrigues et al. (2016) was used to collect
data for the purpose of measuring four major variables. The first variable was the
sociodemographic information of the respondents described in the previous section and
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depicted in tables 2-5. For the purpose of analysis, this data was treated as categorical,
defining the demographic characteristics of the sample population in terms of age,
gender, workplace activity, workplace setting, and workload (i.e., number of patients per
day and average amount of time needed per patient).
The second major variable measured included 17 statements collecting data on the
knowledge, attitudes, and perceptions (KAPs) of providers regarding antibiotic use and
antimicrobial resistance. This data was treated as numeric and was measured via the use
of an unnumbered 10cm horizontal continuous visual analog scale (VAS). Each provider
response was measured using this technique and was scored from full disagreement (0) to
full agreement (100). Scores were recorded from zero to 100, where lower scores (< 49)
indicated greater disagreement, median scores (50) indicated agreement indifference, and
higher scores (>50) indicated greater agreement with the statement. The 17 KAPs
statements were intended to assess provider fear (fear if an antibiotic is not prescribed),
complacency (perception of patient expectations/pressure), ignorance (knowledge
deficits), indifference (neither agree or disagree), and responsibility of others (Brown,
2017).
The third major variable included nine statements evaluating the usefulness of
sources of knowledge for guiding the prescription of antibiotics. Measured using the
same VAS technique previously described, providers rated their level of agreement with
nine various sources of knowledge they deemed as being useful in guiding the use of
antibiotics in the clinical setting. The nine statements were intended to collect data on
common sources of knowledge providers use when making clinical decisions regarding
the use of antibiotics. The fourth and final major variable included a section placed at the
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end of the survey intended to collect qualitative data. The blank section was included
under the question “Do you have some suggestions about antibiotic use and resistance?”
allowing providers to comment using a free-text answer format.
Analysis and Results
All analyses were completed via the use of Qualtrics XM survey developer and
statistical analysis software (Qualtrics, Provo, UT, 2020). Using this program, descriptive
statistics using cross tabulation were performed to determine the average (mean) provider
level of agreement and standard deviation (SD) with the 17 KAPs statements and nine
sources of knowledge statements. After determining the mean level of agreement with
each of the 26 survey statements, univariate analysis of variance (ANOVA) was
performed to determine if any statistically significant differences existed between mean
scores and categorical data (sociodemographic characteristics).
According to Qualtrics XM, analysis of variance (ANOVA) is used to test the
relationship between a categorical and numeric variable by examining differences
between two or more means (Qualtrics, Provo, UT, 2020). The ANOVA was used to
determine whether any statistically significant differences existed between provider mean
scores and sociodemographic characteristics categorized by age, gender, type of practice
activity, practice setting, and provider workload. The goal of the project was to determine
provider KAPs in terms of antibiotic use and resistance, identify facilitators and barriers
to appropriate antibiotic use, and determine useful sources of knowledge for guiding
antibiotic use in both the primary and secondary care setting. With those objectives in
mind, the use of descriptive statistics to determine mean levels of agreement and standard
deviations (SD), and univariate analysis using ANOVA were determined to be
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appropriate statistical analyses and tests that were well-aligned with the overall purpose
of the project and research questions of interest.
Table 6 provides a visual depiction of the results of provider mean levels of
agreement with the 17 statements relating to knowledge, attitudes, and perceptions about
antibiotic use and resistance. Using univariate analysis of variance (ANOVA) as the
statistical test, any statistically significant differences between mean scores and
sociodemographic categorical data (age, gender, type of activity, workplace, emergency
service, number of patients per day, and minutes per patient) are given in the form of a pvalue. Using Qualtrics XM, all statistical tests used exact p values (p < 0.05) with 95%
confidence intervals (CI) (Qualtrics, Provo, UT, 2020).
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Table 6. Knowledge, Attitudes, and Perceptions (KAPs) About Antibiotic Use and Resistance*
Statement
Avg. or Standard Age
Gender Type of
Workplace
Mean
Deviation
Activity
()
(SD or )
1. Antibiotic resistance is an
90.5
14.4
important Public Health
Problem. (n=54)
2. In a primary-care context, one
41.3
21.8
___
______
_________ _________
should wait for the microbiology
results before treating an
infectious disease. (n=54)
3. Rapid effective techniques are
57.0
27.2
___
_____
_______
_______
required for diagnosis of
infectious disease. (n=54)
4. The prescription of antibiotics
17.9
24.4
___
0.036
______
_______
does not influence the possible
appearance of resistance. (n=47)
5. I am convinced new
36.5
28.9
___
_____
______
_______
antibiotics will be developed to
solve the problem of resistance.
(n=53)
6. The use of antibiotics on
50.2
29.8
___
_____
______
_______
animals is an important cause of
the appearance of new resistance
to pathogenic agents in humans.
(n=53)
7. In case of doubt, it is
41.6
31.5
___
_____
______
_______
preferable to use a widespectrum antibiotic to ensure
that the patient is cured of an
infection. (n=52)
8. I frequently prescribe an
49.8
32.1
___
____
______
0.017
antibiotic in situations where it is
impossible for me to conduct a
systematic follow-up of the
patient. (n=52)
9. In situations of doubt as to
30.9
29.9
___
0.010
______
______
whether a disease might be of
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Emergency
Service

# of
Patients
Per Day
0.028

Minutes
Per
Patient

_________

_______

________

________

_______

<0.00001

________

_______

_______

________

_______

_______

________

_______

0.013

________

_______

_______

0.039

______

______

_______

______

0.049

bacterial etiology, it is preferable
to prescribe an antibiotic. (n=50)
10. I frequently prescribe
15.9
23.6
___
____
______
<0.00001
______
______
______
antibiotics because patients insist
on it. (n=48)
11. I sometimes prescribe
13.1
23.3
___
____
______
<0.00001
_______
______
______
antibiotics so that patients
continue to trust me. (n=46)
12. I sometimes prescribe
15.2
25.7
___
0.027
______
_______
_______
______
______
antibiotics, even when I know
they are not indicated because I
do not have the time to explain
to the patient the reason why
they are not called for. (n=44)
13. If a patient feels that he/she
31.7
29.8
___
____
______
_______
_______
______
______
needs antibiotics, he/she will
manage to obtain them without a
prescription, even when they
have not been prescribed. (n=52)
14. Two of the main causes of
67.8
27.0
___
0.015
______
_______
0.043
______
0.049
the appearance of antibiotic
resistance are patient selfmedication and antibiotic
misuse. (n=52)
15. Dispensing antibiotics
69.2
32.3
___
____
______
______
______
______
______
without a prescription should be
more closely monitored. (n=51)
16. In a primary-care context,
39.0
30.6
___
____
______
______
______
______
______
amoxicillin is useful for treating
most respiratory infections.
(n=53)
17. The phenomenon of
19.8
23.0
___
0.041
0.040
______
0.019
______
______
resistance to antibiotics is
mainly a problem in the hospital
setting. (n=48)
*Avg. or Mean () is the Level of Agreement with the Statement measured from zero (totally disagree) to 100 (totally agree) [< 49 greater disagreement,
=50 neither agree or disagree, and > 50 greater agreement]; Standard Deviation (SD or ); Statistically Significant p < 0.05 with 95% CI; ----- NonSignificant
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The following sections will discuss the findings presented in Table 6. The
providers mean level of agreement with the 17 KAPs statements and any statistically
significant differences identified via analysis of variance will discussed. For the purpose
of organization, the 17 KAPs statements will be divided into statements that had a
consensus of agreement and those where there was a consensus of disagreement. All
statistical tests were done via the use Qualtrics XM, using exact p-values (p= <0.05) and
a confidence interval (CI) of 95% (Qualtrics, Provo, UT, 2020).
KAP Statements: Consensus of Agreement
Statement 1: The providers strongly agree that antibiotic resistance is an important
public health problem (Statement 1;  score= 90.5). Using 90.5 as the mean score, a
statistically significant difference was found in terms of patients seen per day (p= 0.028).
Providers who reported seeing approximately 5 to 10 patients per day had a mean level of
agreement of 60.0 and providers who reported seeing greater than 31 patients per day
reported a mean level of agreement of 70.5.
Statement 3: There was a mean level of agreement ( score= 57.0) with statement 3
(“Rapid effective techniques are required for diagnosis of infectious disease”). A
statistically significant difference (p= <0.00001) was noted in providers who needed 45
minutes (x score= 27.0) or greater (x score= 46.7) to attend to one patient.
Statement 6: There was a weak mean level of agreement ( score=50.2) bordering
indifference with statement 6 (“The use of antibiotics on animals is an important cause of
the appearance of new resistance to pathogenic agents in humans”). A statistically
significant difference (p= 0.013) was noted in providers reporting they needed
approximately 30 minutes to attend to one patient (x score= 81.6). In contrast, providers
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requiring either more or less than 30 minutes to attend to one patient generally disagree
with statement 6, signified by a mean score of 49 or less.
Statement 14: The providers had a mean level of agreement ( score=67.8) with
statement 14 (“Two of the main causes of the appearance of antibiotic resistance are
patient self-medication and antibiotic misuse”). Using an overall mean score of 67.8,
three statistically significant differences were found in terms of gender (p= 0.015),
emergency service (p= 0.043), and minutes per patient (p= 0.049). There was a greater
level of agreement with statement 14 reported by female providers (x score= 76.2)
compared to male providers (x score= 59.4). Providers who worked in emergency
services reported a lower level of agreement (x score= 61.4) compared to those who did
not (x score= 78.0). Lastly, providers who reported they needed approximately 60
minutes or greater to attend to one patient had a mean level of disagreement (x score=
42.3) with statement 14.
Statement 15: There was a mean level of agreement ( score=69.2) with statement 15
(“Dispensing antibiotics should be more closely monitored”). No statistically significant
differences among provider characteristics was found.
KAP Statements: Consensus of Disagreement
Statement 2: A mean level of disagreement ( score=41.3) with statement 2 (“In a
primary-care context, one should wait for the microbiology results before treating an
infectious disease”) was noted. No statistically significant differences among provider
characteristics was found.
Statement 4: On average, the providers strongly disagree ( score= 17.9) with statement
4 (“The prescription of antibiotics does not influence the possible appearance of
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resistance”). A statistically significant difference in the level of agreement was noted in
terms of gender (p= 0.036). Although both genders disagree with the statement, there was
a stronger level of disagreement from female providers (x score= 13.2) when compared
to male providers (x score= 23.2).
Statement 5: A mean level of disagreement ( score= 36.5) with statement 5 (“I am
convinced new antibiotics will be developed to solve the problem of resistance”) was
noted among the providers. No statistically significant differences among provider
characteristics was found.
Statement 7: The providers generally disagreed ( score= 41.6) with statement 7 (“In
case of doubt, it is preferable to use a wide-spectrum antibiotic to ensure that the patient
is cured of an infection”). No statistically significant differences among provider
characteristics was found.
Statement 8: A weak mean level of disagreement ( score= 49.8), bordering
indifference, was noted among providers when answering statement 8 (“I frequently
prescribe an antibiotic in situations where it is impossible for me to conduct a systematic
follow-up of the patient”). Two statistically significant differences in provider
characteristics was noted in terms of workplace (p= 0.017), and emergency service (p=
0.039). Primary care providers had a strong level of disagreement with statement 8 (x
score= 31.4), whereas providers in the hospital setting had a mean level of agreement
with statement 8 (x score= 63.2). To note, of the five providers who reported working in
both the primary care and hospital setting, a mean level of disagreement with statement 8
was found (x score= 44.2). Providers who reported they did not work in emergency
services had a mean level of disagreement with statement 8 (x score= 36.6). In contrast,
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emergency service providers had a mean level of agreement with statement 8 (x score=
57.3).
Statement 9: On average, a mean level of disagreement ( score= 30.9) with statement 9
(“In situations of doubt as to whether a disease might be of bacterial etiology, it is
preferable to prescribe an antibiotic”) was noted. There was a statistically significant
difference noted in provider characteristics with statement 9 in terms of gender (p=
0.010), and minutes per patient (p= 0.049). Although both genders had a mean level of
disagreement with statement 9, female providers had a greater level of disagreement (x
score= 20.0) when compared to male providers (x score= 40.8). Providers who reported
the need for approximately 45 minutes per patient (x score= 66.0) and 60 minutes or
greater to attend to a patient (x score= 47.7) had a higher level of agreement with
statement 9 when compared to the overall average of the sample ( score= 30.9).
Statement 10: There was a strong level of disagreement ( score= 15.9) noted among
providers with statement 10 (“I frequently prescribe antibiotics because patients insist on
it”). A statistically significant difference was noted in the provider characteristic
regarding workplace (p= <0.00001). When compared to providers working in either the
hospital setting (x score= 13.3) or primary care alone (x score= 13.0), providers
working in both settings had a higher level of agreement with statement 10 (x score=
46.8).
Statement 11: A strong level of a disagreement was noted among providers ( score=
13.1) when measuring the level of agreement with statement 11 (“I sometimes prescribe
antibiotics so that patients continue to trust me”). A statistically significant difference
was noted in provider characteristics in terms of workplace (p= <0.00001). Similar to the
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finding for statement 10, when compared to providers working in either the hospital
setting (x score= 7.7) or primary care alone (x score= 13.3), providers working in both
settings had a higher level of agreement with statement 11 (x score= 43.5).
Statement 12: There was a strong level of disagreement ( score= 15.2) noted in
providers when rating statement 12 (“I sometimes prescribe antibiotics, even when I
know they are not indicated because I do not have the time to explain to the patient the
reason why they are not called for”). There was a statistically significant difference noted
in provider demographics in terms of gender (p= 0.027). Female providers had a stronger
level of disagreement (x score= 7.3) with statement 12, when compared to male
providers (x score= 24.0).
Statement 13: On average, a mean level of disagreement ( score= 31.7) was noted
among providers when measuring the level of agreement with statement 13 (“If a patient
feels that he/she needs antibiotics, he/she will manage to obtain them without a
prescription, even when they have not been prescribed”). In an analysis of variance
(ANOVA), no statistically significant differences among provider characteristics was
found.
Statement 16: A mean level of disagreement ( score= 39.0) was noted among provider
when measuring the level of agreement with statement 16 (“In a primary-care context,
amoxicillin is useful for treating most respiratory infections”). No statistically significant
differences among provider characteristics was found.
Statement 17: There was a strong mean level of disagreement ( score= 19.8) noted with
statement 17 (“The phenomenon of resistance to antibiotics is mainly a problem in the
hospital setting”). Three statistically significant differences were noted in provider
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characteristics in terms of gender (p= 0.041), type of activity (p= 0.040), and emergency
service (p= 0.019). Although both genders had an average level of disagreement with
statement 17, female providers had a stronger level of disagreement (x score= 13.8)
when compared to male providers (x score= 25.9). Out of the three types of activity
reported, providers working in both public and private practice had the highest level of
disagreement (x score= 1.7) with statement 17 when compared to providers who
reported working in private practice (x score= 17.6) or public practice (x score= 21.5)
alone. Lastly, providers who reported working in the emergency setting had a weaker
mean level of disagreement (x score= 24.7) with statement 17 when compared to
providers who do not work in the emergency setting (x score= 10.8).
Table 7 provides a visual depiction of the findings pertaining to the providers
level of agreement with nine statements regarding the usefulness of various sources of
knowledge for guiding antibiotic use in clinical practice. Methods of descriptive statistics
(means, SD) were used to identify major source of knowledge. Using univariate analysis
of variance (ANOVA) as the statistical test, any statistically significant differences found
between mean scores and provider characteristics (sociodemographic data) were
identified in the form of a p-value.
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Table 7. In the Treatment of Respiratory Tract Infections, Rate the Usefulness of Resources of Knowledge*
Avg. or Standard Age Gender Type of
Statement
Workplace Emergency # of
Minutes
Mean
Deviation
Activity
Service
Patients Per
()
(SD or )
Per
Patient
Day
18. Clinical practice
85.9
17.6
0.043
_____
guidelines. (n=54)
19. Documentation furnished
46.0
28.1
0.013
_____
by the Pharmaceutical
Industry. (n=53)
20. Courses held by the
40.6
25.7
_____
0.017
Pharmaceutical Industry.
(n=52)
21. Information furnished by
54.3
24.7
_____
0.005
Medical Information Officers.
(n=52)
22. Previous clinical
71.5
20.7
_____
_____
experience. (n=54)
23. Continuing Education
79.8
18.0
0.003
_____
courses. (n=54)
24. Others, e.g., contribution
79.2
23.5
_____
0.005
of specialists
(microbiologists, infectious
disease specialist, etc.).
(n=54)
25. Contribution of peers (of
63.9
26.9
_____
0.003
same specialization). (n=54)
26. Data collected via the
39.9
27.3
_____
_____
internet. (n=53)
*Avg. or Mean () is the Level of Agreement with the Statement measured from zero (totally disagree) to 100 (totally agree) [< 49 greater disagreement,
=50 neither agree or disagree, and > 50 greater agreement]; Standard Deviation (SD or ); Statistically Significant p < 0.05 with 95% CI; ----- NonSignificant
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The following sections will discuss the findings presented in Table 7. The
providers mean level of agreement with the nine statements pertaining to the usefulness
of sources of knowledge and any statistically significant differences identified via
analysis of variance will be discussed. For the purpose of organization, the nine
statements will be divided according to those where there was a consensus of agreement
and those where there is a consensus of disagreement. All statistical tests were done via
the use Qualtrics XM, using exact p-values (p= <0.05) and a confidence interval (CI) of
95% (Qualtrics, Provo, UT, 2020).
Useful Resources of Knowledge Statements: Consensus of Agreement
Statement 18: Providers were asked to rate their level of agreement with nine statements
pertaining to the usefulness of resources of knowledge used to guide clinical decisions
involving the use of antibiotics in the practice setting. Statement 18 (“Clinical practice
guidelines”), on average had the highest level of agreement among the 54 providers
surveyed ( score= 85.9). One statistically significant difference was found in provider
characteristics regarding gender (p= 0.043). Female providers had a higher overall level
of agreement with statement 18 (x score= 90.8) when compared to male providers (x
score= 81.0).
Statement 21: There was a weak level of agreement ( score= 54.3) with statement 21
(“Information furnished by medical information officers”) pertaining to the perceived
usefulness of this information as a knowledge resource. One statistically significant
difference was noted in the provider characteristic pertaining to the number of patients
per day (p= 0.005). Providers who reported seeing approximately five to ten patients per
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day (x score= 27.5) and 31 or more patients per day (x score= 15.0) had an overall
mean level of disagreement with statement 21 compared to the other providers.
Statement 22: On average, there was a mean level of agreement ( score= 71.5) among
providers with statement 22 (“Previous clinical experience”). No statistically significant
differences among provider characteristics were found pertaining to the level of
agreement with statement 22.
Statement 23: A strong mean level of agreement ( score= 79.8) among providers was
noted when rating statement 23 (“Continuing education courses”). One statistically
significant difference in the provider characteristics of gender was found (p= 0.003).
Female providers had an overall higher level of agreement (x score= 87.1) with
statement 23 when compared to male providers (x score= 72.6).
Statement 24: There was a strong mean level of agreement ( score= 79.2) among
providers concerning statement 24 (“Others, e.g., contribution of specialists
[microbiologists, infectious disease specialists, etc.]”). One statistically significant
difference was noted in the provider characteristic concerning the number of patients seen
per day (p= 0.005). Similar to the finding noted in statement 21, providers who reported
seeing approximately five to ten patients per day (x score= 48.0) and those who saw 31
or greater patients per day (x score= 33.5) had an overall mean level of disagreement
with statement 24 concerning its usefulness as a knowledge source for guiding antibiotic
use.
Statement 25: A mean level of agreement ( score= 63.9) among providers was found to
be associated with statement 25 (“Contribution of peers [of the same specialization]”).
One statistically significant difference was found in the provider characteristic regarding
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the number of patients seen per day (p= 0.003). Again, providers who reported seeing
five to ten patients per day (x score= 54.0) and those who reported seeing 31 or greater
patients per day (x score= 10.0) had an overall lower mean level of agreement with
statement 25 as a useful resource for knowledge pertaining to antibiotic use.
Useful Resources of Knowledge Statements: Consensus of Disagreement
Statement 19: Providers reported a weak mean level of disagreement ( score= 46.0) to
statement 19 (“Documentation furnished by the pharmaceutical industry”) as a useful
source of knowledge. A statistically significant difference was found among provider
characteristics pertaining to gender (p= 0.013). It was found that female providers tended
to agree with statement 19 as a useful source of knowledge (x score= 56.1). In contrast,
male providers tended to disagree with statement 19 as a useful source of knowledge (x
score= 35.5).
Statement 20: An overall mean level of disagreement with statement 20 (“Courses held
by the pharmaceutical industry”) was found among providers ( score= 40.6). There was
a statistically significant difference noted in the provider characteristics pertaining to the
number of patients seen per day (p= 0.017). Providers who reported seeing 31 patients or
greater per day had an overall higher level of disagreement with statement 20 (x score=
16.5) when compared to all other reported provider workloads.
Statement 26: Lastly, a mean level of disagreement ( score= 39.9) was found among
provider regarding statement 26 (“Data collected via the internet”) as a useful resource of
knowledge for guiding antibiotic use. No statistically significant differences among
provider characteristics were found pertaining to statement 26.
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Qualitative Data: Provider Comments Regarding Antibiotic Use & Resistance
The last section of the survey asked the providers the following question “Do you
have some suggestions about antibiotic use and resistance”. This was provided in an
optional free-text answering format intended to collect qualitative data from providers
that would allow for anonymous disclosure of questions, comments, and/or
recommendations regarding antibiotic use and resistance.
Given in bullet points and quotation marks, the following is a representation of the
comments and recommendations that were provided by the respondents of this survey:
•

“Be judicious.”

•

“Decrease the use of antibiotics in both the hospital and out-patient setting.
Incentives to pharm companies to research and develop new antibiotics. Alter the
perception of that patient’s want/need an antibiotic. Decrease patient loads to
improve education provided to individual patients.”

•

“Better public education regarding viral URIs and their treatments.”

•

“Follow local antibiotic resistance trends from your local hospitals. Our facility
publishes antibiograms every 2 years.”

•

“We live in a quick-fix society and patients often do not understand and get very
mad/upset when not given what they perceive they need. Often these complaints
come back on the provider. More education to the public is needed.”

•

“Practice evidence-based medicine.”

•

“More public education. Consistency among providers from one practice and the
use of the same up-to-date guidelines should be followed.”
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•

“Stop prescribing antibiotics for the common cold and mild ear infections in
children. Patient’s need to complete the course of antibiotics that are prescribed,
and patients should refrain from sharing antibiotics. Having access to more rapid
testing for viral illnesses (unfortunately have to “prove” to parents that it is a
virus) would help decrease prescribing in my opinion. Better access and
distribution of evidence-based medicine to providers would help as well. Urgent
care providers need to be taught that not everyone needs to leave with a
prescription for antibiotics!”

•

“Public awareness is limited, especially in rural, lower socioeconomic areas like
ours. Physicians have a role in education, but others can and should be helping
overcome the general populations ignorance of this growing problem.”

•

“Allow physicians to use their own judgment and not checkboxes. Put
information out, and then physicians should be the one to make the decision.”
Summary of Chapter IV.
The overall purpose of this project was to identify and explore provider’s

knowledge, attitudes, perceptions, and prescribing practices regarding antibiotic use and
resistance. A pre-validated survey developed by Rodrigues et al. (2016) was adapted and
used to assess providers working in the primary care and secondary care setting. The
survey included the following: 1) 17 statements assessing the provider’s level of
agreement concerning knowledge, attitudes, and prescribing practices regarding antibiotic
use and resistance; 2) nine statements assessing the provider’s level of agreement with
various sources of knowledge and their usefulness in guiding antibiotic use in the clinical
setting; 3) seven questions concerning sociodemographic provider characteristics (age,
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gender, care activity, workplace, emergency service, and workload); and 4) one openformat question intended to collect qualitative data concerning provider’s suggestions
regarding antibiotic use and resistance.
116 providers from three clinical settings in Southeast Kansas and Southwest
Missouri were anonymously invited to take the survey. After accounting for non-response
and partial completion, a total of 54 (N=54) provider responses were included in the
analysis, resulting in an overall response rate of 46.6%. Analysis of the results were
completed via the use of Qualtrics XM survey developer and statistical analysis software
(Qualtrics, Provo, UT, 2020). Using this program, descriptive statistics using cross
tabulation was performed to determine the average (mean) provider level of agreement
and standard deviation (SD) with the 17 KAPs statements and nine sources of knowledge
statements. After determining the mean level of agreement with each of the 26 survey
statements, univariate analysis using the statistical test analysis of variance (ANOVA)
was performed to determine if any statistically significant differences existed between
mean scores and provider characteristics (e.g., age, gender, type of activity, workplace,
emergency service, and workload). Results of the analysis were provided in the form of
tables with mean scores, standard deviation, and any statistically significant findings
using exact p values (p < 0.05) and 95% confidence intervals (CI). A discussion of the
findings in relation to the outcomes of this project and the identified research questions
will be addressed in detail in the following section (Ch. 5 Discussion).
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Chapter V.

Discussion

Chapter five, the final chapter of this DNP project, will focus on the discussion of
results related to the outcomes of this research project. General observation pertaining to
the project’s findings and the relation to the target population of primary and secondary
care healthcare providers will be discussed. A discussion of the results related to the
theoretical framework and logic model of this project will be included. The limitations of
the research project will be identified and discussed. Implications for future research,
practice, health policy, and education will be addressed. Lastly, a conclusion
summarizing the overall study purpose, outcomes, and contributions to nursing in terms
of knowledge and practice will be provided at the end of this chapter.
Relationship of Outcomes to Research
The overall purpose of this project was to identify and explore provider’s
knowledge, attitudes, perceptions, and prescribing practices regarding antibiotic use and
resistance. The following section is organized by the two identified research questions
this project set out to answer. The researcher will attempt to answer each research
question by summarizing the knowledge discovered from survey results. By weighing the
findings of this project to evidence found in the literature review, the researcher will
attempt to determine how the results either support or refute previous research findings.
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Lastly, the researcher will address how the outcomes of this project’s research findings
match the intended purpose the researcher set out to accomplish.
Research Question #1: What are the knowledge, attitudes, and perceptions (KAPs)
underlying providers prescription of antibiotics for common respiratory indications
in the primary and secondary care setting? Aligned with the project’s purpose, the
primary outcome of measure was to determine the mean level of provider’s agreement
with statements regarding attitude/knowledge, prescribing practices, and sources of
knowledge concerning antibiotic use and antimicrobial resistance. To answer research
question one, descriptive statistical analysis using Qualtrics XM software to create cross
tabulations were completed to examine provider means scores and standard deviations
with each of the 26 survey statements pertaining to antibiotic use and resistance.
Knowledge & Attitudes
Antibiotic resistance is considered to a global health crisis and has been deemed
one of the greatest public health threats of our time (George Washington University,
2018; WHO, 2017). In a study in 2018 measuring outpatient antibiotic use, an estimated
80-90% of antibiotic consumption by volume occurred in the outpatient setting (CDC,
2018). Showing a good overall understanding of the gravity and scope of the problem, the
providers of this study were aware and agreed that antibiotic resistance is a major public
health problem ( score= 90.5) and understood that antibiotic resistance is not a
phenomenon confined to the hospital setting ( score= 19.8)
The providers strongly disagree that prescription of antibiotics has no influence
on the appearance of resistance ( score= 17.9), and strongly agree that two major causes
of resistance are the product of patient misuse and self-medication ( score= 67.8). The
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provider’s knowledge regarding the use of antibiotics and resistance is well-aligned with
the findings from the CDC (2013) who stated: “the use of antibiotics is the single most
important factors leading to antibiotic resistance” (p.11). Furthermore, similar previous
studies also found that providers generally agree that the main drivers of antibiotic
overuse and resistance are likely related to patient satisfaction and patient pressures to
prescribe antibiotics (PEW Charitable Trust, 2017).
Although bordering indifference, the providers acknowledged the use of
antibiotics for agricultural and farming purposes as an important factor influencing the
appearance of new resistant organisms in humans ( score= 50.2). This finding is
congruent with statements made by the CDC warning the food industry that the use of
antibiotics in animals and food products can result in resistant bacterium being passed on
to human hosts who consume food products that have been treated with antibiotics (CDC,
2013).
Evidenced by a mean score of 36.5 (), the providers were not convinced that
new antibiotics would be developed to solve the problem of resistance. Although cited as
a possible solution to address the antimicrobial resistance crisis, a relative lack of policy
initiatives and program funding incentives have resulted in pharmaceutical companies
placing low priority in the research and development of antibiotics (Ventola, 2015). To
further potentiate the problem, major regulatory barriers imposed on pharmaceutical
companies have made the development of new antibiotics difficult (Ventola, 2015).
The providers of this study agree that the dispensing of antibiotics without a
prescription should be more closely monitored ( score= 69.2). Agreement with this
statement is aligned with previous research findings urging for greater regulation of
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antibiotics in other countries where antibiotics can be purchased over-the-counter or even
online without a prescription (Ventola et al., 2015). The providers did however disagree
that patients will manage to obtain antibiotics without a prescription if he/she feels they
need an antibiotic ( score= 31.7).
Prescribing Practices
The providers disagree that amoxicillin is a useful antibiotic for treating most
respiratory infections in the primary care setting ( score= 39.0). Contrary to this finding,
a study in 2018 found that azithromycin and amoxicillin were the most common
antibiotics prescribed in the outpatient setting (CDC, 2018). The providers disagreed in
waiting for microbiology results before treating an infectious disease in the primary care
setting ( score= 41.3). Although controversial, because traditional microbiology results
are often not available for 24 to 72 hours after obtaining a sample, initial therapy for
many infections are often empiric and guided by clinical presentation (Leekha, Terrell, &
Edson, 2011).
The providers agreed with the usefulness of rapid effective techniques as a
diagnostic requirement for infectious disease ( score= 57.0). Multiple studies support
the use of rapid effective diagnostics to guide the proper use of antibiotics, slow the rise
of antimicrobial resistance, and improve the overall approach to treating bacterial
infections through targeted therapies (O’Neill, 2015). Within a matter of minutes, rapid
respiratory panels can be used to detect viral pathogens (i.e. influenza, rhinovirus,
adenovirus, RSV, parainfluenza, coronavirus) as the cause of many upper respiratory
infections (Abbas et al., 2019). The rapid antigen detection test (RADT) is a
recommended diagnostic for all patients presenting with features of Group A Beta-
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Hemolytic Strep (GABHS), a common cause of acute pharyngitis (Hart, 2007). These
tests, among others, can be used in both the inpatient and outpatient setting to
differentiate the etiology of many common acute respiratory conditions while providing
evidence that reinforces the proper use and/or withholding of antimicrobial drugs.
(O’Neill, 2015).
In situations of doubt, the providers disagreed with the use of wide-spectrum
antibiotics to ensure a cure from infection ( score= 41.6). This finding is contradictory
to a similar study that identified a provider knowledge gap in the proper use of broad
versus narrow-spectrum antibiotics in clinical practice (Sanchez et al., 2014). Fear of
complications and low confidence in prescribing abilities often leads to the prescription
of broad-spectrum antibiotics (Sanchez et al., 2014). Evidenced by an overall mean level
of disagreement with the use of broad-spectrum antibiotics in situations of doubt, the
providers of this survey showed a good understanding pertaining to proper antibiotic
selection.
Results showed a mean level nearing indifference ( score= 49.8) when providers
were asked if they frequently prescribed antibiotics in situations where it was impossible
to conduct a systemic follow-up of the patient. Previous studies have found that
antibiotics are more likely to be prescribed in situations where follow-up with the patient
is perceived as unlikely (Hayhoe, Butler, Majeed, & Saxena, 2018). A study in 2014
found a strong correlation between clinical uncertainty and unnecessary antibiotic
prescription (Dempsey, Businger, Whaley, Gagne, & Linder, 2014). However, in
situations of doubt as to whether a disease might be of bacterial etiology, the providers of
this study disagreed with the practice of prescribing antibiotics ( score= 30.9). This
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finding shows the providers have a good understanding of withholding antibiotics based
on clinical uncertainty alone.
The providers of this study strongly disagreed with frequently prescribing
antibiotics based on a patient’s insistence ( score= 15.9) or for the purpose of harboring
continued patient trust ( score= 13.1). The providers also strongly disagreed with
prescribing antibiotics, even when they know they are not indicated, because they did not
have time to explain to the patient why they were not called for ( score= 15.2). These
three findings provide evidence that the providers of this study do not fall into the fallacy
of prescribing antibiotics based on patient pressures, insistence, or perceived lack of
knowledge. However, these findings are contradictory to those found by previous studies
where clinicians cited patient pressure, customer satisfaction, and lack of time to educate
patients as major root causes involved in the inappropriate prescription of antibiotics
(Fleming-Dutra, Mangione-Smith, & Hicks, 2016).
Sources of Knowledge
Nine statements representing various sources of knowledge used in guiding
antibiotic use in the clinical setting were provided in the survey. In rating these nine
statements, providers were given the following instructions, “In the treatment of
respiratory infections, rate the usefulness of resources of knowledge”. Evidenced by the
highest mean level of agreement ( score= 85.9), results of the survey revealed that
clinical practice guidelines represent the major source of knowledge used in guiding
antibiotic use. Major sources such as the Centers for Disease Control and Prevention
(CDC) and the World Health Organization (WHO) recommended that the
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appropriateness of antibiotic prescribing should be determined in accordance with
evidence-based national and local clinical practice guidelines (CDC, 2019; WHO, 2020).
Evidenced by an overall mean level of agreement, other sources of knowledge
found to have usefulness in guiding antibiotic use in the clinical setting included the
following:
•

Continuing Education Courses ( score= 79.8)

•

Others, e.g., Contribution of Specialists (microbiologists, infectious disease
specialist, etc.) ( score= 79.2)

•

Previous Clinical Experience ( score= 71.5)

•

Contribution of Peers (of same specialization) ( score= 63.9)

•

Information Furnished by Medical Information Officers ( score= 54.3)

Evidenced by the lowest mean level agreement ( score= 39.9), results of the survey
revealed that data collected via the internet was the least useful source of knowledge for
guiding antibiotic use in the clinical setting. Although deemed by the providers as having
minimal use in the clinical setting, data collected via the internet can be useful in
informing antibiotic use in terms of tracking, surveillance, and antibiogram data (CDC,
2019). Various data sources for tracking and colleting antibiotic use data are available
online. Data on antibiotic consumption has been used to identify target interventions
designed to improve antibiotic use in the clinical setting (CDC, 2019). Evidenced by an
overall mean level of disagreement, other sources of knowledge found to have minimal
usefulness in guiding antibiotic use in the clinical setting included the following:
•

Courses Held by the Pharmaceutical Industry ( score= 40.6)

•

Documentation Furnished by the Pharmaceutical Industry ( score= 46.0)
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Research Question #2: What differences exist between provider characteristics and
antibiotic-prescribing behavior and knowledge of antimicrobial resistance in the
primary and secondary setting? The secondary outcome of this project was to
determine whether any differences between provider mean scores and provider
characteristics existed. To answer research question two, univariate analysis of variance
(ANOVA) statistical tests were done to identify whether any differences between
numerical data (means scores) and provider characteristics existed (sociodemographics).
Using exact p-values (p< 0.05) and 95% confidence intervals (CI), the following will
discuss any statistically significant differences that were found between mean scores and
provider characteristics, and how these differences relate to previous evidence.
Age
No statistically significant differences were found between statement mean scores
and the provider characteristic of age. This finding implies that differences in the
provider’s years of age does not have a significant impact on antibiotic prescribing
behavior. This finding is contradictory to a study conducted on 898 providers in the
Carolinas Healthcare System from 2014 through 2016 (Dall, 2018). The results of this
study found that providers aged 51-60 years were more than four times more likely to
prescribe antibiotics for upper respiratory infections than providers aged 30 years or
younger (Dall, 2018).
Gender
The provider characteristic of gender represented the largest proportion of
statistically significant differences noted in an analysis of the surveys’ results. A total of
eight statistically significant differences were found to exist between male and female
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providers. Of these eight differences, five were noted in responses pertaining to
knowledge, attitudes, and perceptions (KAPs) and three were noted in statements
regarding useful resources of knowledge.
Compared to male providers (x score= 23.2), female providers (x score= 13.2)
had a stronger level of disagreement with statement 4 (“The prescription of antibiotics
does not influence the possible appearance of resistance”) (p= 0.036). When compared to
males (x score= 40.8), female providers (x score= 20.0) more strongly disagreed with
the prescription of antibiotics in situations of doubt pertaining to disease etiology (p=
0.010). When compared to male providers (x score= 24.0), female providers (x score=
7.3) reported a stronger level of disagreement with prescribing antibiotics when facing
time constraints as a barrier to explaining antibiotic indications (p= 0.027). When
compared to male providers (x score= 25.9), female providers (x score= 13.8) more
strongly disagreed that the phenomenon of antibiotic resistance is mainly a problem
confined to the hospital setting (p= 0.041). Lastly, when compared to male providers (x
score= 59.4), female providers (x score= 76.2) more strongly agreed that the two main
causes of antibiotic resistance are related to factors involving patient self-medication and
antibiotic misuse (p= 0.015).
In terms of rating useful resources of knowledge, female providers had a higher
level of agreement pertaining to the use of clinical practice guidelines (x score= 90.8, p=
0.043) and continuing education courses (x score= 87.1, p= 0.003) as useful resources
of knowledge for guiding antibiotic prescriptions in the clinical setting. Female providers
reported they were more likely to use documentation furnished by the pharmaceutical
industry (x score= 56.1), while male providers (x score= 35.5) generally disagreed with

92

the usefulness of these resources to guide antibiotic practices in the clinical setting (p=
0.013).
In a study published in 2018 on 11,285 general provider (GP) consultations, the
authors found that female GPs prescribed antibiotics less often than male GPs
(Eggermont, Smit, Kwestroo, Verheij, Hek, & Kunst, 2018). In a study on 95,344 family
practitioners, the authors Fleming-Dutra et al. (2017) stated that “male primary care
providers aged 40 to 64 years were more likely to be high-volume antibiotic prescribers
than their younger female colleagues” (p.2).
Type of Activity
In an analysis of variance (ANOVA), one statistically significant difference (p=
0.040) was found between mean scores and provider type of activity with statement 17
(“The phenomenon of resistance to antibiotics is mainly a problem in the hospital
setting”). Providers working in both private and public practice had a higher level of
disagreement (x score= 1.7) with statement 17 when compared to providers who
reported working in private practice (x score= 17.6) or public practice (x score= 21.5)
alone.
Although found to be statistically significant, these differences between mean
scores and type of activity are negligible and insignificant for the purpose of making
generalizations. What can be inferred is that the majority of the providers strongly
disagreed that antibiotic resistance is a problem primarily confined to the hospital setting.
This inference is well-aligned with previous research findings cited by the CDC and
PEW Charitable Fund. In an analysis of key U.S. antibiotic prescribing statistics, the
CDC found 80-90% of antibiotic consumption by volume occurs in the outpatient setting
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(CDC, 2018). Furthermore, 1 in 3 antibiotics prescribed in U.S. outpatient settings are
inappropriate (PEW Charitable Trust, 2017). Thus, it is fair to say that outpatient
antibiotic prescribing is a major contributor to the overuse of antibiotics and issues of
resistance in the U.S.
Workplace
A total of three statistically significant differences were found in the provider
characteristic of workplace. In response to statement 8 (“I frequently prescribe an
antibiotic in situations where it is impossible for me to conduct a systematic follow-up”),
primary care providers strongly disagreed with this statement (x score= 31.4). In
contrast, representing a statistically significant difference (p= 0.017), providers in the
hospital setting agreed with the prescription of an antibiotic in situations of doubt
regarding questionable follow-up (x score= 63.2). Current trends in antibiotic
prescribing suggest that 80-90% of antibiotic consumption occurs in the outpatient setting
(CDC, 2018) and one in three antibiotics prescribed in the outpatient setting are
unnecessary (PEW Charitable Trust, 2018). In contrast, over fifty percent (50%) of all
patients in the hospital-setting receive antibiotics (PEW Charitable Trust, 2018).
However, current reporting on antibiotic use in the hospital setting is voluntary, not
mandatory. Thus, with only a small fraction of hospitals currently reporting data on
antibiotic usage, determining the appropriateness of antibiotic use in the hospital setting
is limited. (PEW Charitable Trust, 2018).
Overall, the providers strongly disagreed with statement 10 (“I frequently
prescribe antibiotics because patients insist on it”) ( score= 15.9) and statement 11 (“I
sometimes prescribe antibiotics so that patients continue to trust me”) ( score= 13.1).
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Providers working in both primary care and hospital settings had weak levels of
disagreement with the above statements when compared to providers who worked in
either primary care or the hospital setting alone. Although statistically significant (p=
<0.00001), these differences were negligible. Regardless of workplace, all the providers
had an overall mean score of disagreement with these statements. Furthermore, the low
number of providers working in both workplace settings (n=5) would make it difficult to
generalize any significant findings to a larger population.
Emergency Service
A total of three statistically significant differences were found in providers who
reported working in emergency services. The first statistically significant difference was
noted in the mean level of agreement between non-emergency providers and emergency
providers regarding statement 8 (“I frequently prescribe an antibiotic in situations where
it is impossible for me to conduct a systematic follow-up of the patient”) (p=0.039).
Regarding situations of doubt involving questionable patient follow-up, non-emergency
providers disagreed with the prescription of antibiotics (x score= 36.6), whereas
emergency providers weakly agreed with the prescription of antibiotics (x score= 57.3).
A study published by the Vermont Medical Society (VMS) involving emergency
department (ED) providers from 12 separate hospitals found that the most common
factors cited in influencing prescribing decisions in the ED included: 1) clinical
uncertainty, 2) concern over lack of follow-up, and 3) patient expectations (VMS
Education & Research, 2016). The lack of definitive follow-up, inability to reassess
patient conditions after discharge, the need to make a definitive diagnosis and treatment
plan in a timely manner, and organizational pressures to satisfy patient needs and prevent
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readmissions are all factors that influence the prescription of antibiotics in the ED (Denny
et al., 2019).
Statistically significant differences were found between non-emergency and
emergency service providers regarding the level of agreement with statement 17 (“The
phenomenon of resistance to antibiotics is mainly a problem in the hospital setting”) (p=
0.019) and statement 14 (“Two of the main causes of the appearance of antibiotic
resistance are patient self-medication and antibiotic misuse”) (p= 0.043). However, the
overall mean score denoting either agreement (statement 14) or disagreement (statement
17) with these statements remained the same regardless of provider type (emergency
versus non-emergency). Thus, these differences noted between emergency and nonemergency providers is likely insignificant in terms of making any generalizations to a
larger population.
Number (#) of Patients per day
Intended to assess provider workload, data on the reported number of patients
seen per day and time (minutes) needed to attend to one patient was evaluated. A total of
four statistically significant differences were noted in the provider characteristic of
number of patients per day. Of these four statistically significant findings, one difference
was noted among KAP statements and three among useful resources of knowledge.
Of all 17 KAP statements, the greatest overall level of agreement ( score= 90.5)
was noted in statement 1 (“Antibiotic resistance is an important Public Health problem”).
Representing a statistically significant difference (p= 0.028), the lowest level of
agreement was noted in providers who reported seeing 5-10 patients per day (x score=
60.0) and providers who reported seeing 31 patients per day (x score= 70.5).

96

Representing two extremes, providers who saw the least and greatest number of patients
per day had a lower overall level of knowledge regarding antimicrobial resistance as a
major threat to public health. This finding, although likely insignificant, suggests that
low-volume and high-volume patient workloads are possibly related to provider
ignorance pertaining to antimicrobial resistance.
In terms of usefulness as a knowledge resource to guide antibiotic use, a
statistically significant difference was noted in statement 20 (“Courses held by the
Pharmaceutical Industry”) (p= 0.017). Compared to the average level of agreement (
score= 40.6), providers who saw the greatest volume of patients per day (>31) had the
highest level of disagreement with statement 20 (x score= 16.5). This finding may
suggest that providers with higher overall patient workloads lack the time needed to
attend continuing education offered by representatives of the pharmaceutical industry.
Compared to an overall mean level of agreement reported by all other providers,
statistically significant differences were also noted in statement 21 (p=0.005), statement
24 (p= 0.005), and statement 25 (p= 0.003). Providers with lowest patient workload (510 patients per day) and providers with the greatest workload (>31 patients per day)
disagreed with the following resources of knowledge as being usefulness in guiding
antibiotic use in the clinical setting: a) information furnished by medical information
officers, b) contributions from other specialties, and c) contributions from peers of the
same specialty. The differences noted in the level of agreement of providers with highvolume workloads could be attributed to barriers related to time constraints. However, as
time constraints would not be a factor in providers with low-volume workloads, the
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differences noted here would be difficult explain and therefore would be challenging to
imply any generalizations.
Time Needed to Attend to a Patient
Overall, the providers agreed with the use of rapid effective techniques as a
requirement for diagnosis of infectious disease ( score= 57.0). However, providers who
reported they needed 45 minutes (x score= 27.0) or greater (x score= 46.7) to attend to
one patient disagreed with use of rapid effective diagnostics (p=<0.00001). In an effort to
reduce disruption of existing patient workflows, providers who require more time to
attend to a patient may opt to prescribe antibiotics rather than using available diagnostic
techniques (Van Hecke, Butler, Mendelson, & Tonkin-Crine, 2019).
Regarding statement 6 (“The use of antibiotics on animals is an important cause
of the appearance of new resistance to pathogenic agents in humans”), only the providers
who reported they needed approximately 30 minutes to attend to a patient agreed with
this statement (x score= 81.6) while all other providers requiring either more or less than
30 minutes disagreed (x score= < 49). This statement specifically measures knowledge
relating to the responsibility of others (i.e. agricultural and food industries). The overuse
of antibiotics on food and animal products can result in resistant bacteria to contaminate
food and serve as a carrier that can be passed on to people who consume these foods
(CDC, 2013). The poor mean level of agreement with the use of antibiotics on animals as
an important cause to resistance signifies a knowledge gap identified in this provider
population. However, regarding this statement it is difficult to explain the differences
noted between mean scores and the time needed per patient.
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Statement 9 (“In situations of doubt as to whether a disease might be of bacterial
etiology, it is preferable to prescribe an antibiotic”) was intended to measure an aspect of
clinical uncertainty. A statistically significant difference was noted in terms of minutes
per patient (p= 0.049). Providers who reported they needed approximately 45 minutes per
patient (x score= 66.0) and 60 minutes or greater to attend to a patient (x score= 47.7)
had a higher level of agreement with statement 9 when compared to the overall average
level of disagreement of the sample ( score= 30.9). This finding suggests that providers
who need greater amounts of time to attend to a patient may opt to prescribe antibiotics in
situations of clinical uncertainty at higher rates when compared to providers who need
less time to attend to a patient. In a qualitative study of provider KAPs concerning
antibiotic use, the authors found that the most frequent reason cited for over-prescribing
antibiotics was clinical uncertainty (VMS Education & Research, 2016). In a study
investigating determinants of antibiotic prescribing, the authors Chan, Bin-Ibrahim,
Wong, Ooi, and Chow (2019) stated that “despite departmental norms of not prescribing
antibiotics for upper respiratory tract infections (URTIs), physicians would prescribe
antibiotics when faced with uncertainty in patients’ diagnoses, especially under time
constraints” (p.1).
Statement 14 (“Two of the main causes of appearance of antibiotic resistance are
patient self-medication and antibiotic misuse”) was intended to measure a factor related
to provider ignorance. Compared to an overall mean score of agreement ( score=67.8),
providers who reported they needed approximately 60 minutes or greater to attend to one
patient had a mean level of disagreement (x score= 42.3) with statement 14 (p= 0.049).
This finding suggests that providers who require greater amounts of time to attend to a
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patient have a lower level of knowledge pertaining to major causes of antibiotic
resistance. As stated by the CDC (2013), “the use of antibiotics is the single most
important factor leading to antibiotic resistance” (p.11). Improving the use of antibiotic is
a major priority necessary for combatting the antimicrobial resistance crisis (CDC, 2013).
Observations
Knowledge, attitudes, and perception (KAPs) statements and usefulness of
clinical resource statements were measured to assess provider-related factors (fear,
complacency, ignorance, indifference, and responsibility of others) pertaining to
antibiotic use and resistance. Based on overall mean scores, the providers of this sample
possessed a strong level of understanding pertaining to knowledge of antibiotic use and
resistance. The findings suggest that inappropriate antibiotic use is not the result of
provider ignorance or unfamiliarity with clinical practice guidelines. Rather,
inappropriate prescribing may be better explained as the result of complex interactions
involving both patient-related and provider-related factors. Factors related to patient
satisfaction/pressures, time constraints, patient workload, gender differences,
questionable follow-up, and clinical uncertainty all appear to be linked with the
inappropriate use of antibiotics.
In an analysis of variance (ANOVA) of statement mean scores and
sociodemographic data, interesting observations were noted in the provider
characteristics of gender, workplace, emergency services, number of patients seen per
day, and time needed to attend to a patient. In terms of gender, female providers had an
overall greater understanding of appropriate antibiotic use, antimicrobial resistance, and
were more likely to utilize multiple knowledge resources in the clinical setting.
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Compared to male providers, the findings suggest that female providers are less likely to
prescribe antibiotics in situations of doubt and are less likely to give into patient pressures
to prescribe antibiotics under time constraints. Female providers showed an overall
greater level of knowledge pertaining to the major causes of antimicrobial resistance.
Showing a greater level of understanding that the phenomenon of antibiotic resistance is
not isolated to the hospital setting, female providers were less likely to displace
responsibility of appropriate antibiotic prescribing. Lastly, the findings suggest that
female providers are more likely to use various forms of knowledge resources to guide
antibiotic use in the clinical setting.
Another interesting finding was noted in providers who worked in emergency
medicine and the hospital setting. The findings suggest that providers working in the
emergency department and hospital setting frequently prescribe antibiotics in situations
of questionable patient follow-up. Additionally, when compared to providers who work
in primary care or the hospital setting alone, providers working in both settings were
more likely to prescribe antibiotics due to patient pressures and/or insistence.
Regarding provider workload, the findings suggest that providers with highvolume patient workloads are less likely to utilize knowledge resources to guide
antibiotic use. In terms of time needed to attend to one patient, the results suggest that
providers who need 45 minutes or more are less likely to use rapid effective diagnostic
techniques to aid in the diagnosis of infectious disease in the clinical setting.
Additionally, providers who need 45 minutes or greater are more likely to prescribe
antibiotics in situations of clinical uncertainty and are less likely to recognize antibiotic
misuse as a major cause of antimicrobial resistance. These findings suggest that high-
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volume workloads and time constraints contribute to the inappropriate use of antibiotics,
lack of resource utilization, and knowledge-gaps pertaining to the etiology of
antimicrobial resistance.
Evaluation of Theoretical Framework
The “Theory of Planned Behavior” or TPB developed by the author Icek Ajzen
(1991) was the theoretical framework used for the purpose of this scholarly project
(Figure 1). The predictive theory of planned behavior was selected for the purpose of
facilitating the process of investigating “why” antibiotic prescribing behaviors are
influenced by personal beliefs, societal norms, and perceived control over one’s own
behavior. The student used this theoretical framework as the basis for selecting the prevalidated survey used to explore provider’s knowledge, attitudes, and perceptions
regarding antibiotic use and resistance.
Personal beliefs of the providers were measured in terms of level of agreement
with KAP statements that assessed provider perception of patient pressure, perception of
responsibility of others, complacency, and knowledge of antimicrobial use and resistance.
The perceived control over one’s own prescribing ability was assessed through
statements that addressed clinical uncertainty, use of diagnostic techniques,
differentiation of disease etiology, and prescribing in situations of doubt. Lastly, societal
norms were assessed through statements addressing perceived patient pressure,
knowledge of antimicrobial resistance as a public health crisis, attitudes towards
providers of other practice settings, perceptions of antibiotic selection, root causes of
resistance, and potential solutions to address issues of resistance. Results of the project
support the TPB theory’s suggestion that personal beliefs and attitudes held by the
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provider, societal beliefs, patient satisfaction/pressure, and control over one’s own
behavior all influence the prescription of antibiotics either appropriately or
inappropriately.
Evaluation of Logic Model
After evaluating the results, the proposed logic model appears to support the
overall intended purpose the model intended to accomplish. The logic model (Figure 2)
depicted a series of relationships the project set out to define and accomplish. These
relationships included inputs, interventions, outputs, and effects. The proposed input was
to develop a greater understanding of provider antibiotic prescribing behavior by
exploring their knowledge, attitudes, and perceptions. Interventions involved the use of a
pre-validated survey to explore provider-level factors involved in antibiotic use and
knowledge of resistance. Proposed outputs included the participants, study site,
population, time-frame, and collection method. The inputs, interventions, and outputs
proposed in the logic model remained the same throughout the progression of the project.
The proposed effects of the survey involved outcome measurements of survey results
using statistical analysis. One area where the proposed logic model differed from the
actual project was the statistical testing methodology used for data analysis. Univariate
analysis of variance (ANOVA) replaced the proposed use of the Chi-Square test as the
method for determining statistically significant findings. Lastly, as proposed in the logic
model, application of survey results was used to identify target educational resources and
strategies focused on enhancing both provider and consumer awareness of appropriate
antibiotic use and resistance.
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Limitations
A major limitation of this study was the sample size. Using a Cohen’s Statistical
Power Analysis, an estimated sample size of 85 participants was determined to be an
appropriate number for determining statistical significance. Despite re-opening the survey
and sending out multiple reminders, the researcher was able to include only 54 participant
responses in the final product of this scholarly project. The low response rate (46.6%)
incurred in this project was in part thought to have occurred due to the timing of the
survey’s distribution. With the onset of major holidays and vacation-time that are
inherent during the months of December and January, the overall response rate of the
survey likely could have been enhanced by distributing the survey either before or after
these months.
An inherent limitation common in many study’s that involve surveys is difficulty
in controlling respondent bias. As the survey used in this project sought to identify
knowledge gaps pertaining to the proper use of antibiotics, the possibility for demand or
socially desirable bias cannot be ruled out. Rather than answering truthfully, the
providers may have felt pressured to answer statements in ways they deemed correct,
socially acceptable, and/or aligned with evidenced-based medicine. Respondent bias is
highly suspected as the overall results of this study show that the providers of this sample
obtain a high level of knowledge and understanding pertaining to proper antibiotic use
and antimicrobial resistance. In contrast to these findings, current trends in antibiotic use
suggest at least 30% and up to 50% of all antibiotics prescribed are unnecessary (CDC,
2018). A consensus of current data show that although providers understand current
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practice guidelines, antibiotics continue to be prescribed inappropriately at exponentially
high rates in both the inpatient and outpatient setting.
While convenience sampling is the most widely used methodology employed in
developmental science, it nevertheless constitutes a limitation of this study (Jager,
Putnick, and Bornstein, 2017). Relative to probability sampling techniques, convenience
sampling is often chosen for its cost-effectiveness, ease of use, and less time required to
carry out the sampling process. Compared to probability sampling, data constructed by
convenience sampling produces less clear generalizability (Jager et al., 2017). As the
sample was not chosen at random, it is therefore important to note that inherent bias in
convenience sampling may result in a sample that is less likely to be representative of the
population being studied.
The pre-validated survey used in this project employed a continuous unnumbered
visual analogue scale. In contrast to the traditional Likert VAS commonly used in similar
studies, the continuous unnumbered VAS measurement methodology minimizes the
possibility of extreme response and neutral response biases. In addition, rather than
simply rating on a scale of 1-to-10 or agree-to-disagree, the continuous unnumbered VAS
provides greater versatility for respondents to answer using specific numeric ratings that
allows for more accurate statistical data reporting through determination of mean scores.
However, as the authors Pincus et al. (2008) stated, the relatively new concept of
unnumbered continuous VASs may increase the difficulty in understanding the
complexity of the rating methodology and possibly lead to higher rates of respondent
non-compliance.
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Lastly, it is important to note that the original survey developed by Rodrigues et
al. (2016) was adapted for the purpose of this study. A total of three adaptions were made
to the original survey. Described in greater detail in chapter three, adaptions included
omission of wording and exclusion of two survey statements. The original survey was
developed in South America. Differences in laws and regulations having influence on
antibiotic prescribing and use exist between countries of South America and are quite
different from those in the United States. For example, the general public can obtain an
antibiotic without a prescription in many areas throughout South America. For this
reason, statements pertaining to the concept of obtaining an antibiotic without a
prescription are less applicable to providers in the U.S. Furthermore, wording and
sentence structure slightly differ from one country to another. Thus, some of the
providers may have found some statements confusing or redundant. Whether these subtle
differences reflect any form of limitation is unclear, nevertheless it remains important to
note as a potential disadvantage of this study.
Implications for the Future
Current trends in antibiotic use in the U.S. suggest that at least 30% and up to
50% of all antibiotics prescribed are unnecessary (CDC, 2018). Antibiotic misuse is not a
phenomenon that occurs in a vacuum and blame can neither be placed fully on the patient
nor the provider. The outdated practice of indiscriminate antibiotic prescribing that has
taken place for centuries has left current and future providers with major challenges in
controlling the expectations and lack of knowledge of the general public pertaining to the
appropriateness of antibiotics. However, the prescription of an antibiotic still remains
heavily dependent on the clinical knowledge, experience, and discretion of the provider.
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Therefore, understanding the knowledge, attitudes, perceptions of the prescribing
provider is an essential aspect for developing targeted antimicrobial stewardship
education and interventions to address the public health crisis of antimicrobial resistance
(CDC, 2013).
Implications for future research pertaining to this project include the wide-spread
use of KAP surveys in various clinical settings incorporating large samples sizes
following probability sampling techniques. Enhancing the sample size and targeting
multiple clinical settings through random sample collections would provide greater value
and generalizability of the findings to the population.
The majority of statistically significant findings of this study involved differences
in KAPs according to gender and provider workload. Further future research should be
done to examine differences between female and male antibiotic prescribing practices,
including KAPs, use of clinical decision tools, and overall prescribing rates between both
genders. Statistically significant differences in provider KAPs were also noted in reported
numbers of patients seen per day and time needed to attend to a patient. Supported by
previous studies, provider-related factors including time-constraints and patient
workloads have been cited as major factors influencing antibiotic prescribing decisions
(VMS Education & Research, 2016). Thus, further research should be done to examine
the impact of factors such as the workplace/environment, patient care-load expectations,
and time-constraining pressures influence on provider’s antibiotic prescribing rates and
behaviors.
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Implications for Practice, Health Policy, & Education
Participants of this study recognized that antibiotics are widely over-used.
Participants recognized that antimicrobial resistance poses as a major threat to public
health. Providers in both the primary and secondary setting recognized the shared
responsibility of prescribing antibiotics appropriately and that blame cannot be placed
and isolated to one practice setting over another. Participants recognized the usefulness of
clinical practice guidelines as the most important tool for guiding decisions related to
antibiotic use. Statistically significant differences noted in KAP statements suggest that
female providers have an overall greater level of understanding pertaining to appropriate
antibiotic use and knowledge of resistance. Compared to primary care providers, the
findings suggest that hospital and emergency medicine providers are more likely to
prescribe antibiotics in situations of clinical uncertainty and questionable follow-up.
Lastly, providers with high-volume patient workloads were less likely to utilize rapid
diagnostic techniques, less likely to utilize clinical decision resources, more likely to
experience greater clinical uncertainty, and had an overall poorer level of understanding
pertaining to major root causes of antimicrobial resistance.
A comprehensive literature review revealed that the most common factors cited in
influencing inappropriate antibiotic use include: 1) patient pressures of expectation and
satisfaction, 2) clinical uncertainty, and 3) concerns over the lack of follow-up (Dekker et
al., 2015; Hruza et al., 2018; PEW Charitable Trust, 2017; Sanchez et al., 2014; VMS
Education & Research, 2016; Yates et al., 2018). Major findings of participant responses
suggest that inappropriate antibiotic selection is not caused by lack of knowledge of
clinical practice guidelines or evidence-based practice. Rather, the findings of this project
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suggest that inappropriate prescribing may better be explained as the result of complex
interactions between both the prescribing provider and the patient seeking care. Analysis
of variance (ANOVA) revealed that provider characteristics including gender, clinical
uncertainty, concerns over lack of follow-up, and time constraints influence the
appropriate use of antibiotics. Lastly, qualitative data of provider responses suggest that
patient-related factors pressure providers into inappropriately prescribing antibiotics.
Provider cited patient-related factors included the following: 1) lack of education, 2) false
perceptions of proper antibiotic use, 3) ignorance of viral self-limiting etiology versus
bacterial etiology, and 4) poor balance of patient health versus customer satisfaction.
The overall purpose of this scholarly project was to identify and explore
provider’s knowledge, attitudes, perceptions, and prescribing practices related to
antibiotic use and resistance. Improving prescribing by understanding the underlying
factors influencing prescribing behaviors is a central component necessary for identifying
educational strategies and designing effective antimicrobial stewardship interventions
(PEW Charitable Trust, 2017). Based on a comprehensive literature review and the
results of this study, target educational strategies were identified. Educational stratagies
focusing on public awareness and professional learning opportunities have been shown to
enhance knowledge of appropriate antibiotic use (Lee et al, 2015). The clinical
significance of the findings of this project have implications in APRN practice, health
policy and education by enhancing the body knowledge of appropriate antibiotic use and
resistance in the primary and secondary care setting. Identified educational strategies
targeted at improving appropriate antibiotic use will be discussed in the following
paragraphs.
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Targeted Educational Strategies
Insufficiency of knowledge pertaining to the appropriate use of antibiotics is a
major driver of antibiotic resistance (Lee et al., 2015). Targeted educational strategies
aimed at both the prescribers and the public have been identified as an effective and
important means for enhancing knowledge of prudent antibiotic use in both the primary
and secondary care setting (Lee et al., 2015).
Acute upper respiratory tract infections are one for the most common reasons for
which antibiotics are prescribed (CDC, 2013). In the outpatient setting, an estimated 40%
to 50% of antibiotics prescribed for Acute URIs are unnecessary (Hart, 2007). Clinical
practice guidelines (CPGs) have been developed to help aid in the proper diagnosis and
treatment of acute URIs. Respondents of this project support the use of CPGs to help
reduce inappropriate antibiotic prescriptions. One provider commented “better access and
distribution of evidence-based medicine” would be beneficial. Another provider
emphasized the importance to “practice evidence-based medicine”. Furthermore, one
provider stated the need for “consistency among providers” and emphasized the “use of
the same up-to-date guidelines” should be incorporated and followed per local hospital
policy. Current evidence-based recommendations and CPGs for the diagnosis and
treatment of common acute URIs are found in the appendices of this project (Appendix D
& Appendix E).
Useful educational resources, handouts, posters, and fact sheets have been
developed by the CDC for the purpose of enhancing public awareness on the appropriate
use of antibiotics and issues of resistance. These resources are provided free-of-charge on
the CDCs website and are intended to be printed, distributed, and advertised in the
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primary and secondary care setting (CDC, 2020). Based on the findings of this project
and suggestions made by the providers, the researcher identified CDC educational
resources that can be used in the clinical setting for the purpose of enhancing patient and
healthcare provider awareness of appropriate antibiotic use and resistance. These targeted
educational resources are found in the appendices of this project (Appendix I-K).
Appendix I includes targeted educational resources for patients. Appendix J includes
educational resources and strategies that health care providers can utilize in the clinical
setting to help curb inappropriate antibiotic use. These strategies include symptomatic
relief, delayed prescribing, and watchful waiting. Lastly, Appendix K represents posters
of targeted educational information intended to be advertised in both the inpatient and
outpatient setting.
Based on qualitative data collected from respondent suggestions, key educational
pearls and messages concerning antibiotic use and resistance were included. The
following (Table 8) represents pertinent data compiled from the CDCs “Be Antibiotics
Aware” toolkit (2020). As a compliment to the U.S. Antibiotic Awareness Week
(USAAW) campaign, “Be Antibiotics Aware” is a year-round CDC educational effort
intended to raise public awareness on the importance of appropriate antibiotic use and the
current crisis of antimicrobial resistance. The CDC invites users to openly share key
messages and resources from the toolkit to healthcare partners, organizations, and the
general public.
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Table 8. Key messages from the Centers for Disease Control & Prevention (CDC) “Be Antibiotics Aware” toolkit *
Topic/Target Population
Key Messages
• Antibiotics are live-saving medications but anytime antibiotics are
Antibiotic Resistance
•
•
•
•

•
Antibiotic Considerations

•
•
•
•
•

Messages for Consumers

•
•
•
•
•
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used, they can cause adverse effects and can lead to antibiotic
resistance
Antimicrobial resistance is one of the most urgent threats to the
public’s health
In the U.S. alone, more than 2.8 million infections occur from
antibiotic-resistant bacteria and more than 35,000 die every year
as a result
Antibiotic resistance is the result of bacteria developing the ability
to survive antibiotics mechanism of action
When bacteria become resistant, antibiotics lose their
effectiveness, and the bacteria multiply
Resistant bacteria can be hard or even impossible to treat and can
spread from person to person
Antibiotics save lives and are critical tools used to treat infections,
but they can lead to adverse effects
1 out of 5 medication-related visits to the emergency department
(ED) are caused by reactions from antibiotics
Reaction from antibiotics are the most common cause of
medication-related ED visits in children
Common side effects of antibiotics include rash, dizziness, nausea,
diarrhea, and yeast infections
Improving the way providers prescribe antibiotics, and the way we
take antibiotics, helps keep us healthy now, helps prevention
antibiotic resistance, and ensures that the life-saving abilities of
antibiotics will be available for future generations
Antibiotics save lives
Antibiotics are not always the answer
Antibiotics do not work on viruses
Thick, yellow, or green mucus alone does not indicate a bacterial
infection
Antibiotics are only indicated to treat bacterial infections, but even
some bacterial infections get better without antibiotics

•
•
•
•
•
•

Messages for Outpatient Healthcare Providers

•

•
•

•

•
•
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The majority of common upper respiratory infections do not
require antibiotics
Antibiotics will not help or make you feel better if you have a
virus, and the side effects could still cause harm
Taking antibiotics can lead to antibiotic resistance
If an antibiotic is needed, take exactly as prescribed
Development of severe diarrhea, while taking or shortly after
taking antibiotics, could indicate C. difficile infection
Practice Prevention:
o Frequent handwashing
o Cover your mouth or nose when coughing or sneezing
o Stay at home when sick
o Stay up-to-date on recommended vaccinations
Follow clinical practice guidelines to determine:
o Antibiotic indication
o Selection of appropriate antibiotic class, dose, and
duration
A key antibiotic stewardship strategy that should be employed in
all healthcare settings= Shortening the duration of antibiotic
therapy to the minimum effective duration
Protect your patients:
o Only prescribe antibiotics when necessary
o Harm can be caused by prescribing antibiotics when they
are not needed
Viral Illnesses:
o Educate your patients on why antibiotics are not indicated
o Provide alternative symptomatic treatment
o Educate on return precautions
Educate your patients about the possible harms from antibiotics,
including adverse reactions, allergic reactions, C. difficile, and
resistance
Perform hand hygiene and follow infection prevention measures
with every patient encounter

Messages for Inpatient Healthcare Providers

•
•
•
•
•

The Antimicrobial Resistance (AMR) Challenge

•

•

Follow clinical practice guidelines
Review antibiotic therapy 48 to 72 hours after initiation based on
the patient’s condition and culture results, and stop or adjust
antibiotic orders as needed
Educate about when antibiotics are not needed, and discuss
possible harms of antibiotic therapy
Be aware and consider antibiotic resistance patterns in your
facility and community (i.e. antibiogram)
o Use this data to inform prescribing decisions
Perform hand hygiene and follow infection prevention measures
with every patient encounter
The AMR Challenge is a U.S. Government yearlong effort
intended to accelerate the prevention of antibiotic resistance
encompassing actions across multiple sections including
governments, private industries, and civil societies.
The five commitment (or key actions) of the AMR Challenge
include:
o Antibiotic use: Improve antibiotic use, ensure continued
access
o Environment & sanitation: Decrease antibiotics and
resistance in the environment
o Infection prevention and control: Prevention of infections
and reduce the spread of resistant organisms
o Tracking and data: Share data and improve data collection
o Vaccines, therapeutics, and diagnostics: Invest in
development and improved access

*Reference: Centers for Disease Control and Prevention. (2020). Be antibiotics aware partner toolkit: Key messages. Centers for
Disease Control and Prevention (CDC). Retrieved from https://www.cdc.gov/antibiotic-use/week/toolkit.html#anchor_1538597291
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Practice & Health Policy Suggestions
In 2014, the CDC released a document titled “Core Elements for Hospital
Antibiotic Stewardship” that called for the incorporation of antimicrobial stewardship
programs in all major U.S. hospitals. At the time of its publication in 2014, only 41% of
acute care hospitals reported having antimicrobial stewardship programs in place. In
2018, 85% of acute care hospitals in the U.S. reported having all seven core elements of
the CDCs proposed antimicrobial stewardship program in place (CDC, 2020). The core
elements proposed by the CDC later went on to form the foundation for antibiotic
stewardship accreditation standards of the Joint Commission (CDC, 2020).
The Joint Commission (2019) identified antimicrobial stewardship as an
organizational priority stating, “effective January 1, 2020, new antimicrobial stewardship
requirements will be applicable to Joint Commission-Accredited Healthcare
Organizations (JCAHO) that routinely prescribe antimicrobial medications” (p.1). As of
2019 under the conditions of participation (CoP) rule, all U.S. hospitals will now be
required to have infection and prevention and stewardship programs in order to receive
payments from Centers for Medicare and Medicaid services (CMS) (Dall, 2019). The
JCAHO and CMS requirements are to be aligned and based on the recommendations
developed by the CDCs “Core Elements of Antimicrobial Stewardship Programs” (CDC,
2019). Under the U.S. National Action Plan to combat antimicrobial resistance, the CDC
set a goal for the implementation of antimicrobial stewardship core elements in all U.S.
hospitals that receive federal funding (CDC, 2020).
In addition to policy initiatives structured to reduce antibiotic use in the hospital
setting, the document published by the CDC titled “Core Elements of Outpatient
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Antibiotic Stewardship” specifically addresses strategies to reduce inappropriate
antibiotic prescribing in outpatient and ambulatory care settings (CDC, 2016). The four
core elements of outpatient antibiotic stewardship include: 1) commitment, 2) action for
policy and practice, 3) tracking and reporting, and 4) education and expertise (Appendix
F). At least 30% and up to 50% of all antibiotics prescribed in the outpatient setting are
unnecessary (CDC, 2018). As stated by the CDC (2018), “antibiotic prescribing
nationally has improved, with a 5% decrease from 2011 to 2016, but more progress needs
to be made” (p.5). In 2016, in response to the continued urgent need to combat antibiotic
resistance, Congress appropriated financial resources for the CDC to implement the
“Antibiotic Resistance (AR) Solutions Initiative”.
The Antibiotic Resistance (AR) Solutions Initiative is a federally-funded program
designed to improve the United States’ capacity to: 1) detect, respond to, and contain
emerging resistance, 2) prevent and stop the spread of resistant infections in healthcare
and the community settings, and 3) improve the overall use of antibiotics (CDC, 2018).
Through the AR Solutions Initiative, the CDC partners with various organizations
throughout both healthcare and community settings to aggressively drive political action
and empower the nation to comprehensively respond to the growing threats of resistance
(CDC, 2020). An overview of the CDCs AR Solutions Initiative as well as information
on the latest antibiotic resistance activities for the states of Missouri and Kansas can be
found in the appendix of this project (Appendix L).
The CDC set a national standard goal to reduce inappropriate antibiotic
prescribing practices by 50% in the outpatient setting and 20% in the hospital setting
(CDC, 2020). Applicable to the overall purpose of this DNP project, the AR Solutions
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Initiative describes the importance of monitoring and tracking data pertaining to
antibiotic use and trends to better understand prescribing practices in both the hospital
and outpatient setting (CDC, 2020). To accomplish this, the AR Solutions Initiative
recommends expanding the use of the CDC’s National Healthcare Safety Network
(NHSN). The NHSN surveillance program can be used to develop strategies for
improvement by collecting pertinent data that helps us better understand differences in
prescribing patterns of inpatient and outpatient settings at both the state and national level
(CDC, 2020).
The NHSN is a secure internet-based surveillance system developed and managed
by the CDC’s Division of Healthcare Quality Promotion (DHQP) that collects mandated
and voluntary reported data on antimicrobial use and resistance (CDC, 2014). The
program uses the Standardized Antimicrobial Administration Ratio (SAAR) metric as the
means for analyzing and reporting antimicrobial use data (CDC, 2014). Nationally
reported SAAR metric is used by institutions to track antimicrobial use, assess
antimicrobial stewardship program effectiveness, and compare their findings with
national SAAR benchmark data reported by other various programs participating in the
program (Avedissian et al., 2019).
The CDC’s NHSN surveillance program is an effective means of monitoring and
tracking antibiotic use in the U.S. However, in its current state, the majority of
participation is voluntary, with only a small fraction of healthcare settings required to
make mandatory use of the program (PEW Charitable Trust, 2018). As stated by the
PEW Charitable Trust (2018), “mandatory reporting would provide the data needed to
establish a more accurate baseline of current use, identify where and what types of
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stewardship interventions would be most effective, and measure progress toward
reducing inappropriate prescribing” (p.5). Future efforts should focus on establishing
national policies that require major healthcare organizations to mandatorily report
antibiotic use data to the NHSN surveillance program.
Conclusion
Antimicrobial resistance (AMR) is a major public health crisis that threatens the
very integrity of our nation’s healthcare system. AMR contributes significantly to
increased healthcare costs, increased length of hospital stays, higher readmission rates,
increased morbidity and mortality, and overall poorer patient outcomes. The single most
important factor leading to resistance is the use of antibiotics (CDC, 2013). Current
estimates suggest that at least 30% and up to 50% of all antibiotics prescribed are
unnecessary (CDC, 2018). The outpatient and ambulatory setting accounts for the
majority of antibiotic consumption in the U.S., with acute upper respiratory conditions
being the most common reason for which antibiotics are prescribed. The majority of
acute URIs are the manifestation of self-limited viral infections that rarely warrant an
antibiotic prescription; however, antibiotics are prescribed 40% to 50% of the time for
these conditions (Hart, 2007).
Countless clinical practice guidelines and evidence-based resources strongly
recommend against the prescription of antibiotics for common acute upper respiratory
indications (CDC, 2020). Despite surmounting evidence, antibiotics continue to be
inappropriately prescribed for these conditions at alarmingly high rates across all
healthcare settings (CDC, 2018). In an effort to describe this phenomena, major interest
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has been placed on exploring provider-related factors concerning antibiotic prescribing
behaviors.
The overall purpose of this DNP scholarly project was to identify and explore
healthcare provider’s knowledge, attitudes, perceptions, and prescribing practices
concerning antibiotic use and resistance. For this purpose, an adapted pre-validated
survey developed by Rodrigues et al. (2016) was administered to 116 providers working
in primary and secondary care settings in Southwest Missouri and Southeast Kansas. A
total of 54 responses (46.6% response rate) were included in the final product of this
project. Statistical analysis utilizing mean scores and univariate analysis of variance
(ANOVA) found that the providers of this sample had a good overall understanding or
antibiotic prescribing practices. Statistically significant differences in mean scores
suggested the following: 1) compared to males, female providers had an overall greater
understanding of appropriate antibiotic prescribing practices; 2) compared to primary
care providers, providers in the hospital and emergency medicine setting are more likely
to prescribe antibiotics in situations of doubt and questionable follow-up; and 3)
providers with high-volume workloads were less likely to utilize clinical decision tools,
rapid diagnostic techniques, had an overall poorer comprehension of major causes of
antibiotic resistance, and were more likely to prescribe antibiotics in the face of clinical
uncertainty.
Outcomes of this study suggest that barriers to appropriate antibiotic prescribing
are related to time constraints, high-volume workload, clinical uncertainty, and lack of
patient education. Previous studies provide evidence that patient pressures involving
satisfaction and lack of knowledge are also a major factor involved in the inappropriate
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prescription of antibiotics (Dekker et al., 2015; PEW Charitable Trust, 2017) A
consensus of current data show that providers understand the concept of appropriate
antibiotic prescribing and are familiar with current practice guidelines, yet antibiotics
continue to be prescribed inappropriately at exponentially high-rates in both the inpatient
and outpatient setting. In addition to the findings of this project, the presentation of
pertinent substantiated literature concerning current guidelines, educational resources,
and national/political strategies combine to contribute and enhance the body knowledge
of appropriate antibiotic use and resistance in the primary and secondary care setting.
Improving prescribing by understanding the underlying factors influencing
prescribing behaviors is a central component necessary for identifying educational
strategies and designing effective antimicrobial stewardship interventions (PEW
Charitable Trust, 2017). Based on previous findings, findings of this project, and replies
from the respondents, targeted educational resources and strategies were identified and
supplied in the appendices. The targeted educational resources are intended to enhance
both patients’ and providers’ awareness of antibiotic use and resistance while also
providing the latest evidence-based recommendations and strategies to support the
appropriate use of antibiotics in the clinical setting.
Antibiotics save lives and are one of the most widely used medications in modern
medicine (CDC, 2013). However, antimicrobial resistance threatens the future usefulness
of these life-saving medications. The unchecked inappropriate use of antibiotics that has
plagued our healthcare system for centuries has resulted in the incidence of resistance to
occur in nearly all antibiotics offered in medicine. Antibiotic misuse is not a phenomenon
that occurs in a vacuum and blame can neither be placed fully on the patient nor the
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provider. Organizations, healthcare providers, and patients all must work together to
promote the appropriate use of antibiotics. Enhancing the awareness of antimicrobial
resistance, improving the way we as providers prescribe antibiotics, and educating and
altering patient expectations, will help keep us healthy now, helps prevent the occurrence
of resistance, and ensures that the life-saving abilities of antibiotics will be available for
future generations (CDC, 2020).
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APPENDIX

Appendix A
Literature Review
DESCRIPTIVE LITERATURE
Title/Author/Date/Journal or Source
An evidenced-based approach to the diagnosis and management
of acute respiratory infection. Hart. 2007. Journal for Nurse
Practitioners.

Key Findings
-Acute respiratory infections (ARIs) are the most common reason
for which antibiotics are prescribed.
-ARIs include: common cold, acute rhinosinusitis, acute
pharyngitis, and acute bronchitis.
-Most ARIs are due to self-limited viral infections, however
antibiotics are prescribed 40% to 50% of the time.
-Two most common reasons clinicians prescribe antibiotics
inappropriately: 1) patient satisfaction, and 2) misinformed about
the nature and course of ARIs and often possess outdated
information.
-Common Cold: viral non-specific infection lasting 1-2 weeks. Less
than 2% complicated by bacteria. Antibiotic do not shorten the
course and are not recommended. Management: symptom relief
(decongestant, anti-inflammatories)..
-Acute Rhinosinusitis: inflammation of nasal mucosa and paranasal
sinuses lasting less than 4 weeks. Less than 2% from bacterial
origin. Consider bacterial origin only if moderate to severe
symptoms (sinus pain, tooth pain, and nasal congestion) for greater
than 7 days. Management: symptom relief (decongestants, antiinflammatories, nasal steroids).
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-Acute Pharyngitis: mostly viral (adenovirus, rhinovirus, influenza).
5% to 15% due to Group A Beta-Hemolytic Strep (GABHS).
Pharyngeal cultures or rapid antigen detection test (RADT)
recommended testing in all patients with features of GABHS
(sudden, fever, inflammation, N/V, hx of exposure, age 5-15yrs,
etc.). Management: acetaminophen, NSAIDs, fluids, and consider
short course of oral steroids.
-Acute Bronchitis: cough as predominant symptom that is persistent
for less than 3 weeks. Mostly viral. 5% to 10% bacterial. In the
absence of B. Pertussis, antibiotics are not recommended.
Management: reassurance of viral origin and spontaneous resolution
usually in 2 weeks, Inhaled short-acting beta agonists and short trial
of antitussives reasonable.
- Purulent drainage, tonsillar exudate, and sputum color/consistency
are poor diagnostic indicators for bacterial infection.

Antibiotic resistance threats in the United States, 2013. 2013.
Centers for Disease Control and Prevention.
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-Withholding antibiotics for ARIs does not decrease patient
satisfaction and symptomatic relief should be offered in place of
antibiotics for most patients presenting with ARIs.
-The 1940’s, often referred to as the “Golden Era of Antibiotics”,
marks the introduction of antibiotics for the purposes of treating
serious infections. “Since then, antibiotic have saved millions of
lives and transformed modern medicine (p.41)”.
• However, resistance to penicillin was noted shortly after its
introduction in the 1940’s. And just like the resistance
developed against penicillin, over the past 70 years “bacteria
shown the ability to become resistant to every antibiotic that
has been developed (p.41)”.
• Antibiotics are a highly effective but limited resource.
History shows us that the more antibiotics are used, the more

quickly bacteria develop resistance, and the less likely
antibiotics will remain effective in the future.
-Antibiotic resistance, also commonly referred to as antimicrobial
resistance (AMR), is a global threat. Strains of antibiotic resistance
bacteria can be passed from person-to-person, cross international
boundaries, and spread between continents with remarkable speed
and ease.
-Described as “nightmare bacteria” that “pose a catastrophic threat”
to persons in every country of the world (CDC, 2013, p.11).
-AMR is associated with considerable excess health care costs,
extended hospital stays, increased surgical complications, increased
morbidity and mortality, and poor patient outcomes.
-As AMR continues, antibiotics used to treat infections do not work
as well or at all. Many acute illness and exacerbations of chronic
illnesses rely on the ability of antibiotics to fight infections. When
the ability of antibiotics to effectively fight infections is lost, the
ability to offer “many life-saving and life-improving modern
medical advantages will be lost with it” (CDC, 2013, p.24).
-An estimated $20 billion in excess of direct health care costs and
$35 billion in indirect costs in the United States alone is attributed
to AMR, although the actual number is likely much higher.
-In the United States, 2 million illnesses & 23,000 deaths per year
caused by antibiotic resistant infections.
-Clostridium Difficile, although not significantly resistant to drugs,
is directly related to antibiotic use and resistance. At least 250,000
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illnesses and 14,000 deaths due to C. difficile each year in the
United States.
-“The use of antibiotics is the single most important factor leading
antibiotic resistance (p.11).”
-Antibiotics are the most common medications prescribed in
modern medicine. However, an estimated 50% of all antibiotic
prescribed are unnecessary.
-Improving the use of antibiotics is a priority identified by the CDC,
describing it as a necessary core action to combat AMR.
-Urgent Threats (require urgent public health attention): C. difficile,
carbapenem-resistant enterobacteriaceae (CRE), and drug-resistant
Neisseria gonorrhoeae.
-Serious Threats (declining availability of therapeutic agents,
require ongoing health monitoring to prevent from becoming
urgent): Drug-resistant Acinetobacter, Campylobacter,
Pseudomonas aeruginosa, Salmonella, Shigella, Streptococcus
pneumoniae, Tuberculosis,
-Threats resistant to specific antibiotics: carbapenem-resistant
enterobacteriaceae (CRE) an urgent threat, serious threats such as
extended spectrum beta-lactamase producing enterobacteriaceae
(ESBL), vancomycin-resistant Enterococcus (VRE), methicillinresistant Staphylococcus aureus (MRSA), and concerning threats
(many therapeutic agents exist, require monitoring) including
vancomycin-resistant Staphylococcus aureus (VRSA),
erythromycin-resistant Group A Streptococcus, and clindamycinresistant Group B Streptococcus.
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-Gram negative pathogens (enterobacteriaceae, Pseudomonas
aeruginosa, Acinetobacter), are the most worrisome because they
are becoming resistant to nearly all drugs used in their treatment.
-In addition to causing increased resistance, the inappropriate use of
antibiotics is associated with adverse drug events including allergic
reactions (most common reason for emergency care visits due to an
allergic reaction), C. difficile, drug interactions, and side effects
(nausea, diarrhea, stomach pain, etc.).
-Identified Gaps in Knowledge of Antibiotic Resistant:
1)Limited capacity at the national, state and federal level to detect
and respond to urgent and emerging AMR threats.
2)No systematic international surveillance of AMR threats currently
exists.
3)Lack of systematic collection of data on human and agricultural
antibiotic use.
4)Programs to improve antibiotic prescribing (antimicrobial
stewardship) are not widely used in the United States.
-Inappropriate antibiotic use drivers:
• Healthcare providers: 1) prescribing antibiotics when not
needed, 2) prescribing the wrong antibiotic or the wrong
dose, 3) not following guideline directed diagnostics before
initiating treatment with an antibiotic, 4) falling into patient
pressures to satisfy a patient’s expectation of an antibiotic.
• Patients: 1) lack of awareness and consequences of
inappropriate antibiotic use and AMR, 2) demands for
treatments to conditions that do not require an antibiotic
(viral illness).
• Food Industry: Use of antibiotics in animal food products
(chicken, pork, beef, etc.) to promote growth. Results in
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resistant bacteria to contaminate food and serve as a carrier
that can be passed on to people who consume these foods.
-Improving antibiotic prescribing and stewardship:
• Is the single most important action needed to slow the
development and spread of AMR. This can be accomplished
by changing the way antibiotics are used. Antimicrobial
stewardship is a “commitment to always used antibiotics
appropriately and safely—only when they are needed to
treat disease, and to choose the right antibiotics and to
administer them in the right way in every case (p.31).”
-Antimicrobial Stewardship:
• Increases patient outcomes
• Decreases antibiotic resistance
• Decreases C. Difficile infections
• Decreases healthcare costs
• Shortens length of hospital stays
• Improves the morbidity and mortality rates of the nation
Otitis media: Diagnosis and treatment. Harmes, Blackwood,
Burrows, Cooke, Van Harrison, and Passamani. 2013. American
Academy of Family Physicians.

-Acute Otitis Media (AOM) infection or inflammation of middle ear
and structures. Otitis media with effusion (OME) is middle ear
effusion without acute symptoms/signs of infection.
• 80% of children will have at least one episode of AOM
• 80-90% will have at least one episode of OME
-AOM is the most common infection for which antibiotics are
prescribed for in children.
-Often a complication of Eustachian tube dysfunction following an
acute viral upper respiratory tract infection, AOM is the most
common bacterial respiratory tract infection in children.
• Predominantly affects children age 6 months to two years
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Most common causes: Streptococcus pneumoniae,
Haemophilus influenzae, and Moraxella catarrhalis.

-AOM is a clinical diagnosis that requires stringent otoscopic
criteria to make an accurate diagnosis. AOM diagnosis requires:
• Moderate-to-severe bulging of TM
• New-onset of otorrhea
• OR
• Mild TM bulging with new-onset (<48hrs) of otalgia or
erythema
-AOM should not be diagnosed in the absence of middle ear
effusion (MEE).
-Inaccurate diagnosis leads to inappropriate use of antibiotics and
contributes to the development of AMR.
-OME is often mistaken for AOM and is a major contributor to
inappropriate use of antibiotics.
• Antibiotics do not hasten the clearance of middle ear fluid
and is not recommended.
-AOM antibiotic Indications:
• Children 6 months or older with severe signs or symptoms
(moderate to severe ear pain, ear pain for at least 48hrs,
temperature 102.2 or higher, or toxic appearing).
• Children 2 years or younger with bilateral AOM.
-Due to the major concern of resistance, deferring antibiotic
treatment in children who are least likely to benefit has become a
priority and major strategy for improving AOM management.
• Even in the presence of MEE, antibiotic therapy can be
deferred in children two years or older with mild symptoms.
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The antibiotic resistance crisis, part 1: Causes and threats.
Ventola. 2015. Pharmacy and Therapeutics.
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Observation can be considered in the presence of AOM
symptoms.
• Study found that two of three children will recover without
the use of antibiotics.
• Do NOT prescribe antibiotics to children two to 12 years of
age with non-severe symptoms.
• Avoid the use of amoxicillin alone in children who have
been exposed to this antibiotic in the past 30 days.
• If observation strategy chosen: either provide parent with
delayed prescription or schedule follow-up visit within 4872hrs to evaluate for symptom persistence.
-History of ABX & Resistance:
• 1928—Discovery of Penicillin by Sir Alexander Fleming
• 1940’s—Penicillin (PCN) introduced into medicine, known
as the “Golden Era of Antibiotics”
• 1950’s—Substantial development of PCN resistance and
subsequent development of new beta-lactam antibiotics
• 1962—first case of methicillin-resistant Staphylococcus
aureus (MRSA) identified
• 1972—Vancomycin introduced to treat MRSA infections
• 1979—Vancomycin resistance identified
• 1960’s-1980’s—surge of antibiotic research and
development by pharmaceutical companies to address the
resistance problem
• Today—Major lack of research and development of
antibiotics by pharmaceutical companies. Resistance
identified in nearly all antibiotics currently available on the
market.
-Benefits & Impact of ABX:
• Prevent & treatment of infections in:
o Cancer patients receiving chemotherapy

o Patients with chronic diseases (DM, RA, ESRD) who
are immunocompromised
o Complex surgeries requiring prophylaxis (organ
transplants, joint replacements, cardiac surgeries)
o Food-borne and poverty-related infections in
developing countries with poor sanitation
• Epidemiological Shift:
o 1920’s—average life expectancy was 56.4yrs with
major morbidity and mortality attributed to infectious
diseases
o Today—average life expectancy is 80yrs with major
morbidity and mortality attributed to chronic diseases
o ABX have played a pivotal role in major
achievements of modern medicine.
o ABX save lives and have been attributed as a vital
component to the major decrease in morbidity and
mortality and increased life-expectancy that has
occurred over the last century
-Causes of Antibiotic Resistance:
• Overuse:
o As early as 1945 Sir Alexander Fleming himself
recognized the threat of resistance stat the “public
will demand antibiotics… then will begin an era… of
abuses” (p.2)
o Epidemiological studies show a direct relationship
between antibiotic consumption and development of
resistant strains of bacteria.
o Bacteria can develop resistance spontaneously
through mutations in genes.
o Genes can be transferred to other bacteria causing
them to become resistant.
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o U.S. antibiotic consumption estimate—22.0 units (1
unit = one pill, or ampule) per person in the U.S.
population was prescribed in 2010
o In some states, the number of prescribed antibiotics
per year exceeded the entire population of that state
o In many other countries, antibiotic use is unregulated
and can be purchased over the counter without a
prescription
o ABX can be purchased online in countries where
ABX are regulated
Inappropriate Prescribing:
o Up to 50% of all antibiotics prescribed in the U.S.
are unnecessary.
o In a U.S. study of 17,435 patients hospitalized for
community-acquired pneumonia, only 7.6% of the
patients had an identified pathogen.
Extensive Agricultural Use:
o An 80% of antibiotics sold in the U.S. are used for
growth promotion in livestock.
o Antibiotic resistance that develops in livestock can
be transferred to humans via the consumption of
meat products.
Availability of Few New ABX:
o Beginning after the late 1980’s a major decline in
research and development (R&D) of new antibiotics
has occurred.
o Of the 18 major pharmaceutical companies, 15 have
abandoned the antibiotic R&D field.
o Pharmaceutical companies choose to invest in
profitable medications used for the treatment of
chronic diseases.

o Antibiotics are used for acute illnesses and are only
required for a short period of time making them
much less profitable than medications that are taken
on a daily basis.
• Regulatory Barriers:
o Regulatory barriers posed by the FDA
o Challenges of the clinical trial design provide a
major obstacle in gaining new antibiotic approval
o Further potentiates pharmaceutical companies lack of
interest in developing nee antibiotics.
-ABX Resistance Threats:
• At the global level, gram-positive resistant pathogens pose
the greatest threat. These include MRSA and VRE.
• MRSA kills more U.S. citizens each year than HIV/AIDS,
Parkinson’s disease, emphysema, and homicide combined.
• Global spread of common respiratory pathogens
Streptococcus pneumoniae and Mycobacterium tuberculosis
has become an epidemic.
• Gram-negative multi-drug resistant pathogens (Klebsiella
pneumoniae, Pseudomonas aeruginosa, Acinetobacter, E.
Coli, and Neisseria gonorrhoeae) are becoming increasing
prevalent in the community as well.
-ABX Resistance Burden:
• Increased morbidity and mortality.
• Over 2 million deaths per year in the U.S. are attributed to
resistance infections.
• Considerably longer hospital stays.
• Limits the usefulness of first and second-line therapies
resulting in the use of alternative agents that are more
expensive and toxic to the patient.
• Higher incidence of long-term disability and reduced patient
outcomes.
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Current concepts in adult acute rhinosinusitis. Aring, and Chan.
2016. American Academy of Family Physicians

Economic burden of $20 billion in health care costs and $35
billion a year in lost productivity in the U.S. alone.
-Acute Rhinosinusitis (ARS): inflammation of the mucosal lining
of the paranasal sinuses and nasal cavity.
• AKA “Sinusitis”
• One of the most common conditions treated in the
ambulatory care setting.
• One in seven adults affected yearly
• Fifth most common diagnosis for which antibiotics are
prescribed in the U.S.
• Categorized as acute viral rhinosinusitis (AVRS) and acute
bacterial rhinosinusitis (ARBS).
• Most cases are the result of a viral etiology (rhinovirus,
adenovirus, influenza virus, and parainfluenza virus).
-Four Signs & Symptoms: that significantly increase the likelihood
of a bacterial etiology. Combination of at least 3 of the following 4
signs and symptoms has a specificity of 81% and sensitivity of 66%
for ARBS.
• Double-Sickening—Initial improvement with worsening of
symptoms between days 5 and 10)
• Purulent Rhinorrhea & Sinus pain— predominantly
unilateral local sinus pain/tenderness coupled with purulent
rhinorrhea 85% reliability for diagnosing ARBS.
• ESR greater than 10mm/hr
• Purulent secretions in the nasal cavity
• Note:
• Providers should not rely solely on colored nasal
drainage as an indication for antibiotic therapy.
• 60% probability of ARBS with persistence of signs
and symptoms without evidence of improvement for
at least 10 days beyond onset

152

•

Erythrocyte sedimentation rate (ESR) and C-reactive
protein (CRP) are somewhat useful tests for
confirming ARBS.
-Clinical Recommendations:
• Watchful waiting with or without symptomatic relief
(intranasal steroids, analgesics, saline irrigation) is
recommended for the treatment of uncomplicated ARS for
the first 7-10 days after symptoms appear.
• Mild rhinosinusitis with symptoms lasting fewer than 10
days can be managed with supportive care (analgesics,
intranasal steroids, saline irrigation)
• Antibiotic therapy is recommended if symptoms persist > 7
days with no evidence of improvement or is symptoms
worsen after initial improvement (double sickening)
• First-line antibiotic therapy: Amoxicillin or Augmentin.
• For PCN allergy: doxycycline or a fluoroquinolone ABX
can be used.
• Diagnostic imaging is not recommended unless a
complication or an alternative diagnosis is suspected.
Acute bronchitis. Kinkade, and Long. 2016. American Academy of
Family Physicians.

-Acute Bronchitis: clinical diagnosis with predominant symptoms
of cough lasting two to three weeks that is due to inflammation of
trachea and large airways in the absence of pneumonia.
-Etiology: 90% due to a viral infection.
• Study showed bacteria etiology of only 1% to 10% of acute
bronchitis cases.
-Treatment & Management:
• Acute bronchitis is a self-limited disease and should be
treated in a similar fashion to the common cold.
• Symptomatic relief is the cornerstone of therapy
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Dextromethorphan, guaifenesin, and/or honey as well as
increased fluid intake should be used for acute bronchitis
symptom management.
• Bronchodilators can be used if wheezing is present.
-Antibiotics:
• “The strongest predictor of an antibiotic prescription is the
clinician’s preception of patient desire for antibiotics” (p.5).
• All major guidelines on acute bronchitis do not recommend
the use of antibiotics for uncomplicated acute bronchitis.
• Antibiotics should only be considered if there is high
suspicion of pneumonia (high-grade fever, dyspnea,
tachycardia, tachypnea, bloody sputum, focal lung
consolidation), pertussis (confirmed via testing, persistent
cough accompanied by paroxysmal cough, whooping cough,
post-tussive emesis, or recent pertussis exposure), or older
frail adults with multiple co-morbidities (esp. COPD).
-Strategies to Reduce ABX:
• Purulent sputum (green or yellow) is a poor indicator for
bacterial etiology and should not indicate the need for an
antibiotic.
• Use of delayed prescribing
• Address patient concerns with providing symptomatic relief.
• Refer to acute bronchitis as a “chest cold”.
• Educate patient on the course of illness and cough duration
of two to three weeks. One study found that the average
duration of cough in acute bronchitis was 18 days.
• Explain that antibiotics do not shorten the course of illness,
do not provide any therapeutic benefit and can result in
adverse effects and development of resistance.
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What drives inappropriate antibiotic use in outpatient care?.
2017. PEW Charitable Trust.
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-Overuse of Antibiotics:
• In the U.S. 1 in 3 antibiotics prescribed in the outpatient
setting is inappropriate, equally 47 million prescriptions per
year.
-Factors Influencing Prescribing Decisions:
• Patient Satisfaction and pressure:
o Cited as the main driver for the antibiotic
prescribing.
o Patients wrongfully believe that they would benefit
from receiving an antibiotic based on previous
experiences when an antibiotic provided relief
(fever).
o Study found clinicians are much more likely to
prescribe antibiotics for pediatric patients based on
perceived belief that child’s parents expected them.
o Poor balance of patient health versus customer
satisfaction. Fear of losing patients to competitors if
antibiotic is not given.
o Believe prescribing an antibiotic will increase patient
satisfaction.
• Time Constraints:
o Feeling of being ill-equipped in terms of resources
and time
o Study found that clinicians with higher patient
workloads prescribed antibiotics at higher rates when
compared with their less busy colleagues.
o Save time by avoiding lengthening conversations
with patients of why antibiotics are not needed.
o Study found “decision fatigue” that occurs as a
typical workday wore on leading to providers
prescribing antibiotics for ARI at a much higher rate.

•

Diagnostic Uncertainty:
o Viral and bacterial ARIs have similar presentation
(congestion, cough, sore throat)
o Limited diagnostics availability in the office-setting
for rapid differentiation between etiologies.
o Prescription of antibiotics seen as a safe choice due
to fear of worsening or progression, uncertain
follow-up, or fear of legal ramifications.
• Externalized Responsibility:
o Displacing blame
o Studies interviewing clinicians found that all
participants agreed that antibiotic resistance and
overprescribing was a problem but attributed the
cause of inappropriate use to other clinicians.
-Improving Prescribing by Understanding Behavior:
• “Central to designing effective antimicrobial stewardship
interventions is understanding the underlying factors that
influence prescribing behaviors” (p.4).
• This knowledge provides stakeholders with needed
information and provides new insight into antibiotic
stewardship strategies
• By determining clinician’s antibiotic prescribing behavior
interventions can be developed to target providers’
underlying social motivation in order to influence decisionmaking.
• Educational Strategies:
o Public awareness campaigns and professional
learning opportunities.
• Communication Training:
o Improve provider-to-patient communication by
understanding patient concerns and agreeing on a
treatment plan.
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o Suggesting treatment alternative with non-antibiotic
OTC and home remedies for symptomatic relief.
Audit & Feedback Strategies:
o Aimed to increase clinician’s awareness of their own
prescribing behaviors.
o Review and relay individuals prescribing behaviors
o Benchmarked against colleagues or expected
prescribing rates
o Studies show audit and feedback to be effective but
benefits last only as long as audit and feedback in
place
Clinical Decision Support Systems:
o Consistent with current clinical practice guidelines,
CDS systems help guide the process of evaluation
and treatment
o Studies show effectiveness of CDS at increasing
appropriate antibiotic prescribing
Delayed Prescriptions:
o Help clinicians in managing diagnostic uncertainty.
o AKA “Watchful Waiting” in which an antibiotic
prescription is written but patient is advised to only
fill if symptoms persist or worsen.
o Studies show this an effective strategy to reducing
inappropriate antibiotic use.
Commitment Pledging:
o Study involving clinicians’ signing a letter pledging
their commitment to prescribe antibiotics according
to current practice guidelines. Letters were enlarged
to create commitment posters that were publicly
placed in doctors’ offices. The study found that
providers participating in the poster intervention
inappropriately prescribed antibiotics at a rate 20%
lower than those who did not participate.

•

Unleashing the power of diagnostic tests in the fight against
antibiotic resistance. 2017. Antibiotic Resistance Action Center,
Milken Institute of Public Health, George Washington University.

Merit-Based Strategies:
o In another study, participating providers were
required to justify prescriptions of antibiotics in the
patient chart which was visible to other clinicians.
Results found this behavioral intervention led to
significant reductions in inappropriate prescribing.
o Another study ranked providers by their level of
inappropriate prescribing. Providers that
inappropriately prescribed the least were termed
“Top Performers” while their peers who wrote more
prescriptions were not. Results led to significant
decreases in inappropriate prescribing.
-Discovery of Antibiotics: one of the greatest medical discoveries
in modern history and became the cornerstone of modern medicine.
However, due to the overuse of antibiotics the development of
resistance is causing antibiotics to lose their effectiveness.
-AMR a Global Crisis:
• Up 50% of all antibiotics prescribed today are unnecessary.
• The overuse of antibiotics has led to a sharp increase in
drug-resistance infections that effects nearly every aspect of
healthcare.
-If Antibiotic Resistance is Allowed to Continue at its Current
Rate:
• “Without urgent coordinated action by many stakeholders
the world is headed for a post-antibiotic era, in which
common infection and minor injuries, which have been
treatable for decades can once again kill” (p.1).
• “It is estimated that by 2050, 10 million people a year will
die from drug-resistant infections and $100 trillion in global
economic productivity will have been lost over that time
period” (p.1).

158

Measuring outpatient antibiotic prescribing: Key U.S. statistics.
2018. Centers for Disease Control and Prevention.

Antibiotic resistance 101: An Overview. 2018. Antibiotic
Resistance Action Center, Milken Institute of Public Health, George
Washington University.

-Current Key U.S. Statistics on Antibiotic Use in Outpatient
Setting:
• At least 30% and up to 50% of all antibiotics prescribed are
unnecessary.
• In 2016, 270.2 million courses of antibiotics were dispensed
to outpatient pharmacies (equivalent to 836 prescriptions per
every 1,000 persons in the U.S.).
• Antibiotic prescribing in the outpatient setting varies by
state. Local outpatient prescribing practices contributes
significantly to local resistance patterns.
• Prescribing is greatest in the winter months.
• Antibiotic consumption is highest in the South-Central
region of the U.S. and decreases as you move towards the
Western region of the U.S.
• Acute respiratory indications are the most common
reason for which antibiotics are prescribed, including:
o Acute Rhinosinusitis
o Acute Bronchitis
o Common cold or non-specific upper respiratory tract
infection (URI)
o Pharyngitis
o Acute Otitis Media (AOM)
• 80-90% of antibiotic consumption by volume occurs in the
outpatient setting.
• Azithromycin and amoxicillin are the most common
antibiotics prescribed in the outpatient setting.
-Antibiotic resistance is one of the greatest public health threats of
our time.
-How Does Antibiotic Resistance Occur? Bacteria develop the
ability to mutate, survive the killing effects of antibiotics, and
therefore become resistant to the effects of antibiotics.
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-Today: antibiotic resistant infections kill tens of thousands of
people every year in the United States.
-If Antibiotic Resistance is Allowed to Continue at its Current
Rate:
• AMR is a natural and expected consequence that occurs
in every antibiotic after a period of continued use.
• As bacteria become increasingly resistant to antibiotics,
common bacteria that once caused easily treatable
infections (UTI, AOM, etc.) will become resistant to
treatment, rendering first-line therapies ineffective, and
possibly even become life-threatening.
• The Antibiotic Resistance Action Center (ARAC) at the
Milken Institute of Public Health (2018) stated: “in the
next 30 years, antibiotic resistant infections are expected
to overtake cancer as the leading cause of death
worldwide, and experts predict that based on current
estimates, could kill one person every three seconds”
(p.1).
• As pre-surgery antibiotics become less effective,
surgeries and routine procedures will be threatened by
higher risks of antibiotic resistant infections resulting in
poor outcomes.
• Dramatic impact on women’s health as childbirth and
gynecologic surgeries become less safe due to AMR.
-Major Contributors to AMR:
• Widespread and inappropriate use of antibiotics in modern
medicine and livestock production.
• Antibiotics sold without a prescription in developing
countries.
• Lack of research and development of new antibiotics as
pharmaceutical companies development of more lucrative
drugs.
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CRITICAL APPRAISAL OF PREVIOUS STUDIES
Title/Author/Date/Journal

Effects of knowledge,
attitudes, and practices of
primary care providers
on antibiotic selection,
United States. Sanchez,
Roberts, Albert, Johnson,
and Hicks. 2014. Emerging
Infectious Diseases.

Theoretical/
Conceptual
Framework
Not explicitly
identified

Research
Question(s)/
Hypotheses
“Does provider
knowledge,
attitudes, and
self-reported
practices effect
the appropriate
selection of
antibiotic
drugs?”

Methodology

Qualitative open-ended
interviews with 36
primary care providers in
the United States.
-Included physicians
(n=27), nurse practitioners
(n=5), and physician
assistants (n=4).
-Interviews consisted of
digitally recorded
telephone calls transcribed
into text. Conducted in
May of 2013 by a
professional moderator.
-Screening questionnaire
used to recruit.
-Inclusion criteria: 50%
of practice time in
primary care setting, 30
years of age, and fluent in
English.
-Exclusion criteria:
immediate family member
working in an area of
conflict of interest, board
certified in an area other
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Analysis &
Results
-Participant
interviews were
reviewed and
transcribed into text
by project staff.
-To identify
frequency of
responses, excerpts
from the interviews
were compiled and
coded into themes via
inductive and
deductive methods.
- In-depth analysis of
themes was
performed by coding
responses using
Nvivo 9.
-Study was reviewed
and approved by the
CDC.
-Results of the
interview analyses
were identified in the
form of a table.

Conclusions

-The study was conducted to
explore provider’s
knowledge, attitudes, and
practices (KAPs) in regard to
antibiotic prescribing,
selection, and resistance.
-Participants were familiar
with CPGs but admitted to
intermittent non-compliance.
-Concerns for patient
satisfaction and pressures
was the most common
perceived reason for
inappropriate antibiotic
prescribing.
-Inconsistencies and noncompliance of other
providers negatively impacts
patient expectations.
-Fear of complications and
low-confidence in
prescribing abilities often
leads to the prescription of
broad-spectrum antibiotics.
-Knowledge gap identified as
inconsistent definitions of

than primary care, and
practiced medicine >30
years.
-Sponsoring organization:
Centers for Disease
Control and Prevention
(CDC).
-Interview questions
addressed: practice
setting, patient population
served, self-reported
antibiotic prescribing
practices, perception of
peers prescribing
practices, attitudes
towards clinical practice
guidelines (CPGs) for
common infections,
assessed knowledge of
narrow and broadspectrum antibiotics,
preferred resources used
for antibiotic treatment
and education, and
attitudes towards
antibiotic resistance.
-Participants were asked
to rank 12 factors that
influence their
prescription of antibiotics.
-Clinical scenario
questions were asked to
assess compliance with
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-Results were
categorized into 5
major themes:
1) Antibiotic
selection
2) Broad VS.
Narrow-spectrum
3) Education and
resources
4) Changing
prescribing habits
5) Antibiotic
resistance

broad and narrow-spectrum
antibiotics.
-Consensus agreement that
antibiotic resistance is a
major health care issue;
however, resistance is not
commonly considered when
selecting therapy.
-Consensus agreement that
the best way to change
prescribing behavior is to
alter the expectations of
patients so to reduce the
pressure to prescribe
antibiotics.
Strengths:
1) Inappropriate antibiotic
selection is not caused by
lack of knowledge of CPGs.
2) Inappropriate prescribing
is the result of complex
interactions between both the
patient and provider.
3) Inappropriate antibiotic
use is strongly linked to
patient satisfaction and
pressures, and fear of
repercussions and/or patient
illness if an antibiotic is not
prescribed.
Limitations:
1) Qualitative designs
making it difficult to
generalize findings.

clinical practice
guidelines.

2) Biased opinions of
providers cannot be excluded

-Each participant received
a cash incentive for
participation.

Relevance to current
practice: Greater
comprehension of “Why”
providers prescribe
antibiotics including barrier
and facilitators to appropriate
antibiotic utilization.
Recommendations for
future research:
1) Incentives for appropriate
antibiotic prescribing
practices
2) Develop standardized
methods to encourage firstline agents
3) Identify interventions that
improve antibiotic selection
4) Education both patients
and providers on promoting
appropriate antibiotic use.

Title/Author/Date/Journal

Inappropriate antibiotic
prescription for
respiratory tract
indications: Most
prominent in adult
patients. Dekker, Verheij,
and Van Der Velden. 2015.
Family Practice.

Theoretical/
Conceptual
Framework
Not explicitly
stated

Research
Question(s)/
Hypotheses
Approximately
one-half of all
antibiotics are
inappropriately
prescribed for
respiratory tract
indications and is
greatly related to
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Methodology

Analysis &
Results

Conclusions

-Design: Mixed
methods
research/observational
study using both
quantitative and
qualitative measures.

-Baseline
characteristics of
2724 consultations
were calculated
according to
percentages,
means, and SDs.

-Goal: increase
awareness of indications
of factors related to
antibiotic overprescribing
to facilitate development
of targeted strategies to
enhance GP’s prescribing
behaviors for RTIs.

provider
prescribing
practices and
patient pressures.
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-Problem:
Inappropriate
antibiotic use in RTIs
of primary care
settings leading to
increased rates of
resistance.

Recommendations
from national
guideline were
used as the
benchmark to
classify GP’s
prescribing
-Aim: to quantify and decisions as
qualify inappropriate
correct or
antibiotic prescriptions incorrect.
for respiratory tract
1) Prescribing
indications (RTIs)
when indicated
among general
(correct)
practitioners (GPs)
2) Non-prescribing
caring for adults in the when not indicated
primary care setting.
(correct)
3) Prescribing
-Data/Location/Time: when not indicated
data obtained from
(over prescription)
2739 RTI
4) Non-prescribing
consultations by GPs
when treatment
from 48 Dutch primary was indicated
care practices during
(under
the winter seasons of
prescription)
2008 to 2010.
-Prescribing rates
Data Collection:
and
-all patients with an
overprescribing
acute RTI that have
rates were
specific evidencedcalculated
based guidelines: acute according to:
otitis media,

-Nearly half of all
antibiotics prescribed for
RTIs were not indicated
in accordance with
guideline
recommendations
-Overprescribing was
highest in adults (18 to
65 yrs) & lowest in
children
-Less than 4% of
antibiotics were underprescribed
-Relative overprescribing was highest
in throat indications &
absolute over-prescribing
was highest in lower
respiratory RTIs
-GPs perceived that overprescribing of antibiotics
was most effected by
patient expectations &
fever with symptoms
lasting 7day.
Strengths:
-Large sample size
(n=2724)

rhinosinusitis, acute
sore throat, and acute
cough.
-Guidelines used to
benchmark data are
based on combinations
of signs and
symptoms, patient
characteristics, and
disease severity.

- Comprehensive
documentation inputted
into a registry that
considered multiple
variables including a
complete range of RTIs.
-Specific comparisons of
cases to guideline
recommendations
-Provides insight into the
quality of community
-GPs Registered the
Analysis: (SPSS)
antibiotic use for RTIs
Following:
-Factors
-Registry forms were
1) Patient
associated with
provided in a simplistic
characteristics
overformat that could be
2) Medical history
prescription:
completed in a timely
3) Patient’s specific
Multivariable logic fashion during everyday
signs and symptoms
regression
routine.
4) Findings of physical analysis, P-value
examination
<0.2, Chi-square
Limitations:
5) Patient or parent
test, stratified
-GPs subjective
expectation of
regression of age
interpretation of illness of
antibiotic
and RTI type, odds severity as a possible bias
6) Diagnosis recorded ratios, 95%
-Possibility of GPs
according to IPC code confidence
overestimating illness
7) if prescribed, an
intervals.
severity in order to justify
antibiotic was recorded Results:
their prescription
by its Anatomical
-Illness severity
-Registry form did not
Therapeutically
rated high in
provide an open-ended
Chemical Code
elderly
discussion section
8) Additional
-Patient
allowing GPs to justify
management
expectations of
their treatment decisions.
(reassurance, advice,

165

1)Age (children,
adult, elderly)
2) Indication (ear,
throat,
nose/sinuses,
lower respiratory
tract)
3) IPC code
(primary care
diagnosis)

referral or secondary
testing) if indicated
-Of the 2739 RTI
consultations recorded,
15 were excluded for
missing data (n=2724)
-Calculations:
1) Percentages
2) Means
3) SDs
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antibiotic highest
in adults
-38% overall
prescribing rates
and increased with
age
-Amoxicillin most
prescribed in
children
-Doxycycline most
prescribed in
adults and elderly
-Reassurance/
advice given in
80%
- 46% of all
antibiotics were
not indicated
(over-prescription)
-36% were
indicated
(appropriate
prescribing)
- <4% were
indicated but not
prescribed (underprescription)
-Over-prescribing
highest in adults
(18 to 65 years)
and was directly
related to patient
expectations of an

Application to Practice:
-Most antibiotics are
prescribed in the primary
care setting and the most
common reason for
antibiotic prescriptions
are for respiratory tract
indications (RTIs).
-This study provides
insight into
appropriateness of
antibiotic prescriptions
based on age,
indication/chief
complaint while also
identifying areas in need
of improvement to reduce
inappropriate antibiotic
use.
-Based on this data,
target
strategies/interventions
can be developed and
evaluated according to a
broad range of
respiratory complaints
and benchmarked against
national guideline
recommendations in an
effort to enhance
antibiotic appropriateness
and reduce rates of
resistance.

antibiotic and
fever with
complaints
>1week.
-Relative overprescribing highest
in throat
indications
(tonsillitis) (58%)
- Lowest in ear
indications (AOM)
(4%)
-Absolute overprescriptions
highest in lower
RTIs (bronchitis)

Title/Author/Date/Journal
Physicians’ attitudes and
knowledge concerning
antibiotic prescription
and resistance:
Questionnaire
development and
reliability. Teixeira
Rodrigues, Ferreira, Roque,
Falcao, Ramalheira,

Theoretical/
Conceptual
Framework
Not explicitly
stated

Research
Question(s)/
Hypotheses
Development of
a questionnaire
tested for validity
and reliability
will lead to an
enhanced
appreciation of
physicians’ ABX
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Methodology

-Aim: to develop a
reliable and valid
questionnaire
instrument to assess
the attitudes and
knowledge underlying
physician antibiotic
prescribing behaviors
in both primary and

Analysis &
Results
-Primary Care
Response Rates:
1) Pretest: 64%
(n=39)
2) Retest: 49%
(n=30)

-Additionally, this study
shows that patient
pressures from
expectations of receiving
an antibiotic is a strong
determining factor in the
inappropriate prescription
of antibiotics.
Recommendations for
Future:
-Future research should
focus on exploring
patient concerns and
expectations to provide
reassurance and
education as well as
alternative treatment
modalities when an
antibiotic is indeed not
indicated.
Conclusions

-Main Study Objective:
develop a measurement
tool to identify
underlying factors
regarding antibiotic
prescriptions and
resistance.

Figueiras, and Herdeiro.
2016. BioMed Central
Infectious Diseases

prescribing
behaviors?

hospital-based care
settings.
-Conducted in
September of 2013.
-Convenience sample
of 61 primary care
physicians and 50
hospital physicians
(N=111) in
Portuguese.
-Development and
validation process
divided into two major
steps:
1) Content & face
validation
2) Reliability analysis
-Content Validity:
1) Development
stage: literature
review, and previous
qualitative studies
published
2) Judgmental stage:
panel of experts (n=10)
-Face Validity: panel
of experts including
clinical psychologists
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-Hospital Care
Response Rates:
1) Pretest: 66%
(n=33)
2) Retest: 60%
(n=30)
-Content Validity
resulted in 9
changes to the
professional
concepts of the
questionnaire
-Face Validity
resulted in 19
changes to the
linguistic and
interpretive terms
of the
questionnaire.
-Reliability
Analysis results:
1) Internal validity
via Cronbach
alpha value (
>0.70) considered
satisfactory.
2) ICC values
indicated fair to
good

-Many questionnaires
have historically been
used to assess physician
attitudes and knowledge
regarding antibiotic use
and resistance but most
lack full validation.
-Analysis of the
questionnaire revealed
that content and face
validity was reliable in
terms of internal
consistency and
reproducibility.
-Strengths:
1) Questionnaire
structured to be utilized
in both primary and
hospital-care settings.
2) Allows for
comparisons of
demographic, knowledge
and prescribing practices
of primary and hospitalcare groups
3) use of a non-numerical
VAS allows for the
assessment of minute
differences among
respondents.
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and Portuguese
linguists

reproducibility
(ICC >0.4).

-Reliability Analysis:
1) Pilot study: primary
care physicians (n=61)
and hospital care
physicians (n=50).
Internal consistency
using Cronbach’s
alpha analysis.
2) Re-test study:
primary care (n=30) &
hospital care (n=30).
Reproducibility
assessed with
intraclass correlation
coefficient (ICC).
- interval of 2-4 weeks
between pre-test and
post-tests

-The final
questionnaire
included the
following five
sections:

Section 1:
instructions for
completion of
questionnaire
Section 2: 17
statements on
agreement via
visual analog scale
(VAS) regarding
attitudes and
knowledge of
antibiotic
prescribing, use
and resistance
Section 3: 9
statements
regarding
importance of
various sources of
knowledge.
Section 4:
Demographic and

-Limitations:
1) Small sample size
inadequate to confirm
construct validity
2) Convenience sampling
process
-Relevance to Current
Practice:
1) Questionnaire useful
for better understanding
physicians’ attitudes,
knowledge and antibiotic
prescribing behaviors
considered to be
important factors
contributing to resistance.
2) Questionnaire pretest/re-test format proves
useful for evaluating
antimicrobial stewardship
intervention and
effectiveness.
-Recommendations for
the Future:
1) use of the
questionnaire in different
countries/settings to
ascertain and compare
geographical differences
among prescribing
practices

Title/Author/Date/Journal

Prevalence of
inappropriate antibiotic
prescriptions among US
ambulatory care visits,
2010-2011. Fleming-Dutra,
Hersh, and Hicks. 2016.
JAMA.

Theoretical/
Conceptual
Framework
Not explicitly
stated

Research
Question(s)/
Hypotheses
To what extent is
outpatient
antibiotic use
inappropriate in
US ambulatory
care settings?
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professional
information
Section 5: blank
section allowing
participants to
express ideas and
views on antibiotic
use and resistance
Analysis &
Results

2) Conduct future studies
using this questionnaire
with a larger sample size
to evaluate construct
validity

Analysis:
Using national
guidelines and
regional variations
in prescribing the
following was
Objective: To
determined:
estimate rates of total
1)Diagnosisoral antibiotic
specific prevalence
prescriptions by age
and rates of total
and diagnosis &
antibiotic
estimate the
prescriptions
proportions of
2)Diagnosisinappropriate antibiotic specific prevalence
use in adults and
and rates of
children in US
appropriate
ambulatory care.
antibiotic
prescriptions
Methods of
Measurement:
-Total &
1)2010-2011 National appropriate
Ambulatory Medical
antibiotic

Conclusions:
In 2010 to 2011
-50% of all ABX
prescriptions for acute
respiratory conditions
were inappropriate.
-Sinusitis was the most
diagnosis for which
antibiotics are prescribed.
-31% of all ABX
prescribed for all ages
and diagnoses were
inappropriate.

Methodology

Design: Quantitative
observational study of
population-adjusted
antibiotic (ABX)
prescription rates.

Conclusions

-Such estimates provide
evidence supporting the
urgency of ABX misuse
in the US and the need
for establishment of outpatient antibiotic
stewardship programs.

Care Survey
(NAMCS)
2)2010-2011 National
Hospital Ambulatory
Medical Care Surveys
(NHAMCS)
Methods of
Estimation:
1)Annual Numbers
2)Population-adjusted
rates with 95%
confidence intervals of
ambulatory visits with
oral antibiotic
prescriptions by age,
geographical region,
and diagnosis.
Determination of
Appropriateness:
-National guidelines
and regional variations
in prescribing.
Sample Size:
-184,032 visits
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prescription rates
were combined to
determine: an
estimate of annual
rates of
appropriate
antibiotic
prescriptions per
1000 population.

Strengths:
-Study supports the
notion that most
inappropriate antibiotic
use occurs in acute
respiratory conditions.
-Capture an estimation of
antibiotic use in the US
that can be compared to
ABX use of various
Results:
regions, both nationally
-Sample size
and internationally
184,032 visits
-The study used national
-12.6% of all visits surveys and evidencedresulted in an ABX based guidelines
prescription
approved by the CDC
-Sinusitis
-Provides national
diagnosis had the
representativeness and
most ABX
inclusion of both
prescriptions per
diagnosis and therapy.
1000 population,
followed by otitis
Limitations of
media and
NAMCS/NHAMCS:
pharyngitis.
-Relies on clinicians
-Acute respiratory diagnosis.
conditions had the -Only limited variables
highest absolute
adjusted for non-response
ABX prescriptions increasing the chance of
-221 ABX
non-response bias
prescriptions were -represents overall visits
given annually for and not episodes of
acute respiratory
illness increasing the
disorders, but only chance of overestimation

111 were
estimated to be
appropriate (50%).
-Combing all ages
and conditions in
2010-2011, an
estimated 506
ABX prescriptions
were given
annually and only
353 were
considered to be
appropriate (69%)

-Time delays limitations
and use of dated data
(2010-2011)
-Urgent care, retail
clinics, hospital
discharges, telemedicine,
and long-term care
settings not included in
estimates
-No method of
differentiating standard
from delayed
prescriptions
Relevance to Practice:
-Annual data and
estimations of antibiotic
use and appropriateness
by disease, age, and
geographical area allows
for targeted interventions
and identification of high
need areas of
antimicrobial stewardship
implementation.
Recommendations for
the Future:
-Conduct a separate study
on appropriate selection
of antibiotics to provide
opportunities to improve
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Title/Author/Date/Journal

Outpatient antibiotic
prescribing among United
States nurse practitioners
and physician assistants.
Sanchez, Hersh, Shapiro,
Cawley, and Hicks. 2016.
Infectious Diseases Society
of America.

Theoretical/
Conceptual
Framework
Not explicitly
stated

Research
Question(s)/
Hypotheses
What are
antibiotic
prescribing rates
of Nurse
Practitioners
(NPs) and
Physician
Assistants (PAs)
in the U.S.
ambulatory care
setting? And,
how do these
differ from
Physician
antibiotic
prescribing
rates?
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Methodology

Analysis &
Results

Design: Quantitative
study analyzing
antibiotic prescribing
rates in U.S.
ambulatory care
setting among provider
type (PA, NP, and
Physician).

Statistical
Analysis: Logistic
regression using
the time period as
the predictor
variable and multivariable logistic
regression model
using antibiotic
prescribing as the
outcome variable
to determine rates
of NP and PA
visits resulting in
ABX prescription
compared to
physician-only
visits.

Data Sources: Two
national surveys
including the National
Ambulatory Medical
Care Survey
(NAMCS) and the
National Hospital
Ambulatory Medical
Care Survey
(NHAMCS) collected
data from 1998 to
2011 to assess trends
in ambulatory visits by
provider type. Data
collected of visits from
2006-2011 was used to
assess both the
proportions of overall
antibiotic prescribing

-Bivariate analysis
using the X2 test
was used to assess
independent
variables.
Results: of the
1,301,474 sampled
visits:

selection and decrease
resistance.
Conclusions

-Few previous studies
have focused on
antibiotic prescribing
according to provider
type. This study provides
insight into antibiotic
prescribing rates
according to provider
type and compares these
rates “in order to guide
public health initiatives
and better understand
antibiotic prescribing
practices across all
provider types” (p.1).
-A substantial increase in
the proportion of NP/PA
ambulatory care visits
was observed during the
study period. Higher
frequencies of
ambulatory visits
resulting in an antibiotic
prescription was
observed when a nonphysician provider was
involved.

for ambulatory care
visits as well as
proportions ABX
prescribing in visits
involving acute
respiratory tract
infections (ARTIs)

-6.3% involved
NPs or PAs.
-Over the study
period, the
proportion of NP
or PA visits more
than doubled
across ambulatory
-Data collected was
care visits, and
categorized according more than tripled
to provider type,
in ED visits. A
diagnoses, and
testament to the
antibiotic class.
rapid expansion
and increase of
-Used in previous
non-physician
studies, the NAMCS
providers entering
and NHAMCS provide the U.S. medical
a nationally
system.
representative sample
of ambulatory care
-From 2006-2011,
visits in the U.S.
the proportion of
antibiotics
Sample Size:
prescribed by
NAMCS/NHAMCS
physicians was
survey data from a
12% for all
total of 1,301,474 U.S. ambulatory visits
ambulatory visits was
and 54% for ARTI
included in this study. visits.
-Based on estimates of
this data, an average of
1.13 billion
ambulatory visits take
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-In comparison,
NP and/or PAs
prescribed
antibiotics in 17%

-When compared to
physicians, NPs and PAs
are more likely to
prescribe antibiotics in all
ambulatory care visits
(17% for NP/PA vs 12%
for physicians) and are
more likely to prescribe
antibiotics in ARTI visits
(61% for NP/PA vs 54%
for physicians).
-“Elements of antibiotic
stewardship are often
included in NP, PA, and
physician education
curricula, suggesting that
potential differences in
antibiotic prescribing are
more likely due to
practice environment,
learned clinical
behaviors, or differences
in patient communication
rather than medical
education” (p.2).

place in the U.S. per
year.

Title/Author/Date/Journal

Not a magic pill: a
qualitative exploration of
provider perspectives on
antibiotic prescribing in
the outpatient setting.
Yates, Davis, Taylor,
Davidson, Connor, Buehler,
and Spencer. 2018. BMC
Family Practice.

Theoretical/
Conceptual
Framework
Not explicitly
stated

Research
Question(s)/
Hypotheses
What barriers
posed in
outpatient
clinical settings
challenge the
success of
appropriate
antibiotic use?
And, how can we
address these
barriers?
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Methodology

Design: Qualitative
study with a
phenomenological
perspective design
using semi-structured
interview with key
informants
Sample/Setting: 17
out-patient providers
(10 physicians and 7
advanced care
practitioners) covering
a large health-care

of all ambulatory
visits and in 61%
of ARTI visits.
-Visits that
involved NPs or
PAs had
independently
higher odds of
prescribing
antibiotics (odd
ratio=1.13) even
after controlling
patient and
practice-level
variables.
Analysis &
Results
Analysis:
-From analysis of
the interviews, 3
major themes were
identified:
1)Current ABX
prescribing
practices
2)Providers
perceptions of
patient knowledge
and awareness
3)
Recommendations

Conclusions

Conclusion: A myriad of
factors are involved in
influencing providers to
prescribe antibiotics. In
regard to inappropriate
antibiotic prescribing
among the most
influential factors include
patient satisfactions,
pressures, and
expectations. Education
targeting both patients
and providers are
considered key elements

system in North
Carolina.
Objectives:
1)Investigate the
elements involved in
influencing providers
antibiotic prescription
decisions
2)Identify possible
interventions from
provider
recommendations to
address inappropriate
antibiotic use
3)Inform clinical
management of
patients with infections
that do not warrant
antibiotics in an
outpatient setting
Method:
-Emails sent out to
various providers in
out-patient settings
responded to emails
electing to partake in
the study
-Semi-structured
interviews of 17
providers who agreed
to the studies terms
and conditions
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for education,
training, and
reporting
-Inductive process
going from
thematic analysis,
to descriptive
interpretation, to
more abstracted
categories.
-First and second
level coding
classifications to
reflect emerging
patterns /
relationships
among data
-NVivo version 10
used to assist in
management and
analysis of data
-Analysis of data
completed by the
same qualitative
researcher who
conducted the
interview
-Consultation with
a transcriptionist,
members of the
project, and project
stakeholders
reviewed the data

to any antimicrobial
stewardship program.
Strengths:
-Incorporates the
perspectives, of not only
physicians but also of
advanced care
practitioners, involving
the ‘how’ and ‘why’
providers prescribe
antibiotics.
-Pressures and challenges
related to antibiotic
prescribing found in this
study are aligned with the
findings of prior studies
from other settings.
-Setting included both
primary and urgent cares,
areas considered to be
highest in antibiotic use.
Limitations:
-No exclusion or
inclusion criteria of
sample selection
explicitly stated.
-Only one researcher
coded the data.

-All interviews
conducted over the
phone in the months of
November-December
2016 by the same
qualitative researcher
-Each interview was
recorded and later
transcribed for analysis
-Interview guide
focusing on questions
developed by project
stakeholders that
specifically addressed
the objectives of the
study:
1)key factors involved
in ABX prescribing,
2)communication with
patients about ABX,
3)attending to patient
satisfaction and ‘want’
to get better,
4)perceptions of
patient knowledge and
experience,
5)the problem of ABX
resistance,
6)barriers and
facilitators to
appropriate antibiotic
prescribing
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Results:
-Key factors in
ABX decision
making: acute
clinical
presentation, best
practices, patient
factors (age), and
workflow.
-Communicating
with patients:
viral versus
bacterial, disease
course,
symptomatic
relief, signs to
watch for, and
follow-up
-Assisting
patients to feel
better: OTC
medications,
personal care, and
rest.
-Perceptions of
patient
knowledge /
experience:
expectations are
high, and desire to

-All participants were
from the same health care
system (limits
generalizability).
-Small convivence
sample (limits
generalizability).
-Individuals volunteered
to participate (selfselection bias).
Relevance to Practice:
-Study’s findings were
aligned with the findings
of previous studies.
-Emphasized importance
of educational materials
disseminated in waiting
rooms, doctor lounges
etc.
-Findings promote that
institutional monthly or
quarterly publication of
ABX use results and
recommendations to
improve prescribing
practices would be well
received.

-Data was collected
until saturation was
achieved beyond the
original goal of 15 key
informants

feel better now
with a quick fix.
-Perceptions of
the problem of
ABX resistance:
public largely
unaware, often
disassociate, and
varies based on
demographics.
-Barriers to
appropriate ABX
prescribing:
patient education
and expectations,
system-level
concerns, and
time-constraints.
-Education and
training for
providers:
system-wide
evidenced-based
guidelines, &
decision support
tools,
-Reporting ABX
use to providers:
multiple forms of
delivery (in
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-Insights derived from
the study can be used in
the development of
patient education
materials, provider
scripting, and reporting
dashboards.
Recommendations for
the Future:
-Study indicated that
patient expectations for
antibiotics strongly
influence providers
decisions to
overprescribe.
-Additionally,
institutional constraints
that promote unrealistic
attainment of patient
satisfaction often lead to
false expectations of
patients and pressures
providers to
inappropriately prescribe
antibiotics.
-In considering these
factors, education of
patients, providers and

person, electronic),
and aligned with
current reporting
practices.

Title/Author/Date/Journal
Clinicians’ beliefs,
knowledge, attitudes, and
planned behaviors on
antibiotic prescribing in
acute respiratory
infections. Hruza,
Velasquez, Madaras-Kelly,
Fleming-Dutra, Samore, &
Butler. 2018. Open Forum
Infectious Diseases.

Theoretical/
Conceptual
Framework
Theory of
Planned
Behavior
(TPB)

Research
Question(s)/
Hypotheses
What provider
perceptions
contribute to
appropriate
antibiotic
prescribing and
how can
knowledge of
these prescribing
behaviors be
used to improve
the use of
antibiotic in the
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Methodology

Analysis &
Results

Design: Qualitative
study design using
one-on-one interviews
with providers (n=20)
working in emergency
departments, primary
care, and communitybased clinical settings
of five VA Medical
centers in the U.S.
conducted May-July
2017.

Beliefs &
Attitudes: Providers
positively
perceived ASP
efforts and
believed strategies
such as auditfeedback and tools
to improve
antibiotic
prescribing

the governing institution
needs to be implemented
in order to successfully
implement an effective
antimicrobial stewardship
program.
-Future studies should
focus on increasing the
awareness of the effect of
patient pressures and
institutional constraints
have on providers
inappropriately
prescribing ABX and
ways to address and
reduce these barriers.
Conclusions

The study found that
providers often intend on
prescribing antibiotics
appropriately. However,
patient gaps in
knowledge and perceived
patient demands were
identified as significant
barriers that influence
appropriate antibiotic
prescribing practices,
especially in the
treatment of ARIs. ASP

treatment of
acute respiratory
infections
(ARIs)?

Objective:
1) To examine
provider perceptions
regarding appropriate
antibiotic use
2) Identify provider
acceptability of
proposed ASP
interventions to
improve antibiotic use
in the treatment of
ARIs in the outpatient
setting.
Methods: The semistructured interview
questions were
developed using the
Theory of Planned
Behavior (TPB) to
assess providers
beliefs and attitudes,
behavior control,
perceptions of societal
norms, and planned
future behaviors for
managing ARIs.

practices would be
well received.
-Perceived barriers
to appropriate
antibiotic
prescribing
included patient
demand, time
constraints, and
resource
limitation.
Behavioral
Control:
-Providers felt they
have full control in
regard to
prescribing or
withholding
antibiotics.
Social Norms:
-Providers
perceived that poor
peer practices and
lack of patient
education play a
role in driving
patient demands
for antibiotics.
Planned Future
Behaviors:
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efforts should utilize
audit-feedback and
shared decision-making
communication strategies
specifically tailored to
consider time constraints,
available resources, and
perceived patient
demands.

Title/Author/Date/Journal

Variability of antibiotic
prescribing in a large
healthcare network
despite adjusting for
patient-mix:
Reconsidering targets for
improved prescribing.
Jung, Sexton, Owens, Spell,
& Fridkin. 2019. Infectious
Diseases Society of
America.

Theoretical/
Conceptual
Framework
Not explicitly
stated

Research
Question(s)/
Hypotheses
What patientspecific and
provider-specific
factors contribute
to inappropriate
antibiotic
prescribing in the
outpatient
setting?
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Methodology

Objective: identify
predictors of
inappropriate antibiotic
(ABX) prescribing for
acute respiratory
infections (ARIs) in
the outpatient setting.
Design: crosssectional study of
patient encounters
presenting with
diagnoses of ARIs in

-Provider’s
perceived that
patient demands
play the largest
role in
inappropriate
antibiotic
prescribing.
-Viable solutions
to address the issue
of perceived
patient demand
included the use of
audit-feedback and
communication
strategies.
Analysis &
Results
-Of the 9600
patient encounters,
more than half
(53.4%) resulted in
an ABX
prescription.
-When prescribing
rates were
modified to
include only ARI
antibioticinappropriate
categories, median

Conclusions

-Significant predictors of
antibiotic prescribing
included: Caucasian race,
older age, and presence
of co-morbid conditions.
-More than 50% of
patients with a diagnosis
of an ARI received an
antibiotic during the twoyear study period. Based
on a an ARI target
prescribing rate of 20%
or less, the data suggests

15 primary care clinics
between 2015 to 2017.
Variables:
-ARI diagnoses by
ICD-10 code. To
evaluate ABX
appropriateness,
antibiotic-appropriate
ICD codes were
excluded including
sinusitis, pharyngitis,
and tonsillitis)
-Patient-Level
Variables: categorized
by race, age, and
presence of comorbid
conditions.
-Provider-Level
Variables: categorized
by professional
training including
physicians, NPs, PAs,
and resident
physicians.
Methods:
- Proportions &
adjusted odds ratios
(aOR) to determine
antibiotic prescribing
rates.
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provider
prescribing rate
remained high at
43%.
-Antibiotic
prescribing rates
were higher in
white patients
(aOR= 1.59),
patients 51 years
or older
(aOR=1.32), and
patients with
comorbid
conditions
(aOR=1.19)
-According to
provider-type,
antibiotic
prescribing rates
were lowest in
resident physician
providers, and no
difference was
found to exist
between NP/PA
and physicians.
-Significant
differences in
antibiotic

that >30% of the patients
unnecessarily received an
antibiotic.
-Resident physicians had
the lowest prescribing
rates out of all provider
types. All residents
within these 15 clinics
are required to rotate with
infectious disease during
their training. Provider
knowledge, beliefs and
attitudes (KAP) may play
a role in prescribing
rates.
-The major clinic-specific
differences noted merits
further investigation into
prescribing behaviors.

-Multivariable logistic
regression analysis
used to identify
predictive
characteristics of
antibiotic prescribing.
Sample Size:
-A total of 9600
(N=9600) of the
10,362 visits met
inclusion criteria.
-After excluding
providers with less
than 10 encounters,
these patients were
seen by 109 providers
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prescribing rates
were found to exist
between clinics.

Appendix B
Healthcare Provider Questionnaire

Figure B1. Provider questionnaire, page 1 of 2. Developed by Teixeira Rodrigues et al.,
2016, https://bmcinfectdis.biomedcentral.com/track/pdf/10.1186/s12879-015-1332-y
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Appendix B
Healthcare Provider Questionnaire

Figure B2. Provider questionnaire, page 2 of 2. Developed by Teixeira Rodrigues et al.,
2016, https://bmcinfectdis.biomedcentral.com/track/pdf/10.1186/s12879-015-1332-y
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Appendix C
Adapted Healthcare Provider Questionnaire
EXPLANATION
This survey has been adapted from a pre-validated questionnaire developed by
Teixeira-Rodrigues et al. (2016). The questionnaire is intended to collect data on health
care provider's knowledge, attitudes, perceptions, and prescribing behaviors involved
in the use of antibiotics and resistance in the clinical setting. The survey and question
responses will be used as part of the completion of a Doctor of Nursing Practice
Scholarly Project, a requirement of the Pittsburg State University Graduate Nursing
program. Participation is completely voluntary. No identifying information will be
obtained or used in the final publication. All responses are anonymous. Thank you for
taking the time to complete this survey, your responses are greatly valued!
FILLING INSTRUCTIONS
In the left column are the questions that will be the subject of your evaluation. To the
right of each question there is a continuous scale where you will use the slider to mark
the place where, according to your opinion represents your agreement with the text
comment. If you are totally in disagreement, you should place the slider at the left end,
and as your agreement increases you should move the slider to the right.

ABOUT ANTIBIOTICS AND RESISTANCES: Use the slider to select your level of
agreement with each statement below, from zero (totally disagree) to 100 (totally agree).
Totally Disagree
1. Antibiotic resistance is an
important Public Health problem
in our setting.
2. In a primary-care context, one
should wait for the microbiology
results before treating an
infectious disease.
3. Rapid and effective diagnostic
techniques are required for
diagnosis of infectious diseases.
4. The prescription of an
antibiotic to a patient does not
influence the possible
appearance of resistance.
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Totally Agree

5. I am convinced that new
antibiotics will be developed to
solve the problem of resistance.
6. The use of antibiotics on
animals is an important cause of
appearance of new resistance to
pathogenic agents in humans.
7. In case of doubt, it is
preferable to use a widespectrum antibiotic to ensure
that the patient is cured of an
infection.
8. I frequently prescribe an
antibiotic in situations in which
it is impossible for me to
conduct a systematic follow-up
of the patient.
9. In situations of doubt as to
whether a disease might be of
bacterial etiology, it is preferable
to prescribe an antibiotic.
10. I frequently prescribe
antibiotics because patients insist
on it.
11. I sometimes prescribe
antibiotics so that patients
continue to trust me.
12. I sometimes prescribe
antibiotics, even when I know
that they are not indicated
because I do not have the time to
explain to the patient the reason
why they are not called for.
13. If a patient feels that he/she
needs antibiotics, he/she will
manage to obtain them without a
prescription, even when they
have not been prescribed.
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14. Two of the main causes of
the appearance of antibiotic
resistance are patient selfmedication and antibiotic
misuse.
15. Dispensing antibiotics
without a prescription should be
more closely monitored.
16. In a primary-care context,
amoxicillin is useful for treating
most respiratory infections.
17. The phenomenon of
resistance to antibiotics is
mainly a problem in hospital
settings.

IN THE TREATMENT OF RESPIRATORY TRACT INFECTIONS, HOW
WOULD YOU RATE THE USEFULLNESS OF EACH OF THESE
RESOURCES OF KNOWLEDGE?:
Totally Disagree

Totally
Agree

18. Clinical practice
guidelines.
19. Documentation furnished
by the Pharmaceutical
Industry.
20. Courses held by the
Pharmaceutical Industry.
21. Information furnished by
Medical Information
Officers.
22. Previous Clinical
Experience.
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23. Continuing Education
Courses.
24. Others, e.g., contribution
of specialists
(microbiologists, infectious
disease specialists, etc.).
25. Contribution of peers (of
the same specialization).
26. Data collected via the
internet.

SOME QUESTIONS ABOUT SOCIODEMOGRAPHIC DATA AND ABOUT
YOUR CLINICAL PRACTICE
27. How old are you? _____years

31. Do you work at the emergency
service?
1 Yes
2 No

28. Gender:
1 Female

32. Approximately, what is the number of
patients seen per day? _______patients

2 Male
33.Approximatley, how much time do you
need to attend to one patient?
_____minutes
29. What type of activity?
1 Public Practice
2 Private Practice
3 Both
30. In which workplace?
1 Hospital Care
2 Primary Care
3 Both
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DO YOU HAVE SOME SUGGESTIONS ABOUT ANTIBIOTIC USE AND
RESISTANCES?

Figure C1. Adapted healthcare provider questionnaire. Adapted from Teixeira Rodrigues
et al., 2016, https://bmcinfectdis.biomedcentral.com/track/pdf/10.1186/s12879-015-1332y
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Appendix D
Summary of Appropriate Antibiotic Use Recommendations for ARTIs in Adults

Figure D1. The american academy of physicians and centers for disease control and
prevention advice for high-value care on appropriate use to antibiotics for acute
respiratory tract infections in adults, page 1 of 1. Developed by Harris, Hicks, and
Qaseem, 2016, http://www.ashnha.com/wp-content/uploads/2015/05/ACP-URIguidelines-1.pdf
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Appendix E
Diagnosis and Treatment of Respiratory Illness in Children and Adults Algorithms

Figure E1. Institute for Clinical Systems Improvement (ICSI): Diagnosis and treatment
of respiratory illness main algorithm, page 1 of 4. Developed by Short et al., 2017,
https://www.icsi.org/_asset/pwyrky/RespIllness.pdf
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Appendix E
Diagnosis and Treatment of Respiratory Illness in Children and Adults Algorithms

Figure E2. Institute for Clinical Systems Improvement (ICSI): Diagnosis and treatment
of respiratory illness acute pharyngitis algorithm, page 2 of 4. Developed by Short et al.,
2017, https://www.icsi.org/_asset/pwyrky/RespIllness.pdf
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Appendix E
Diagnosis and Treatment of Respiratory Illness in Children and Adults Algorithms

Figure E3. Institute for Clinical Systems Improvement (ICSI): Diagnosis and treatment
of respiratory illness non-infectious rhinitis algorithm, page 3 of 4. Developed by Short et
al., 2017, https://www.icsi.org/_asset/pwyrky/RespIllness.pdf
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Appendix E
Diagnosis and Treatment of Respiratory Illness in Children and Adults Algorithms

Figure E4. Institute for Clinical Systems Improvement (ICSI): Diagnosis and treatment
of respiratory illness acute sinusitis algorithm, page 4 of 4. Developed by Short et al.,
2017, https://www.icsi.org/_asset/pwyrky/RespIllness.pdf
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Appendix F
Four Core Elements of Outpatient Antibiotic Stewardship

Figure F1. The centers for disease control and prevention four core elements of
outpatient antibiotic stewardship, page 1 of 1. Developed by Sanchez et al., 2016,
https://www.cdc.gov/antibiotic-use/community/pdfs/16_268900A_CoreElementsOutpatient_508.pdf
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Appendix G
IRB Approval

Figure G1. Pittsburg state university IRB approval, page 1 of 2.
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Appendix G
IRB Approval

Figure G2. Pittsburg state university IRB approval, page 2 of 2.
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Appendix H
Site Approval Letters

Figure H1. Site approval letter, page 1 of 3.
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Appendix H
Site Approval Letters

Figure H2. Site approval letter, page 2 of 3.
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Appendix H
Site Approval Letters

Figure H3. Site approval letter, page 3 of 3.
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Appendix I
Targeted Education Resources for Patients

Figure I1. Examination room written public commitment to patients concerning the use
of antibiotics, page 1 of 1. Developed by CDC, 2020, https://www.cdc.gov/antibioticuse/week/pdfs/Commitment-Poster-english-11x17.pdf
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Appendix I
Targeted Education Resources for Patients

Figure I2. Improving antibiotic use, page 1 of 2. Developed by CDC, 2020,
https://www.cdc.gov/antibiotic-use/community/pdfs/aaw/au_improving-antibioticsinfographic_8_5x11_508.pdf
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Appendix I
Targeted Education Resources for Patients

Figure I2. Improving antibiotic use, page 2 of 2. Developed by CDC, 2020,
https://www.cdc.gov/antibiotic-use/community/pdfs/aaw/au_improving-antibioticsinfographic_8_5x11_508.pdf
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Appendix I
Targeted Education Resources for Patients

Figure I3. Antibiotics are not always the answer brochure, page 1 of 2. Developed by
CDC, 2020, https://www.cdc.gov/antibioticuse/community/pdfs/aaw/AU_trifold_8_5x11_508.pdf
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Appendix I
Targeted Education Resources for Patients

Figure I3. Antibiotics are not always the answer brochure, page 2 of 2. Developed by
CDC, 2020, https://www.cdc.gov/antibioticuse/community/pdfs/aaw/AU_trifold_8_5x11_508.pdf
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Appendix I
Targeted Education Resources for Patients

Figure I4. Acute upper respiratory etiology and antibiotic indications, page 1 of 1.
Developed by CDC, 2020, https://www.cdc.gov/antibioticuse/community/pdfs/aaw/AU_viruses-or-bacteria-Chart_508.pdf
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Appendix I
Targeted Education Resources for Patients

Figure I5. Prevention and treatment of acute bronchitis, page 1 of 2. Developed by CDC,
2020, https://www.cdc.gov/antibiotic-use/community/downloads/Preventing-TreatingBronchitis-p.pdf
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Appendix I
Targeted Education Resources for Patients

Figure I5. Prevention and treatment of acute bronchitis, page 2 of 2. Developed by CDC,
2020, https://www.cdc.gov/antibiotic-use/community/downloads/Preventing-TreatingBronchitis-p.pdf
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Appendix I
Targeted Education Resources for Patients

Figure I6. Prevention and treatment of ear infection, page 1 of 2. Developed by CDC,
2019, https://www.cdc.gov/antibiotic-use/community/downloads/preventing-andtreating-ear-infections-h.pdf
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Appendix I
Targeted Education Resources for Patients

Figure I6. Prevention and treatment of ear infection, page 2 of 2. Developed by CDC,
2019, https://www.cdc.gov/antibiotic-use/community/downloads/preventing-andtreating-ear-infections-h.pdf
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Appendix I
Targeted Education Resources for Patients

Figure I7. Q & A for parents for child with runny nose and cold, page 1 of 1. Developed
by CDC, 2019, https://www.cdc.gov/antibiotic-use/community/pdfs/runny-nose-bwfaqs.pdf
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Appendix J
Targeted Education Resources for Providers

Figure J1. Instructions for symptomatic relief of viral illness, page 1 of 1. Developed by
CDC, 2020, https://www.cdc.gov/antibiotic-use/community/pdfs/aaw/CDCAU_RCx_Relief_for_Viral_Illness_sm_v8_508.pdf
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Appendix J
Targeted Education Resources for Providers

Figure J2. Instructions for watchful waiting, page 1 of 1. Developed by CDC, 2020,
https://www.cdc.gov/antibiotic-use/community/pdfs/aaw/Watchful-Waiting-PrescriptionPads_small-P.pdf
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Appendix J
Targeted Education Resources for Providers

Figure J3. Instructions for delayed prescription, page 1 of 1. Developed by CDC, 2020,
https://www.cdc.gov/antibiotic-use/community/pdfs/aaw/CDCAU_RCx_Delayed_Prescribing_sm_v9_508.pdf
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Appendix J
Targeted Education Resources for Providers

Figure J4. Instruction for taking antibiotics, page 1 of 1. Developed by CDC, 2020,
https://www.cdc.gov/antibiotic-use/community/pdfs/aaw/CDCAU_RCx_Taking_Your_Antibiotics_sm_v8_508.pdf
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Appendix K
Antibiotic Use and Resistance Awareness Posters

Figure K1. Eight key ways to be antibiotics aware poster, page 1 of 1. Developed by
CDC, 2020, https://www.cdc.gov/antibiotic-use/community/materials-references/printmaterials/index.html
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Appendix K
Antibiotic Use and Resistance Awareness Posters

Figure K2. Five important facts about antibiotic resistance poster, page 1 of 1. Developed
by CDC, 2020, https://www.cdc.gov/drugresistance/resources/digital_materials.html
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Appendix K
Antibiotic Use and Resistance Awareness Posters

Figure K3. Antibiotics are not indicated for the treatment of viral illness poster, page 1 of
1. Developed by CDC, 2020, https://www.cdc.gov/antibiotic-use/community/materialsreferences/print-materials/index.html
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Appendix K
Antibiotic Use and Resistance Awareness Posters

Figure K4. Antibiotic resistance global threat awareness poster, page 1 of 1. Developed
by CDC, 2020, https://www.cdc.gov/drugresistance/resources/digital_materials.html

220

Appendix K
Antibiotic Use and Resistance Awareness Posters

Figure K5. Improve antibiotic use awareness poster, page 1 of 1. Developed by CDC,
2020, https://www.cdc.gov/antibiotic-use/week/toolkit.html#anchor_1538597291
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Appendix L
Antibiotic Resistance (AR) Solutions Initiative

Figure L1. Overview of the CDCs antibiotic resistance (AR) solutions initiative in
healthcare settings, page 1 of 1. Developed by CDC, 2020,
https://www.cdc.gov/drugresistance/pdf/cdc-antibiotic-stewardship.pdf
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Appendix L
Antibiotic Resistance (AR) Solutions Initiative

Figure L2. Overview of the CDC’s antibiotic resistance (AR) initiative national
investment factsheet, page 1 of 1. Developed by CDC, 2019,
https://wwwn.cdc.gov/ARInvestments/PDFDocs/Strategy.pdf
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Appendix L
Antibiotic Resistance (AR) Solutions Initiative

Figure L3. Antibiotic resistance (AR) solutions initiative investments state of Missouri
factsheet, page 1 of 2. Developed by CDC, 2019,
https://wwwn.cdc.gov/ARInvestments/PDFDocs/Missouri-CDC-AR-Investments.pdf
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Appendix L
Antibiotic Resistance (AR) Solutions Initiative

Figure L3. Antibiotic resistance (AR) solutions initiative investments state of Missouri
factsheet, page 2 of 2. Developed by CDC, 2019,
https://wwwn.cdc.gov/ARInvestments/PDFDocs/Missouri-CDC-AR-Investments.pdf
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Appendix L
Antibiotic Resistance (AR) Solutions Initiative

Figure L4. Antibiotic resistance (AR) solutions initiative investments state of Kansas
factsheet, page 1 of 1. Developed by CDC, 2019,
https://wwwn.cdc.gov/ARInvestments/PDFDocs/Kansas-CDC-AR-Investments.pdf
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